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1.!SUMMARY!
Male! infertility! affects! 7%! of! the! general! population! and! the! etiology! is! most! frequently!
related! to! primary! testicular! failure.! Half! of! the! cases! of! impaired! spermatogenesis! still!
remain!unexplained!and!are!referred!to!as! idiopathic!male!factor! infertility;!such!cases!are!
likely!to!conceal!a!not!yet!identified!genetic!or!epigenetic!origin.!This!thesis!aims!at!studying!
the! genetic! and! epigenetic! aspects! of! spermatogenesis,! with! the! ultimate! scope! of!
identifying!novel!causes!potentially!leading!to!male!infertility.!
From!the!genetic!standpoint,!the!enrichment!on!the!Y!and!X!chromosomes!of!genes!involved!
in!gonadal!development/differentiation!and/or!predominantly!expressed!in!the!testis!made!
both! sex! chromosomes! an! especially! promising! target! of! investigation! in! the! attempt! of!
discovering!new!genetic! factors! leading! to!male! infertility.! In! this! thesis,! special! focus!was!
given! to! Copy! Number! Variations! (CNVs),! which! have! been! reported! as! important!
contributors! to! a! number! of! complex! diseases,! including! male! infertility.! Firstly,! a! highS
resolution!arraySCGH!platform!specific!for!the!X!chromosome!was!used!to!obtain!an!outline!
of!XSlinked!CNVs!in!infertile!patients!compared!to!normozoospermic!controls,!and!led!us!to!
the!discovery!that!men!with!spermatogenic!impairment!display!a!higher!burden!of!CNVs!in!
terms!of!both!mean!number!and!mean!extension!(size! in!kb).!This!pilot!study!also!allowed!
identifying!8!CNVs!with!potential! clinical! interest.!On!one!hand,! three! recurrent!deletions,!
mapping!to!the!Xq27.3! (CNV64)!and!Xq28! (CNV67!and!CNV69),!drew!our!attention!for! the!
exclusive!(CNV67)!or!prevalent!(CNV64!and!CNV69)!occurrence!in!patients.!In!our!followSup!
study,!sixShundred!and!twentySseven!idiopathic!patients!and!628!normozoospermic!controls!
coming!from!two!Mediterranean!populations!(Spanish!and!Italian)!were!further!screened!for!
these! deletions.! The! molecular! characterization! of! the! deletions’! breakpoint! was! also!
performed! and! intersecting! functional! elements! were! explored.! Our! data! showed! that!
CNV64! and! CNV69! were! significantly! more! frequent! in! patients! than! controls! (p=0.013;!
OR=1.89;! 95%! CI! 1.1! to! 3.3,! and! p=0.023;! OR=2.204;! 95%! CI! 1.05! to! 4.62,! respectively).!
CNV69!displayed! at! least! two!deletion!patterns! (type!A! and! type!B),! of!which! type!B! (the!
larger!one)!was!significantly!more!represented!in!patients!than!controls,!thus!may!account!
for! the! potential! deleterious! effect! of! CNV69! on! sperm! production.! No! genes! have! been!
identified!within! CNV64! and! CNV69,! nevertheless! a! number! of! regulatory! elements,! have!
been!found!to!be!potentially!affected.!CNV67!deletion!was!exclusively!found!in!patients!at!a!
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frequency! of! 1.1%! (p<0.01)! and! a! resemblance! to! the! AZFc! region! on! the! Y! chromosome!
might! be! speculated.! This! deletion! may! involve! the! CTA! gene! MAGE9A! and/or! of! its!
regulatory! elements.! It! may! also! affect! regulatory! elements! of! HSFX1/2! showing! testisS
specific!expression.!Pedigree!analyses!of!two!CNV67!carriers!indicated!that!CNV67!deletion!
is! maternally! inherited.! One! of! these! families! was! especially! informative! since,! of! two!
brothers,! the! carrier! displayed! a! pathological! semen! phenotype! whereas! his! nonScarrier!
brother!had!a!normozoospermic!phenotype,!strongly!suggesting!the!pathogenic!effect!of!the!
CNV67!on!spermatogenesis.!Our!second!followSup!study!focused!on!the!copy!number!state!
of! the!five!selected!patientSspecific!gains!on!the!X!chromosome!and!quantitativeSPCR!on!a!
total! of! 276! idiopathic! infertile! patients! and! 327! controls! in! a! conventional! caseScontrol!
setting! and! for! one! interesting! locus! (intersecting! DUP1A)! additional! 338! subjects! were!
analyzed.! This! study!highlighted!a! statistically! significant!difference! in! the!duplication! load!
between! patients! and! controls! (p=1.65x10S4).! Two! of! the! CNVs! were! private! variants,!
whereas!3!were!found!recurrently!in!patients!and!never!among!controls.!These!CNVs!include,!
or! are! in! close!proximity! to,! genes!with! testisSspecific! expression.!DUP1A,!mapping! to! the!
PAR1,!was!found!at!the!highest!frequency!(1.4%)!that!was!significantly!different!compared!
to! controls! (p=0.047! after! Bonferroni! correction).! !DUP1a! includes! a! long!nonScoding!RNA!
(LINC00685)! that! potentially! acts! as! a! negative! regulator! of! a! gene!with! predicted! role! in!
spermatogenesis,! PPP2R3B.! Therefore,! we! hypothesized! that! DUP1A! may! cause!
spermatogenic!failure!by!affecting!the!correct!regulation!of!the!PPP2R3B9gene!due!to!a!gene!
dosageSmisbalance!effect.!As!an!alternative!hypothesis,!due! to! its! size!and! location! it!may!
disturb!XSY!recombination!between!PAR1!regions!during!meiosis.!
Secondly,!we!performed!a!study!on!the!SHOX!gene!in!order!to!evaluate!the!reliability!of!the!
previously!reported!association!between!YSchromosome!microdeletions!and!SHOX!CNVs,!in!
particular! deletions.! In! our! screening,! none! of! the! men! with! microdeletions! had! SHOX!
deletions,! contrasting! the!aforementioned!hypothesis! that!microdeletions!carriers!are!at!a!
higher! risk! of! developing! pathologies! caused! by! SHOX! haploinsufficiency.! These! data!
represent!an!important!contribution!to!the!genetic!counseling!of!infertile!couples!since!our!
results! reassure! that! the! only! established! risk! for! ART! offspring! born! from! men! carrying!
chromosome!microdeletions! remains! spermatogenic! impairment!and!designates! the!SHOX!
screening!as!an!utterly!unnecessary!practice.!
From!the!epigenetic!standpoint,!a!highSresolution!methylation!microarray!was!employed!to!
obtain! a! comprehensive! outline! of! the! “normal”! sperm! DNA!methylome,! by! defining! the!
methylation! pattern! of! >450,000! CpGs! in! normozoospermic! semen! samples.! Our! study,!
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based!on!the!largest!number!of!subjects!(n=8)!ever!considered!for!such!a!great!quantity!of!
CpGs,! provided! data! able! to! determine! that! the! sperm! DNA!methylation! profile! is! highly!
conserved!among!normozoospermic!subjects!and,!for!the!first!time,!we!demonstrated!that!
this! pattern! in! normozoospermic! men! remains! highly! uniform! regardless! the! quality! of!
sperm!subpopulations.!In!addition,!our!analysis!provided!both!confirmatory!and!novel!data!
concerning! the! sperm! DNA! methylome,! including! its! differential! features! in! relation! to!
somatic!and!cancer!cells.!!
The!widespread!use!of!Assisted!Reproductive!Technology!(ART),!which!allows!infertile!men!
to! father! children,! urges! the! identification! of! undiscovered! causes! and! a! better!
understanding! of! known! ones,! in! order! to! predict! the! consequences! on!
reproductive/general! health! of! patients! and! their! future! offspring.! The!work! presented! in!
this! thesis! represents! an! important! progress! in! the! field! of! idiopathic!male! infertility.! The!
identification! of! novel! factors! that! could!make! a!man! infertile! is! of! particular! importance!
especially!nowadays!in!the!era!of!ART.!Herein,!we!present!data!about!novel!genetic!factors!
associated! to! spermatogenic! impairment! that,! if! confirmed! in! separate! study! populations,!
could!lead!to!a!novel!genetic!test,!which!may!become!part!of!the!routine!diagnostic!work!up!
of! infertile!men.!We!also!provide!novel! insights! into! the! sperm!DNA!methylome!providing!
solid!basis!for!future!both!basic!and!clinically!oriented!research.!
!
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2.!INTRODUCTION!
2.1!Male!Infertility!
2.1.1.9Definition9and9Etiology9
Infertility! is! defined! as! the! inability! of! a! couple! to! become! pregnant! after! one! year! of!
unprotected!intercourse!(WHO,!2010).!Statistics!prove!that!the!incidence!of!this!condition!is!
of!about!15%!in!Western!countries:!in!any!given!year,!about!one!out!of!seven!couples!willing!
to!conceive!is!not!able!to!do!so.!Since!a!male!factor!is!found!in!half!of!involuntarily!childless!
couples,!it!must!be!assumed!that!approximately!7%!of!all!men!are!confronted!with!fertility!
problems.!Mostly,!male!factor!infertility!manifests!as!abnormal!semen!parameters!–reduced!
sperm! number,! motility! and! morphologyS! or! as! alterations! of! the! physicalSchemical!
characteristics!of! the! seminal! fluid.! The!World!Health!Organization! (WHO)!established! the!
reference!ranges!for!normal!values!of!sperm!parameters,!which!are! included! in!the!recent!
upSdated! version! of! the! guidelines! for! the! examination! and! processing! of! human! semen!
(WHO!2010).!The!possible!sperm!number!alterations!are!represented!by:!i)!total!absence!of!
spermatozoa! in! the! ejaculate! where! spermatozoa! cannot! be! detected! even! after!
centrifugation! of! the! semen! sample! (azoospermia);! ii)! reduction! of! sperm! concentration!
below!15!million!spermatozoa/ml!(oligozoospermia).!Three!forms!of!oligozoospermia!can!be!
distinguished:! moderate,! when! sperm! concentration! is! between! 15S10! million!
spermatozoa/ml;! severe,! when! sperm! concentration! is! below! 5! million! spermatozoa/ml;!
cryptozoospermia,!when!spermatozoa!are!detectable!only!after!cytocentrifugation!(in!these!
cases!a!concentration!of!<0.01!million!spermatozoa/ml!is!conventionally!indicated).!
When! it!comes!to!motility,! the!reduction!<32%!of!progressively!motile!spermatozoa! in!the!
ejaculate! defines! a! disorder! called! asthenozoospermia.! As! for!morphology,!we! define! the!
condition!of!teratozoospermia! in!those!cases!where!the!ejaculate!presents! less!than!4%!of!
morphologically!normal!sperm!forms.!The!majority!of!infertile!patients!display!anomalies!in!
all!three!sperm!parameters!simultaneously!and!suffer!a!condition!conventionally!defined!as!
oligoSasthenoS!teratozoospermia.!
Overall,! the! etiology! of! male! infertility! can! be! related! to! a! wide! range! of! congenital! and!
acquired!factors!acting!at!a!preStesticular,!testicular!and!postStesticular!level!(Krausz,!2011).!
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PreStesticular!causes!accounts!for!10%!of!infertile!forms!and!are!mainly!represented!by!two!
types! of! pathological! conditions:! hypogonadotrophic! hypogonadism! and! coital! disorders!
(erectile! dysfunction! and! ejaculatory! disorders,! such! as! eiaculatio9 precox! and! retrograde!
ejaculation).! Primary! testicular! dysfunction! is! the! most! common! cause! of! spermatogenic!
impairment!(75%!of!cases)!and!is!related!to!a!number!of!acquired!and!congenital!etiological!
factors! (testicular!causes).!A! large!number!of!pathologies!may! lead!to!an!acquired!primary!
testicular! failure.! Among! them! are! orchitis,! testis! trauma,! torsions,! iatrogenic! forms!
(gonadotoxic! medications,! chemo/radiotherapy,! previous! inguinal! surgery)! and! some!
systemic! diseases.! Anorchia,! cryptorchidism! (especially! bilateral! forms)! and! genetic!
abnormalities! such! as! karyotype! anomalies! and! Y! chromosome! microdeletions! are! wellS
defined!congenital!testicular!factors!of!male!infertility.!
PostStesticular! causes! represent! 15%! of! cases! and! include! both! congenital! forms! of!
obstruction/subSobstruction! of! the! seminal! tractS! such! as! congenital! absence! of! the! vas!
deferens! (CBAVD)S! and! acquired! forms,! which! develop! from! infections/inflammatory!
diseases!of!accessory!glands!or!to!immunological!causes.!
The!anamnesis,!physical!examination!and!semen!analysis!are!of!fundamental!importance!to!
achieve! an! accurate! diagnosis,! thus! to! reliably! orientate! the! patient! to! further! analyses,!
therapies!or,!should!these!not!be!applicable,!to!artificial!reproduction!techniques!(ART).!
2.1.29Genetics9of9Male9Infertility9
Diagnostic9Features9
With!the!introduction!and!worldwide!diffusion!of!assisted!reproductive!techniques!(ART)!for!
the! treatment!of!spermatogenesis!defects! in! the!male!partner,!many! infertile!or!subfertile!
men! can! now! father! their! own! biological! children.! While! males! with! impaired! sperm!
production!due!to!a!genetic!factor!may!now!benefit!from!the!wide!availability!and!utilization!
of!ART,!the!potential!risk!of!transmitting!genetic!defects!to!the!offspring!deserves!thoughtful!
consideration.! It! is! therefore! of! great! importance! to! detect! any! genetic! anomaly! before!
proceeding!to!the!application!of!ART.!
During! the! last! 30! years,! the! field! of! molecular! genetics! experienced! an! undeniably!
pronounced! progress! with! the! delivery! of! new! diagnostic! tools! that! allowed! the!
identification! of! genetic! anomalies! responsible! for! spermatogenic! impairment.! However,!
known! genetic! factors! collectively! explain! only! 10S15%! of! all! cases! of!male! infertility! and!
despite! the! advances! achieved! in! the! diagnostic! workup! of! the! infertile! male,! the!
etiopathogenesis! of! testicular! failure! remains! undefined! in! about! 50%!of! cases,!which! are!
! 8!
referred! to! as! “idiopathic”.! This! lack! of! understanding! significantly! limits! the! ability! to!
counsel! patients! regarding! prognosis! for! treatment! or! to! optimize! personalized! treatment!
strategies! for! individual! patients.! In! addition,!without! the! identification!of! the! cause! for! a!
man’s! infertility,! it! is! impossible! to! tell!patients! the! likelihood!of! infertility! in! the!offspring!
that!might!result!from!ART.!To!date,!only!a!limited!set!of!genes!is!screened!in!the!evaluation!
of!the!infertile!male!and!include:!!
i) The! analysis! of! the! AR! gene! in! male! with! suspected! mild! form! of! androgen!
insensitivity;!!
ii) Mutation! analysis! of! a! growing! number! of! candidate! genes! in! case! of! congenital!
hypogonadotrophic! hypogonadism,! including! KAL1! (Kallmann! syndrome! 1),!
FGFR1! (Fibroblast!Growth!Factor!Receptor!1)!o!KAL2,!FGF8! (Fibroblast!Growth!
Factor! 8),! PROK2! (ProkineticinS2),! PROKR2! (GSproteinScoupled! receptor! 54),!
GnRH! (GonadotrophinSreleasing! hormone),! GnRHSR! (GonadotrophinSreleasing!
hormone!receptor),!GPR54!(GSproteinScoupled!receptor!54),!LH,!FSH9and!others!
(Bonomi,!2012).!
iii) The!screening! for!CFTR! gene!mutations! in!men!with!congenital!absence!of! the!vas!
deferens!(CAVD)!without!kidney!malformations.!
The! aboveSmentioned! genetic! analyses! are! performed! only! in! selected! cases! when! clear!
evidence! of! the! associated! phenotype! exists.! When! it! comes! to! the! routine! diagnostic!
workup! of! oligo/azoospermic! men,! only! two! genetic! tests! are! currently! performed:! the!
karyotype!analysis!for!the!identification!of!chromosomal!anomalies!and!the!YSchromosome!
microdeletion!screening!(described!in!paragraph!2.3.2).!
Chromosomal9Anomalies9
Chromosomal! aberrations! are! the! consequence! of!meiotic! errors! and! can! be! classified! as!
either! numerical! or! structural.! Since! the! first! description! of! an! extra! X! chromosome! in!
association!with!azoospermia! (FergusonSSmith!et!al.,!1957)!many! investigations!have!been!
performed!to!determine!the!contribution!of!chromosomal!anomalies!to!male! infertility.!All!
these!studies!converge!on!the!hypothesis!of!a!direct!relationship!between!the!frequency!of!
chromosomal!anomalies!and!the!severity!of!the!testicular!phenotype.!For!instance,!patients!
with!<10!million!spermatozoa/ml!in!the!ejaculate!show!10Sfold!increased!incidence!(4%)!of!
carrying! autosomal! structural! abnormalities! compared! to! the! general! population.! Among!
severe!oligozoospermic!men!(<5!million!spermatozoa/ml),! the!frequency! is!doubled!to!8%,!
whereas!men!with! nonSobstructive! azoospermia! apparently! reach! the! highest! values! (15–
16%)! and!abnormalities! are!mainly! related! to! the! sex! chromosomes.! Klinefelter! syndrome!
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(47,!XXY)!represents!the!most!common!karyotype!anomaly!in!azoospermia!and!severe!male!
factor! infertility.! About! 80%! of! patients! bear! a! 47,XXY! karyotype! whereas! the! other! 20%!
represented!either!by!47,XXY/46,XY!mosaics!or!higher!grade!sex!chromosomal!aneuploidy!or!
structurally!abnormal!X!chromosome!(Krausz,!2011).!
A!frequent!chromosome!abnormality!associated!with!azoospermia!is!attributed!to!terminal!
deletions!of!the!long!arm!of!the!Y!chromosome!(YqS),!also!visible!at!the!karyotype!analysis.!
These!large!deletions!can!derive!from!the!formation!of!complex!structural!abnormalities!of!
the! Y! chromosome,! such! as! the! isodicentric! (idicYp)! and! the! isochromosome! (isoYp)! Y!
chromosome.!The!idicYp!is!characterized!by!the!duplication!of!the!short!arm!(Yp)!and!of!the!
most! proximal! region! of! the! YqS! centromere! includedS! and! shows! the! deletion! of! the!
terminal!part!of!the!Yq.!The!isoYp!is!a!monocentric!Y!chromosome!(only!one!centromere!is!
present)!showing!two!Yp!and!lacking!entirely!the!Yq!content.!IdicYp!and!isoYp!chromosomes!
are!among!the!more!common!genetic!causes!of!severe!spermatogenic! failure! in!otherwise!
healthy!men.! IdicYp!or! isoYp! formation! likely! interferes!with! sperm!production!via! several!
distinct!mechanisms.!First,!many!idicYp!and!all!isoYp!chromosomes!lack!distal!Yq!genes!that!
play! critical! roles! in! spermatogenesis! (Skaletsky! et! al.,! 2003).! Further,! idicYp! or! isoYp!
formation!leads!to!the!duplication!of!the!Yp!pseudoautosomal!region!and!deletion!of!the!Yq!
pseudoautosomal! region,! which! results! in! the! disruption! of! XSY! meiotic! pairing! and!
potentially!precludes!progression!through!meiosis!(Mohandas!et!al.,!1992).!The!presence!of!
two! centromeric! regions! makes! idicYp! chromosomes! mitotically! instable.! As! observed! in!
many! human! dicentric! chromosomes,! the!mitotic! stability! of! idicYp,! especially! those!with!
greater!intercentromeric!distances,!is!likely!to!rely!upon!the!functional!inactivation!of!one!of!
the! two!centromeric! regions.!However,! these!chromosomes! tend! to!be! lost!during!mitosis!
leading!to!the!generation!of!45,X!cell!lines!(45,!X!mosaicism).!
As! for! oligozoospermia,! the! most! frequently! found! abnormalities! are! Robertsonian!
translocations,! reciprocal! translocations,! paracentric! inversions! and!marker! chromosomes.!
The! importance! of! detecting! these! structural! chromosomal! anomalies! is! related! to! the!
increased! risk! of! aneuploidy! or! unbalanced! chromosomal! complements! in! the! fetus.! For!
example,!in!the!case!of!Robertsonian!translocations,!there!is!a!consistent!risk!of!uniparental!
disomies,! which! generate! through! a! mechanism! called! “trisomy! rescue”! (repairing! the!
trisomic!status)!during!the!first!division!of!the!zygote.!
This! correlation! between! both! numerical! and! structural! chromosomal! anomalies! and!
impaired! sperm!production!might!be! related! to! alterations! in! the!process!of! chromosome!
synapsis! during! meiosis.! Studies! in! mice! provided! evidence! that! asynapsed! regions! may!
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induce!the!meiotic!checkpoint!machinery!to!eliminate!spermatocytes!(Odorisio!et!al.,!1998).!
A! similar!mechanism!might! explain!why! some! chromosomal! abnormalities! in! humans! are!
associated! with! deficient! spermatogenesis.! Another! explanatory! mechanism! might! be!
related!to!a!structural!effect!of!chromosomal!disruptions!that!might!intersect!genes!involved!
in! spermatogenesis,! some! of! which! may! be! dosageSsensitive! and! potential! mutational!
targets!for!chromosomal!breakpoints.!
State9of9the9Art9in9Research9
Spermatogenesis! is! a! complex! process! regulated! by! the! concerted! action! of! thousands! of!
genes! (Hochstenbach!and!Hackstein,!2000),!but!only!a! small!proportion!has!been!hitherto!
identified! and! even! fewer! have! been! ever! analyzed.! Therefore,! there! is! a! high! probability!
that! a! wide!majority! of! idiopathic! spermatogenic! failure! has! a! genetic! origin! (Krausz! and!
Forti,! 2000).! The! discovery! of! new! genetic! associations! with! male! infertility! has! been!
hampered!by!two!main!factors.!First,!most!studies!are!underpowered!because!of!insufficient!
sample! size! and! ethnic/phenotypic! heterogeneity.! Second,! most! studies! evaluated! single!
candidate! genes,! a! very! inefficient! approach! in! the! context! of!male! infertility,! considering!
that! many! hundreds! of! thousands! genes! are! involved! in! the! process! of! testicular!
development! and! spermatogenesis.! The! soScalled! candidate! gene! approach! apparently!
identified!several!polymorphisms!showing!convincing!associations!with!male! infertility,!but!
the!risk!conferred!by!these!polymorphisms!is!modest!and!most!reported!associations!either!
exist!as!a!single!study,!or!they!fail!to!be!replicated!in!subsequent!studies;!therefore,!they!did!
not!found!any!application!in!the!clinical!practice!(Matzuk!and!Lamb,!2002;!Nuti!and!Krausz,!
2008).!However,!in!spite!of!the!limitations,!several!robust!associations!have!been!identified!
across!multiple!studies!representing!many!hundreds!of!individuals!including!SNPs!in!MTHFR,9
GSTM1!and!FSHB!(Tüttelmann!et!al.,!2012;!Wei!et!al.,!2012;!Song!et!al.,!2013).!The!scarcity!
of! informative! data! derived! from! studies! based! on! the! candidate! gene! approach! in! the!
search!of!mutations/polymorphisms!raised!questions!about!the!appropriateness!of!the!used!
classic!screening!approach!(Nuti!and!Krausz,!2008).!Evidently,!the!challenge!of!characterizing!
the! genetic! basis! of! male! infertility! is! certainly! a! function! of! the! complexity! of! the!
spermatogenic! process! and! underlies! the! significant! advantage! of! wholeSgenome!
approaches!for!discovery!research.!
The! analysis! of! sequence! variants! on! a! genomeSwide! scale! in! exceptionally! large! study!
populationsS!defined!as!Genome!Wide!Association!Study!(GWAS)!approachS!has!been!used!
for!the!identification!of!genetic!factors!in!several!other!complex!diseases.!In!the!field!of!male!
infertility,!four!genome!wide!SNP!association!studies!have!been!performed!so!far!(Aston!and!
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Carrell,! 2009;!Hu!et!al.,! 2012;!Kosova!et!al.,! 2012;! Zhao!et!al.,! 2012).! The! first!pilot! study,!
based!on!a!small!number!of!nonSobstructive!azoospermic!(NOA)!men!and!normozoospermic!
controls!of!European!descent!(Aston!and!Carrell,!2009)!and!the!extended!follow!up!study!on!
172! SNPs! performed! by! the! same! group! (Aston! et! al.,! 2010)! provided! evidence! for! some!
SNPs! as! potential! risk! factors! and! new! candidate! genes! for! impaired! sperm! production.!
However,!these!findings!have!not!been!confirmed!by!two!subsequent!GWAS!studies!based!
on!exceptionally! larger!series!of!NOA!subjects! (about!1000!cases)!and!controls! (more!than!
1500! subjects)! from! the! Han! Chinese! population! (Hu! et! al.,! 2012;! Zhao! et! al.,! 2012).!
Surprisingly,! the! results! from! these! two! studies,! based! on! the! same! population,! do! not!
display!any!overlap!because!different!genomic! regions!have!been! reported!as! significantly!
associated!with!NOA!phenotype!(1p13.3,!1p36.32!and!12p12.1,!by!Zhao!et!al;!6p22!by!Hu!et!
al).!Finally,! in!the!most!recent!male!infertility!GWAS!microarray!genotyping!was!performed!
in! 269!men!deriving! from!a! founder! population!of! European!descent! (the!Hutterites)! that!
desires! large! families! and! proscribes! contraception! (Kosova! et! al.,! 2012).! FortyStwo! SNPs!
associated! with! reduced! fertility! traits! in! the! Hutterites! were! evaluated! in! 123! ethnically!
different! infertile!men!and!only!nine!SNPs!were!significantly!associated!with!sperm!quality!
and/or!function!(Kosova!et!al.,!2012).!The!divergence!between!the!GWAS!studies!mentioned!
above!might!be!only!partially!related!to!ethnic!differences,!since!overlapping!candidate!SNPs!
could!not!be!found!even!in!the!two!large!GWAS!based!on!the!same!Chinese!population.!The!
inability! of! GWAS! approach! in! identifying! relevant! SNPs! involved! in! spermatogenic! failure!
may!actually!depend!on!the!fact!that!SNP!arrays!are!based!on!common!genetic!variants.!For!
instance,!it!has!been!predicted!that!it!is!more!likely!that!“rare”!variants!rather!than!common!
polymorphisms!are!involved!in!the!etiology!of!spermatogenic!impairment!(Aston!and!Carrell,!
2009).!Another!explanation!for!the!inconsistency!and!unsuccessful!outcome!of!GWA!studies!
may!be!that! the!pathogenic!effect!of!SNPs! is! related!to! the!combination!of! low!size!effect!
SNPs!or!their!interaction!with!the!environment.!In!this!regard,!a!significant!association!with!
male!infertility!has!been!clearly!demonstrated!for!the!677C>T!polymorphism!in!the!MTHFR!
(5,10SMetyleneStetraShidrofolate!reductase)!gene!in!populations!with!low!folate!intake!(Nuti!
and!Krausz,!2008).!
A! more! recent! strategy! to! identify! genetic! causes! of! male! infertility! has! been! the!
employment!of!genomic!microarrays!to!identify!Copy!Number!Variations!(CNVs).!The!study!
of!CNVs!was!initially!applied!to!a!number!of!multifactorial!complex!diseases!and!allowed!the!
identification! of! novel! genetic! factors! involved! in! the! etiology! of! some! types! of! cancer,!
neurological!and!autoimmune!diseases!or!susceptibility!to!HIVS1!infections.!Being!infertility!
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indeed! a! complex! disease,! it! is! plausible! that! CNVs! affecting! regions! or!multiScopy! genes!
relevant!to!spermatogenesis!may!also!contribute!to! infertility.!To!date,! the!only!CNVs!that!
have!been!demonstrated! to!be! in!a!clearScut!causeSeffect! relationship!with!male! infertility!
are!the!AZF!microdeletions!on!the!Y!chromosome.!
2.1.3.9Epigenetics9Aspects9
Male!infertility!is!a!complex!condition!where!not!only!genes,!but!also!epigenetic!factors!are!
predicted!to!play!an!important!role.!Epigenetics!is!defined!as!the9study9of9mitotically9and/or9
meiotically9 heritable9 changes9 in9 gene9 function9 that9 cannot9 be9 explained9by9 changes9 in9 the9
DNA9sequence.!These!“epigenetic”!changes!encompass!an!array!of!molecular!modifications!
of! DNA! or! histones,!which! are! intimately! associated!with! the!DNA.! Epigenetic! factors! not!
only!have!a!profound!impact!on!developmental!processes!but!also!have!relevance!in!many!
diverse!areas!of!biology!and!medicine,!including!cancer!biology,!the!study!of!environmental!
effects,! and! the! study! of! aging! (Herceg! and! Vaissière,! 2011;! Liu! and! Rando,! 2011).! For!
instance,!epigenetic!mechanisms!regulate!chromatin!accessibility!throughout!an!organism’s!
lifetime,!as!specific!sets!of!genes!are!active!at!any!stage!of!development.!Each!cell!type!has!
its! own! epigenetic! signature! that! reflects! the! developmental! history! and! environmental!
influences,!and!is!ultimately!reflected!in!the!phenotype!of!the!cell!and!organism.!!
The!sperm!epigenetic!program!is!unique.!First,!a!major!erasure!of!epigenetic!marks!occurs!in!
primordial!germ!cells!(PGCs).!Second,!male!germ!cell!nuclei!undergo!a!reorganization!and!a!
condensation!of! their!genome!during!postSmeiotic!maturation,! including!DNA!methylation,!
histone!acetylation,!implementation!of!histone!variants,!and!histoneStoSprotamine!transition!
during!spermiogenesis.!Epigenetic!signals!are!crucial!for!the!proper!functioning!of!the!sperm!
genome,! and! any! alteration! during! these! processes! may! contribute! to! altering! sperm!
function!and!fertilization!efficiency.!
Human!spermatozoa!undergo!three!types!of!epigenetic!modifications:!!
• Extensive! chromatin! modifications! as! a! result! of! the! removal! of! histones! during!
spermiogenesis!and!their!replacement!with!protamines;!
• Chemical!modifications!seen!in!histones!retained!in!sperm!chromatin;!
• The!methylation!to!the!sperm!DNA!itself.!
All! these! are! potent! modulators! of! gene! transcription,! including! the! transcriptional!
regulation!during!embryogenesis.!However,!for!the!purposes!of!this!thesis!only!sperm!DNA!
methylation!will!be!discussed!in!detail.!
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In! this! thesis,! the! term! epigenome! will! be! used! to! indicate! the! whole! set! of! epigenetic!
modifications!that!can!occur!in!the!genome!and!the!term!methylome!will!refer!specifically!to!
methylation!changes.!!
Sperm9DNA9methylation9
DNA! methylation! is! a! potent! epigenetic! mark! that! mainly! promotes! gene! silencing,! is!
essential! to! alleleSspecific! imprinting! of! certain! genes,! and! is! crucial! in! X! chromosome!
inactivation! (Ng! et! al.,! 1999;! Bronner! et! al.,! 2007).! DNA! methylation! occurs! by! covalent!
attachment! of! a! methyl! group! to! the! C5! position! of! cytosine! bases! found! in! cytosineS
phosphateSguanine! dinucleotides! (CpGs)! of! eukaryotic! DNA.! This! conversion! to! 5S
methylcytosine! is! possible! due! to! action! of! DNA! methyltransferase! (DNMT)! enzymes.!
Different!members!of!the!DNMT!family!of!enzymes!act!either!as!de9novo!DNMTs,!putting!the!
initial! pattern! of!methyl! groups! in! place! on! a! DNA! sequence,! or! as!maintenance! DNMTs,!
copying! the!methylation! from! an! existing! DNA! strand! to! its! new! partner! after! replication!
(Portela! and! Esteller,! 2010).! Mammalian! genomes! are! punctuated! by! DNA! sequences!
containing! an! atypically! high! frequency! of! CpG! sites! termed! CpG! islands! (CGIs).! These!
conspicuous!unique!sequences!are!approximately!1!kb! in! length!and!overlap!the!promoter!
regions!of!60–70%!of!all!human!genes! (Weber!et!al.,! 2007).!CGIs!have!been! shown! to! coS
localize!with!the!promoters!of!all!constitutively!expressed!genes!and!approximately!40%!of!
those! displaying! a! tissue! restricted! expression! profile! (Larsen! et! al.,! 1992;! Zhu! and! Yao,!
2009).!Consistent!with!this!promoter!association,!CGIs!are!generally!characterized!by!a!lack!
of!DNA!methylation,!thus!by!a!transcriptionally!permissive!chromatin!state.!However,!there!
is!a!percentage,!though!small,!of!CGIs!that!acquires!methylation!during!normal!development,!
and!some!of!these!examples!are!known!to!play!a!key!role!in!XSchromosome!inactivation!and!
genomic!imprinting!(Handy!et!al.,!2011;!Liu!et!al.,!2011).!
As! anticipated,! studies! on! mice! allowed! defining! that! mammalian! development! is!
accompanied!by!two!major!waves!of!genomeSwide!demethylation!and!reSmethylation:!one!
during!germScell!development!and!the!other!after! fertilization!(Fig.!2.1).!Upon!fertilization,!
the!zygotic!genome!experiences!a!broad!reprogramming!process,!which!contributes!to!the!
transition!of!the!zygote!into!a!totipotent!state!and!during!which!epigenetic!reprogramming!
crucially! regulates! zygotic! gene! expression.! For! instance,! paternal! DNA! is! actively!
demethylated!at!the!oneScell!stage,! followed!by!passive! loss!of!methylation!that!reaches!a!
minimum! at! the! blastocyst! stage.! Conversely,! maternal! DNA! is! maintained! in! a!
hypermethylated!state!at!the!oneScell!stage!and!is!passively!demethylated! in!a!replicationS
dependent!manner.!Hence,!at!the!blastocyst!stage,!embryos!possess!a!globally!low!level!of!
! 14!
DNA!methylation.!However,!upon!implantation,!the!epiblast!and!early!primordial!germ!cells!
(PGCs)! restore! a! hypermethylated! state! due! the! action! of!de9 novo! DNMTs.! Subsequently,!
after!migration!and!proliferation!of!PGCs,!a!second!wave!of!DNA!demethylation!is!detected.!
Following!gender!determination,!de9novo!DNA!methylation!takes!place!and!new!methylation!
landscapes! are! established! in! an! asymmetrical! pattern! in! male! and! female! germ! cell!
precursors.! In!male! germ! cells,!de9 novo!methylation! initiates! before! the! onset! of!meiosis,!
and!finishes!prior!to!birth.!In!female!germ!cells,!instead,!de9novo!methylation!occurs!during!
the!postnatal!development!of!meiotic!prophase!I!S!arrested!oocyte!(Fig.!2.1).!
!
Figure! 2.1.! Reprogramming! in! mammalian! development.! Two! waves! of! epigenetic!
reprogramming! occur! during! embryo! development.! The! first! phase! of! reprogramming! occurs! in!
the!normal!body!cells!(i.e.,!somatic!cells)!of!the!developing!embryo.!In!mice,!following!fertilization,!
the!embryo!undergoes!genomeSwide!demethylation! that! is! completed!by!embryonic!day!5! (E5).!
The!paternal!genome!(blue!line)!undergoes!rapid,!active!demethylation,!whereas!in!the!maternal!
genome!(pink!line),!demethylation!occurs!via!a!passive!process.!Remethylation!of!the!embryonic!
genome! begins! at! day! E5! and! is! completed! prior! to! birth.! The! second! wave! of! epigenetic!
reprogramming!occurs!in!the!germ!cells!of!the!developing!embryo,!which!will!ultimately!give!rise!
to!gametes!that!contain!sexSspecific!epigenetic!signatures.!The!primordial!germ!cells!(PGCs)!of!the!
developing!embryo!contain!the!methylation!signatures!of!the!parental!genomes.!At!approximately!
E7–8,! the! PGCs! undergo! rapid! demethylation! that! is! complete! by! E15–16.! Following! this,! sexS
specific!methylation! is! reSestablished.! In! the!male!germline,! reprogramming! is!complete!at!birth!
(blue! line),!whereas! in! females,!reprogramming!continues!until!puberty! (violet! line).!Figure!from!
(Ungerer!et!al.,!2013).!
!
To!date,!still!little!is!known!about!the!role!of!sperm!methylation!in!the!epigenetic!regulation!
of!embryonic!development,!but! this! issue! is!progressively!becoming!clarified.!For! instance,!
studies!exploring! the!sperm!methylome! in! relation! to!embryogenesis!have!been!published!
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already! (Hammoud! et! al.,! 2009;!Molaro! et! al.,! 2011)! and! agree! that! developmental! gene!
promoters!are!generally!in!a!hypomethylated!state,!supporting!the!hypothesis!of!a!potential!
embryonic! role! for! the! sperm! genome.! Although! these! studies! provide! indirect! evidence!
only,! they! sustain! a! potential! epigenetic! hypothesis! of! epigenetic! programming! in!
spermatozoa,!in!which!hypomethylation!of!regulatory!regions!S!together!with!simultaneous!
activating! and! silencing! histone! modifications! S! poises,! but! not! yet! actively! marks,! key!
developmental!genes! for! rapid!activation! in!development,!while! the! rest!of! the!genome! is!
either!silenced!by!protamine!binding!or!bound!to!histones!with!silencing!modifications.!
Sperm9DNA9methylation9and9Male9Fertil ity9
Early!evidence!for!a!link!between!epigenetic!markers!and!male!fertility!was!demonstrated!in!
mice!by!the!administration!of!a!demethylating!agent,! the!5SazaS20Sdeoxycytidine.!Reduced!
sperm! production! was! observed! in! association! with! reduction! of! testis! and! epididymal!
weight,!reduced!littermate!size,!and!higher!neonatal!mortality!(Kelly!et!al.;!Doerksen,!1996).!
A! number! of! studies! have! explored! the! relationship! between!DNA!methylation! levels! and!
male! fertility! in! humans.! The! first! association! between!methylation! defects! and! infertility!
was! reported! by! Benchaib! et! al.! (Benchaib! et! al.,! 2005),! who! reported! that! global!
methylation! levels! above! an! arbitrary! threshold! was! seemingly! linked! to! high! pregnancy!
rates.!Another!study!reported!for!the!first!time!that!poorSquality!semen!samples!displayed!
abnormally!elevated!levels!of!DNA!methylation!of!both!imprinted!and!nonSimprinted!genes!
and!other! repetitive!elements! (Houshdaran!et!al.,!2007).!The!authors!proposed! that! these!
elevated! methylation! levels! arose! from! of! an! improper! erasure! of! methylation! marks! in!
cases! of! oligoSasthenoSteratozoospermia! (OAT)! rather! than! from! de9 novo! methylation!
following! epigenetic! reprogramming.! The! analysis! of! 23,094! CpG! probes! performed! by!
(Aston!et!al.,!2012)!allowed!the!identification!of!three!individuals!S!two!men!with!abnormal!
protamine!1/protamine!2!ratio!and!one!patient!resulting! in!abnormal!embryogenesis!after!
IVF/intracytoplasmic!sperm!injection!treatment!S!displaying!broad!disruption!of!sperm!DNA!
methylation!profiles,!thus!suggesting!that!disruptions!in!sperm!DNA!methylation!may!be!an!
important!mark! in! some! infertile!men.! Considering! the! importance! of! genomic! imprinting!
acquisition!during! spermatogenesis,!Marques!et! al.! compared! the!methylation!patterns!of!
H19! (paternally! methylated)! and! MEST9 (paternally! unmethylated)! imprinted! genes! in!
spermatozoa!of!fertile!and!oligozoospermic!infertile!men,!by!bisulphite!genomic!sequencing!
(Marques! et! al.,! 2004,! 2008).! Oligozoospermic! patients! displayed! an! erroneous! loss! of!
methylation!of! the!H19! gene!and! such!decrease!was! associated!with! a!decrease! in! sperm!
count.!Furthermore,!an!unexpected!MEST!hypermethylation!was!observed!in!these!patients!
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(Marques!et!al.,!2008).!These!findings!were!confirmed!by!a!Japanese!study!investigating!the!
DNA!methylation! status!of! seven! imprinted! genes:!H19! and!GTL2! (paternally!methylated),!
and! PEG1,9 LIT1,9 ZAC,9 PEG3! and! SNRPN! (maternally! methylated)! in! infertile! patients.! Also!
they! found! that! oligozoospermic! cases! presented! decreased! methylation! levels! of! the!
paternal!DNA!methylation!in!H19!and!GTL29and!increased!methylation!levels!in!PEG1,9LIT1,9
ZAC,9PEG39and9SNRPN.9Subsequently,!Boissonnas!et!al.! (2010)!quantitatively!compared!the!
methylation! levels! at! 47! different! CpGs! included! in! IGF2! and! H199 genes! between!
normozoospermic! and! oligozoospermic!men! (Boissonnas! et! al.,! 2010).! This! study! showed!
that! these! two! genes!were! abnormally! hypomethylated! in! oligozoospermic!men! and! that!
this! drastic! loss! of! methylation! correlated! with! the! severity! of! the! oligozoospermia.! The!
association! between! OAT! and! methylation! errors,! both! hypermethylaytion! and!
hypomethylation,! were! subsequently! confirmed! by! other! research! groups! even! when!
different! techniques!were! used! (Hammoud! et! al.,! 2010;! Poplinski! et! al.,! 2010;! Sato! et! al.,!
2011;!Aston!et!al.,!2012).!
Finally,!some!groups!studied!the!methylation!state!of!the!promoter!of!some!genes!involved!
in!the!spermatogenic!process.!Patterns!of!abnormal!methylation!associated!with!OAT!were!
reported! in! the! DAZL! promoter(NavarroSCosta! et! al.,! 2010c)! and! the! CREM! promoter!
(Nanassy!and!Carrell,!2011).!Moreover,!aberrant!hypermethylation!of!the!MTHFR!promoter!
was!found!in!53%!of!patients!with!nonSobstructive!azoospermia!(Khazamipour!et!al.,!2009)!
and! in! some! cases! of! idiopathic! infertility! (Wu! et! al.,! 2010).! All! these! studies! support! the!
hypothesis! that! sperm! DNA! methylation! patterns! of! both! imprinted! and! nonSimprinted!
genes!are!essential!for!normal!sperm!function,!fertility,!and!embryo!development.!However,!
the! etiology! and!whether!methylation! errors! are! acquired! during! fetal! or! early! postSnatal!
development!are!still!unresolved!questions.!
Given! that! epigenetic! signals! are! crucial! for! the! proper! functioning! of! the! genome,!
phenotypic!differences! in!sperm!production! (quantitative!and!qualitative! traits)!both!at!an!
interS!and! intraSindividual! level,!existing!even!within!a!context!of!normal!spermatogenesis,!
may! reflect! a! variation! in! the! sperm! epigenome.! The! only! study! available! in! this! regard!
evaluated!intraS!and!interSindividual!DNA!methylation!changes!in!normozoospermic!men!by!
the! analysis! of! 12,198SCpG! sites! (Flanagan! et! al.,! 2006).! The! authors! reported! significant!
intraS!and! interS! individual!variations!for!6!genes,!supporting!the!hypothesis!that!there! is!a!
link!between!epigenetic! variations!and! the!variability!of! semen!phenotypes.!Contrastingly,!
two! later! studies! reported! only! a! limited! interSindividual! variability! in!DNA!methylation! in!
normozoospermic!men,!though!it!must!be!considered!that!comparison!was!performed!
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between! two! sperm! donors! and! using! different! techniques! Smethylated! DNA!
immunoprecipitation!(MeDIP)!procedure!and!promoter!arrays!(Hammoud!et!al.,!2009)!and!a!
genomeSwide!shotgun!bisulfite!sequencing!(Molaro!et!al.,!2011).!
Another! issue! scarcely! investigated! so! far! is!whether! different! semen! fractions! containing!
qualitatively! different! spermatozoa! display! different! epigenetic! landscapes.! The! only! data!
available! in! this! regard! are! provided! in! a! study! by! NavarroSCosta! et! al! (2010),! in! which!
significant! differences! in! the! methylation! pattern! of! the! DAZL! promoter! were! observed!
between!normal!and!defective!germ!cell!fractions!deriving!from!the!same!individual.!
An! attempt! of! filling! this! gap! of! knowledge! in! relation! to!methylation! patterns! in! qualityS
fractioned!semen!samples!was!performed!in!our!laboratory,!and!the!study!performed!will!be!
presented!in!this!thesis.!
2.2.!Copy!Number!Variations!(CNVs)!
2.2.1.9Discovery9and9Definition9
The!discovery!of!Copy!Number!Variations!(CNVs)!dates!back!to!2002!when!Charles!Lee,!in!his!
attempt! of! genotyping! a! group! of! patients,! started! finding! that! healthy! controls! showed!
major!variations!in!their!genetic!sequences,!with!some!having!more!copies!of!specific!genes!
than! others.! Lee! began! to! collaborate! with! Steven! Scherer,! who! had! made! similar!
observations,!and!together!through!arraySbased!comparative!genomic!hybridization!(aSCGH)!
approaches!measured! for! the! first! time! the! occurrence! of! these! copy! variants! across! the!
genome.! Meanwhile,! Michael! Wigler! was! also! observing! differences! in! copy! numbers! in!
healthy!individuals!using!a!complementary!microarray!technique!involving!representational!
oligonucleotide!probes!to!detect!amplifications!and!deletions!in!the!genome.!Finally,!in!2004,!
Lee’s! and! Scherer’s! groups! of! researchers! published! the! first! evidences! that! largeSscale!
variations! in! copy! number!were! common! and! occurred! in! hundreds! of! loci! in! the! human!
genome,! including!areas!coding!for!diseaseSrelated!genes!(Iafrate!et!al.,!2004;!Sebat!et!al.,!
2004).!By!then,!a!CNV!was!defined!as!a!DNA!segment!of!one!kilobase!(kb)!or! larger!that! is!
present! at! a! variable! copy! number! in! comparison! with! a! reference! genome.! The! term!
“variation”!instead!of!“polymorphism”!is!used!because!the!relative!frequency!of!most!CNVs!
in! the! general! population! have! not! yet! been!well! defined! and! the! term! polymorphism! is!
limited!to!genetic!variants!that!have!a!minor!allele!frequency!of!≥1%!in!a!given!population.!
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2.2.2.9What9are9CNVs?9
CNVs!are!a!class!of! structural!variation,!which! includes!also!balanced!alterations! regarding!
position! and! orientation! of! genomic! segments! defined! as! translocations! and! inversions,!
respectively.! The! term! CNV! is! not! generally! used! to! indicate! variations! caused! by!
insertion/deletion!of!transposable!elements.!!
These!unbalanced!quantitative!variants!can!be!classified!into:!
•! Gains!when!an!increase!of!genetic!material! is!observed!compared!to!the!reference!
genome! as! a! consequence! of! duplication/amplification! or! insertion! events.! The!
amplified!DNA!fragments!can!be!found!adjacent!to!(tandem!duplication)!or!distant!
from!each!other!and!even!on!different!chromosomes.!!
•! Losses! when! a! reduction! or! the! complete! loss! of! genetic! material! is! observed!
compared! to! the! reference! genome! as! a! consequence! of! deletion! events.! In! the!
present!thesis!the!terms!“loss”!and!“deletion”!will!be!used!to!indicate!the!reduction!
and! the! complete! loss! (null! genotype)! of! a! given!DNA! sequence! compared! to! the!
reference!genome,!respectively.!
A! CNV! can! be! simple! in! structure! or!may! involve! complex! gains! or! losses! of! homologous!
sequences!at!multiple!sites!in!the!genome!(Fig.2.2).!
!
Figure!2.2.!Different! types!of!CNV.!CNVs!(in!the!sample!genome)!are!defined!by!comparison!with!a!
reference!genome.!DNA!blocks!displaying!sequence!identity!are!represented!with!the!same!color.!a)!
Deletion!of! two!contiguous!fragments! (deletion);!b)!Tandem!duplication!(gain);!c)!Duplication!(gain)!
with! insertion! of! the! duplicated! sequence! far! from! the! origin;! d)! Multiallelic! gain! produced! by!
multiple!duplication!event;!e)!Complex!CNVs!resulting!from!inversion,!duplication!and!deletion!events.!
Figure!from!(Lee!and!Scherer,!2010).!
!
!
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In! 2006,! a! collaboration! of! international! research! laboratories! built! the! first! genomeSwide!
map!of!existing!CNVs!in!the!human!genome!(Redon!et!al.,!2006).!An!examination!of!270!DNA!
samples!from!the!multiethnic!population!employed!by!the!HapMap!Project!revealed!a!total!
of!1447!discrete!CNVs.!Taken!together,!these!CNVs!cover!approximately!360!Mb,!i.e.!12%!of!
the! human! genome,! with! a! prevalence! of! small! rearrangements! (<20! Kb).! The! HapMap!
Project! notes! that! CNVs! encompass! more! nucleotide! content! per! genome! than! SNPs,!
underscoring!CNVs'!significance!to!genetic!diversity.!The!map!of!CNVs!shows!that!no!region!
of! the! genome! is! exempt,! and! that! the! percentage! of! an! individual's! chromosomes! that!
exhibit! CNVs! varies! anywhere! from! 6%! to! 19%! (Redon!et9 al.,! 2006).! The! genomic! regions!
encompassed!by!these!CNVs!contain!hundreds!of!genes!and!functional!elements!and!many!
CNVs!reached!a!population!frequency!greater!than!1%!(Copy!Number!Polymorphisms).!!
These! observations,! together! with! the! interSindividual! variability! in! gene! copy! number!
(Redon!et!al.,!2006;!Jakobsson!et!al.,!2008),!lead!to!hypothesize!the!importance!of!CNVs!in!
the!evolutionary!process!and!in!the!adaptation!to!diverse!environmental!conditions.!Indeed,!
CNVs!are!an!important!genetic!component!of!phenotypic!diversity!(Wong!et!al.,!2007),!and!
represent!the!primary!source!of!interSindividual!variability!between!genomes!(Iafrate!et!al.,!
2004;!Sebat!et!al.,!2004;!Redon!et!al.,!2006).!
With!the!growth!of!information!on!CNVs!in!the!human!genome,!the!accurate!annotation!of!
these! structural! variations! has! become! progressively! important.! At! present,! several!
databases! are! currently! available! for! genomeSwide! investigation! of! genomic! variants,! the!
most! important! of! which! is! the! “Database! of! Genomic! Variants”!
(http://dgv.tcag.ca/dgv/app),! which! provides! a! comprehensive! continuously! upSdated!
catalog! of! the! structural! variations! identified! the! human! genome.! For! each! CNV! several!
information! are! annotated:!whether! it! is! a! gain! or! a! loss,! the! exact! genomic! position,! the!
frequency!and!bibliographic!references!to!trace!back!to!the!study!that!produced!those!data.!
To!date!(December!2014)!a!total!of!353126!CNVs!deposited!by!a!total!of!62!studies.!
2.2.2.9Potential9Mechanisms9of9CNV9Generation9
The!rate!of!CNV!formation! is!estimated!to!be!several!orders!of!magnitude!higher!than!any!
other!type!of!mutation!and!the!molecular!mechanisms!by!which!they!generate!seems!to!be!
similar! in! bacteria,! yeast! and! humans.!De9 novo9 formation! of! CNVs! can! occur! in! both! the!
germline! and! somatic! cells.! Bruder! et! al.! (Bruder! et! al.,! 2008)! provided! evidence! for! the!
possible!generation!of!CNVs!during!mitosis!(in!somatic!cells)!by!reporting!that!monozygotic!
twins! show! different! CNVs! at! different! loci.! These! CNVs! presumably! arose! during! early!
stages!of!embryogenesis,!immediately!before!or!immediately!after!embryonic!division!in!the!
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two! individuals.! It! is! therefore! plausible! that! some! CNVs! might! originate! during!
embryogenesis! even! in! the! case! of! a! single! pregnancy,! generating! a! “chimerism”! for! such!
CNVs! within! the! same! individual;! this! phenomenon! has! been! also! demonstrated! by!
(Piotrowski!et!al.,!2008),!who!observed!the!presence!of!CNVs,!affecting!a!single!organ!or!one!
or!more!tissues!of!the!same!subject.!Other!evidences!for!the!onset!of!CNVs!at!the!somatic!
level! are! the! presence! of! CNV! mosaicism! in! tumor! tissues! (Fridlyand! et! al.,! 2006;! DaraiS
Ramqvist!et!al.,!2008)!as!well!as! in!blood!cells!of!healthy!subjects!(Lam!and!Jeffreys,!2006,!
2007).!
CNVs!often!occur!in!regions!reported!to!contain,!or!be!flanked!by,!large!homologous!repeats!
or!segmental!duplications!(SDs)(Fredman!et!al.,!2004;!Iafrate!et!al.,!2004;!Sharp!et!al.,!2005;!
Tuzun!et!al.,!2005).!SDs!(also!referred!by!some!as! low!copy!repeats!or!LCRs;!(Lupski,!1998)!
can! be! defined! as! duplicated! DNA! fragments! that! are! >1! kb! and!map! either! to! the! same!
chromosome!or!to!different,!nonShomologous!chromosomes!(Bailey!et!al.,!2002;!Lupski!and!
Stankiewicz,! 2005).! Segmental! duplications! could! arise! by! tandem! repetition! of! a! DNA!
segment! followed! by! subsequent! rearrangements! that! place! the! duplicated! copies! at!
different! chromosomal! loci.! Alternatively,! segmental! duplications! could! arise! via! a!
duplicative!transpositionSlike!process:!copying!a!genomic!fragment!while!transposing!it!from!
one!location!to!another!(Eichler,!2001).!
According!to!whether!CNVs!are!associated!with!segmental!duplications!or!not,!they!may!be!
susceptible! to! structural! chromosomal! rearrangements! via! two! general! mechanism,!
respectively:!!
•! Homologous! recombinationSbased! pathways! including! the! nonSallelic! homologous!
recombination!mechanism!(NAHR);!
•! NonShomologous! recombinationSbased! pathways,! including! nonShomologous! endS
joining!(NHEJ)!and!the!Fork!Stalling!and!Template!Switching!(FoSTeS)!models.!
Certain! CNVs!may! be! found! to! be! associated!with! nonSbeta!DNA! structures! (DNA! regions!
that! differ! in! structure! from! the! canonical! rightShanded! alfaShelical! duplex,! including! leftS
handed!ZSDNA!and!cruciforms).!Such!DNA!structures!are!believed!to!promote!chromosomal!
rearrangements! (Kurahashi! and! Emanuel,! 2001;! Bacolla! et! al.,! 2004)! and! may! also!
theoretically! contribute! to! the! genesis! and!maintenance! of! certain! CNVs.! There!may! be! a!
relationship!between! the! size!of! a! given!CNV!and! its! associated!mutational!mechanism(s).!
For! example,! data! from! at! least! two! studies! have! shown! that! larger! CNVs! are! more!
frequently! associated! with! segmental! duplications! than! smaller! CNVs! (Fig.2.3),! which! are!
predominantly!generated!by!nonShomologySdriven!mutational!mechanisms.!!
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Figure! 2.3.! Graph! showing! the!
positive! correlation! between!
the! size! of! CNVs! and! the!
likelihood! of! association! with!
SDs.!This!correlation!is!noted!by!
both! the! Conrad! et! al.! (2006)!
and!Tuzun!et!al.!(2005)!studies.!
!
!
!
NON[ALLELIC9HOMOLOGOUS9RECOMBINATION9MECHANISM9
NAHR! is! driven! by! the! extended! sequence! homology! between! two! region! of! the! genome!
oriented! in!the!same!directionS!such!as!the!above!mentioned!SDs!(Shaw!and!Lupski,!2004;!
Stankiewicz!and!Lupski,!2010)S!where!incorrect!pairing!during!meiosis/mitosis!or!DNA!repair!
across!homologous!regions!can!result!in!a!gain!or!loss!of!intervening!sequence.!Homologous!
recombination! underlies! several! mechanisms! of! accurate! DNA! repair,! where! another!
identical!sequence!is!used!to!repair!a!damaged!sequence.!If!a!damaged!sequence!is!repaired!
using!homologous!sequence!in!the!same!chromosomal!position!within!the!sister!chromatid!
or! in! the! homologous! chromosome! (allelic! homologous! recombination)! no! structural!
variation!will!occur.!However,! if!a!crossover! forms!when!the! interacting!homologies!are! in!
nonSallelic!positions!on!the!same!chromosome!or!even!on!different!chromosomes!this!will!
result! in! an!unequal! crossingSover! causing! the!duplication!and! subsequent!deletion!of! the!
intervening! sequence.! More! specifically,! interSchromosomal! and! interSchromatid! NAHR!
between! LCRs! with! the! same! orientation! results! in! reciprocal! duplication! and! deletion,!
whereas!intraSchromatid!NAHR!creates!only!deletions!(Fig.!2.4).!
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Figure!2.4.!NAHR!mechanisms.!Recombination!occurs!between!two!directly!oriented!SDs!represented!by!yellow!
and!blue!arrows.!Two!scenarios!are!possible:!A.!IntraSchromatid!NARH:!recombination!between!two!homologous!
sequences!on!the!same!chromatid!results!in!the!deletion!of!the!interposed!DNA!segment.!B.!InterSchromatid!or!
interSchromosome! NAHR:! two! nonSallelic! homologous! sequence! on! sister! chromatids! or! chromosomes! are!
involved!in!recombination!leading!to!a!deletion!and!the!reciprocal!duplication.!
!
Theoretically,!the!frequency!of!deletions!should!be!always!higher!than!that!of!duplications.!
However,! if! deleterious! deletions! underwent! negative! selection,! duplications! would! then!
occur! at! a! higher! frequency! (Turner! et! al.,! 2008).! Therefore,! duplication! frequency! should!
not!exceed!deletion!frequency,!unless!negative!selection!in!both!germ!cells!and!somatic!cells!
makes!deleterious!deletions!very!rare!or!not!represented.!
NON9HOMOLOGOUS9END[JOINING9(NHEJ)9
NHEJ! is! one! of! the! two!major!mechanisms! used! by! eukaryotic! cells! to! repair! DNA!double!
strand!breaks!(DBS)!without!involving!a!template!DNA!sequence.!This!nonShomologous!DNA!
repair!pathway!has!been!described!in!organisms!from!bacteria!to!mammals![66S68!in!Gu!et!
al]!and!is!routinely!used!by!human!cells!to!repair!both!'physiological'!DSBs,!such!as!in!V(D)J!
recombination,! and! 'pathological'! DSBs,! such! as! those! caused! by! ionizing! radiation! or!
reactive!oxygen!species.!NHEJ!proceeds!in!four!steps!(Fig.!2.5):!detection!of!DSB;!molecular!
bridging!of!both!broken!DNA!ends;!modification!of!the!ends!to!make!them!compatible!and!
ligatable;!and!the!final!ligation!step!(Weterings!and!van!Gent,!2004).!Being!a!nonShomology!
based! mechanism,! NHEJ! does! not! require! DNA! pairing! for! successful! ligation! and,!
consequently,! unlike!NAHR!does!not!depend!on! the!presence!of! SDs.! Evidence!exists! that!
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NHEJ! is! more! prevalent! in! unstable! (or! fragile)! regions! of! the! genome! such! as! the! subS
telomeric! regions! (Nguyen!et!al.,!2006;!Kim!et!al.,!2008).!Furthermore,!many!NHEJ!events,!
classified! as! microhomologySmediated! end! joining,! require! end!
resection! and! join! the! ends! by! base! pairing! at! microhomology!
sequences!(5–25!nucleotides)(McVey!and!Lee,!2008;!Pawelczak!and!
Turchi,!2008).!NHEJ! leaves!a!“molecular!scar”!since!the!product!of!
repair! often! contains! additional! nucleotides! at! the! DNA! end!
junction!(Lieber,!2008).!
!
!
!
Figure! 2.5.! NHEJ! brings! the! ends! of! the! broken! DNA!molecule! together! by! the!
formation!of! a! synaptic! complex,! consisting!of! two!DNA!ends,! two!Ku70/80!and!
two! DNASPKCS! molecules.! NonScompatible! DNA! ends! are! processed! to! form!
ligatable!termini,!followed!by!repair!of!the!break!by!the!ligase!IV/XRCC4!complex.!
Figure!from!(Weterings!and!Chen,!2008).!
!
Fork9stalling9and9template9switching9(FoSTeS)9
Study!of!stressSinduced!amplification!of!the!lac!genes,!using!the!E.9coli9Lac!system!by!Cairns!
and!(Cairns!and!Foster,!1991),!led!(Slack!et!al.,!2006)!to!propose!that!template!switching!was!
not!confined!to!a!single!replication!fork,!but!could!also!occur!between!different!replication!
forks.! This! model,! now! called! fork! stalling! and! template! switching! (FoSTeS),! illustrated! in!
Figure!2.6,!proposes!that!when!replication!forks!stall!in!cells!under!stress,!the!3w!primer!end!
of! a!DNA! strand! can! change! templates! to! singleSstranded!DNA! templates! in! other! nearby!
replication! forks.! This! hypothesis!was!necessary! because! the!mean! length!of! amplicons! in!
that!study!was!about!20kb! (Slack!et!al.!2006),!which! is! too! long!to!have!occurred!within!a!
replication! fork.!According! to! this!model,!during!DNA! replication,! the!DNA! replication! fork!
stalls!at!one!position,!the!lagging!strand!disengages!from!the!original!template,!transfers!and!
then! anneals,! by! virtue! of! microhomology! at! the! 3'! end,! to! another! replication! fork! in!
physical!proximity!(not!necessarily!adjacent!in!primary!sequence),!'primes',!and!restarts!the!
DNA!synthesis!(Lee!et!al.,!2007).!The!invasion!and!annealing!depends!on!the!microhomology!
between! the! invaded! site! and! the! original! site.! Upon! annealing,! the! transferred! strand!
primes! its!own! template!driven!extension!at! the! transferred! fork.!This!priming! results! in!a!
'join! point'! rather! than! a! breakpoint,! signified! by! a! transition! from! one! segment! of! the!
genome!to!another!–!the!templateSdriven!juxtaposition!of!genomic!sequences.!Switching!to!
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another! fork! located! downstream! (forward! invasion)! would! result! in! a! deletion,! whereas!
switching!to!a!fork!located!upstream!(backward!invasion)!results!in!a!duplication.!!
!
!
!
!
Figure! 2.6.!After! the!original! stalling!of! the! replication!
fork! (dark!blue!and!red,!solid! lines),! the! lagging!strand!
(red,! dotted! line)! disengages! and! anneals! to! a! second!
fork! (purple!and!green,! solid! lines)! via!microhomology!
(1),! followed! by! (2)! extension! of! the! now! 'primed'!
second! fork! and! DNA! synthesis! (green,! dotted! line).!
After!the!fork!disengages!(3),!the!tethered!original!fork!
(dark! blue! and! red,! solid! lines)!with! its! lagging! strand!
(red!and!green,!dotted! lines)!could! invade!a! third! fork!
(gray! and! black,! solid! lines).! Dotted! lines! represent!
newly! synthesized! DNA.! Serial! replication! fork!
disengaging! and! lagging! strand! invasion! could! occur!
several!times!(e.g.!FoSTeS!x!2,!FoSTeS!x!3,!etc.)!before!
(4)! resumption! of! replication! on! the! original! template.!
Figure!from!(Gu!et!al.,!2008).9
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2.2.3.9CNVs9and9Disease:9Functional9Consequences9
As!already!mentioned,!CNVs!are!a!common!feature!of!the!genome!of!healthy!humans!and!
rather! play! an! important! role! in! evolution! and! adaptation! to! different! environments,! as!
major! source!of! genetic! interSindividual! variability! (Iafrate!et!al.,! 2004;! Sebat!et! al.,! 2004).!
However,! the! gain! or! loss! of! DNA! sequence! can! also! produce! a! spectrum! of! functional!
effects!and!human!disease!phenotypes.!One!obvious!way!by!which!CNVs!might!exert!their!
effect!is!by!altering!transcriptional!levels!(and!presumably!subsequent!translational!levels)!of!
the!genes! that!are! in!variable!copy!number.!CNVs!may! influence!gene! function!directly!by!
altering! the! copy! number! of! dosageSsensitive! genes! or! by! disrupting! the! geneScoding!
sequence:! partial! gain! or! loss! of! coding! sequences! can!produce!different! alleles,! including!
both! loss! and! gain! of! function.! For! example,! deleted! internal! exons! could! result! in! a!
frameshift!and!subsequent!loss!of!function!through!truncation!or!nonSsense!mediated!decay.!
Chimeric!proteins!can!also!be!produces!when!CNV!breakpoints!lie!within!two!different!genes,!
leading!to!the!fusion!of!two!partial!coding!regions.!CNVs!in!nonScoding!regions!can!also!lead!
to! several!position!effects! via! the!deletion!or! transposition!of! critical! regulatory!elements,!
such!as!promoters,!enhancers!and!silencers!or!disrupting! the! function!of! these,! leading! to!
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changes! in! sequence! or! location! with! respect! to! a! target! gene! (Hurles! et! al.,! 2008).!
Apparently,!the!functional!effect!of!a!CNV!is!strictly!dependent!on!the!exact!position!of!the!
CNV!breakpoint,!i.e.!the!region!where!a!fragment!was!inserted!(gain)!or!lost!(loss/deletion).!
The!main!consequences!through!which!CNVs!may!act!are!represented!in!Figure!2.7.!CNV!size!
is!scarcely!predictive!of!the!phenotypic!effect,!since!a!number!of!apparently!benign!CNVs!are!
of!an!order!of!magnitude!of!2!Mb,!and!in!some!cases!can!also!reach!a!10!Mb!length!(Redon!
et!al.,!2006;!Hansson!et!al.,!2007).!Although!the!functional!consequences!of!a!CNV!might!be!
difficult! to! predict,!many! CNVs! do! generate! alleles!with! a! clearScut! impact! on! health.! For!
instance,! the! development! of! new! highSresolution! toolsS! such! as! genomeSscanning! array!
technologies! and! comparative!DNASsequence! analysesS! CNVs!have!been!associated!with! a!
growing! number! of! common! complex! diseases,! including! human! immunodeficiency! virus!
(HIV),!autoimmune!diseases!such!as!Chron!disease,!psoriasis,!systemic!lupus!erythematosus!
(Aitman!et!al.,!2006;!Fanciulli!et!al.,!2007;!Willcocks!et!al.,!2008;!Bassaganyas!et!al.,!2013),!a!
spectrum!of! neuropsychiatric! disorders! as! autism,! schizophrenia! (Cook! and! Scherer,! 2008;!
RodríguezSSantiago!et!al.,!2010;!Saus!et!al.,!2010)!and!some!type!of!cancer!(neuroblastoma,!
breast!and!prostate!cancer).!
!
Figure2.7.! Impact! of! CNVs! on! gene! expression.! A.! Single! copy! dosageSsensitive! gene! (reference!
genome):!promoter,!upstream!enhancer!element!and!coding!sequence!are!represented;!partial!and!
complete!deletion!affecting!coding!sequence!(B!and!C);!Deletion!and!duplication!affecting!enhancer!
(D! and! E);! Complete! and! partial! (not! involving! enhancer)! tandem! duplication! (F! and! G);! Complete!
tandem!interSchromosome!duplication!involving!a!regulatory!element!inhibiting!gene!expression!(H);!
Partial!tandem!duplication!disrupting!coding!sequence!(I);!multicopy!gene!loss!(J).!
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Being! infertility! indeed! a! complex! disease,! researchers! involved! in! this! field! started!
investigating! whether! CNVs! might! play! a! role! in! the! etiopathogenesis! of! spermatogenic!
failure:! an! increased! number! or! a! specific! distribution! of! CNVs! could! result! in! defective!
recombination,!meiotic! failure! and! loss! of! germ! cells! or! CNVs!might! affect! the! activity! of!
individual!genes!important!for!spermatogenesis.!To!date,!6!studies!have!been!published!on!
the! relationship!between!CNVs!and!male! infertility! (Tüttelmann!et! al.,! 2011;! Krausz! et! al.,!
2012a;!Stouffs!and!Lissens,!2012;!Lopes!et!al.,!2013)(Tüttelmann!et!al.,!2011;!Krausz!et!al.,!
2012a;! Stouffs! et! al.,! 2012;! Lopes! et! al.,! 2013),! and! all! converge! on! the! hypothesis! that!
infertile!patients!have!a! significantly!higher!burden!of!CNVs! in! their! genome!compared! to!
normozoospermic!controls.!This!issue!was!the!main!objective!of!this!thesis!and!will,!thus,!be!
presented!subsequently.!
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2.3!The!Y!Chromosome!
2.3.1.9Structure9and9gene9content9
The!Y!chromosome!is!a!submetacentric!chromosome!and!with!its!60!Mb!of!length!is!one!of!
the! smallest! chromosomes! of! the! human! genome.! The! Y! chromosome! is! peculiar! in! its!
structure,!which! can! be! conceptually! divided! in! two! genomic! regions:! i)! the!maleSspecific!
region! of! the! Y! (MSY);! ii)! the! pseudoautosomal! regions! (PARs),! which! correspond! to! the!
domain!of!X–Y!homology!involved!in!meiotic!pairing!(Fig.2.8).!
The! MSY! region,! comprising! approximately! 95%! of! the! chromosome! length,! lacks! a!
homologous! region! on! the! other! sex! chromosome,! thus! it! is! genetically! isolated! from!
meiotic!recombination.!Within!the!MSY!region!both!euchromatic!and!heterochromatic!DNA!
sequences! can! be! identified:! the! euchromatic! portion! covers! approximately! 23!Mb!of! the!
chromosome,!including!8!Mb!on!the!short!arm!(Yp)!and!14.5!Mb!on!the!long!arm!(Yq);!apart!
from!the!large!block!of!centromeric!heterochromatin!of!approximately!1!Mb,!(TylerSSmith!et!
al.,! 1993)! typically! found! in! every! nuclear! chromosome,! the! Y! chromosome! also! harbors!
another,!much! longer! heterochromatic! block! (40!Mb)! that! encompasses! the!distal! part! of!
the!Yq.!
!
Figure! 2.8.! Schematic! representation! of! the!whole! Y! chromosome,! including! the! pseudoautosomal!
MSY! regions! (from!Skaletsky!2003).!Heterocromatic! segments!and! the! three!classes!of!euchromatic!
sequences!(XStransposed,!XSdegenerate!and!Ampliconic)!are!shown.!!
!
MSY’s!euchromatic!portion!can!be!divided!into!three!classes,!firstly!defined!by!(Skaletsky!et!
al.,!2003):!
! XOtransposed! sequences:! are! the! result!of!a!massive!XStoSY! transposition!occurred!
about! 3–4!million! years! ago,! after! the! divergence! of! the! human! and! chimpanzee!
lineages! (Page,!1987;!Mumm!et!al.,!1997;!Schwartz!et!al.,!1998).!Subsequently,!an!
inversion!within! the!MSY! short! arm! cleaved! the!XStransposed!block! into! two!nonS
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contiguous!segments,!as!observed!in!the!modern!MSY.!Found!only!on!the!short!arm!
of!the!Y!chromosome,!these!sequences!show!99%!homology!to!some!sequences!in!
Xq21;! notwithstanding! they! do! not! participate! in! X–Y! crossing! over! during! male!
meiosis.!Within! the! XStransposed! segments,!which! have! a! combined! length! of! 3.4!
Mb,!only! two!genes! can!be! identified.! In! fact,! the!XStransposed! sequences!display!
the!lowest!density!of!genes!among!the!three!classes!as!well!as!the!highest!density!of!
interspersed!repeat!elements!(in!particular!LINE).!
! XOdegenerate! sequences:! in! contrast! to! the! XStransposed! sequence! blocks,! these!
segments! are! dotted! with! singleScopy! gene! or! pseudogene! homologues! of! 27!
different! XSlinked! genes.! These! singleScopy! MSY! genes! and! pseudogenes! display!
between!60%!and!96%!nucleotide!sequence! identity! to! their!XSlinked!homologues,!
and! they! seem! to! derive! from! ancient! autosomes! from! which! the! X! and! Y!
chromosomes! coSevolved.! Among! these! is! also! present! the! SRY! (Sex! Determining!
Region)!gene,!which!has!an! important! role! in! sex!determination!and! is! the!only!XS
degenerate!sequence!to!be!expressed!predominantly!in!the!testes.!
Amplicons:!are! large!DNA!blocks!that!exhibit!marked!similarity—as!much!as!99.9%!
identity!over!tens!or!hundreds!of!kilobases—to!other!sequences!in!the!MSY.!These!
sequences!are!located!in!seven!segments!scattered!across!the!euchromatic!long!arm!
and!proximal!short!arm!of!the!Y!chromosome!with!a!combined!extension!of!10.2!Mb.!
Amplicons,!which! can!be! regarded! to!as! SDs,! are! in! turn!organized! in! symmetrical!
arrays!of!contiguous!units!named!“palindromes”!(Fig.2.9!below).!
!
P1b g r P1g br
!
Figure!2.9.!Example!of!organization!of!the!amplicons!(colored!arrows)!
in!a!symmetrical!array!of!continuous!repeat!units!(palindrome!P1)!
!
Eight!massive!palindromes!can!be!identified!in!the!ampliconic!region!of!the!Yq,!each!defined!
by!a!symmetry!axis!separating!two!largely!identical!arms!(with!a!sequence!identity!of!99.94–
99.997%)! constituted! by! single! or! multiple! amplicons! (KurodaSKawaguchi! et! al.,! 2001;!
Skaletsky!et!al.,!2003)!(Fig.!2.9).!Amplicons!represent!approximately!35%!of!the!MSY!region!
and! the! eight! palindromes! collectively! cover! one! quarter! of! the! MSY! euchromatin.!
Consequentially,!the!Y!chromosome!displays!a!significantly!higher!SDs!content!compared!to!
the!rest!of!chromosomes!showing!an!average!content!of!approximately!5%.!The!ampliconic!
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sequences!exhibit!by!far!the!highest!density!of!genes,!both!coding!and!nonScoding,!among!
the! three! sequence! classes! in! the!MSY!euchromatin.!Nine!multiScopy!distinct!MSYSspecific!
proteinScoding!gene! families!can!be! identified,!with!copy!numbers! ranging! from!two! (VCY,9
XKRY,9HSFY,9PRY)!to!three!(BPY2)!to!four!(CDY,9DAZ)!to!six!(RBMY)!to!on!average!35!(TSPY).!
Overall,! these! nine! coding! multiScopy! gene! families! encompass! approximately! 60!
transcription!units!and!are!predominantly!or!exclusively!expressed!in!the!testis.!Furthermore,!
the! ampliconic! sequences! include! at! least! 75! other! transcription! units! for! which! strong!
evidence!of!protein!coding!is!lacking.!Of!these!75!putative!nonScoding!transcription!units,!65!
are!members!of!15!MSYSspecific!families,!and!the!remaining!10!occur!in!single!copy.!Such!an!
abundance! of! multiple! copies! and! palindromes! have! led! researchers! to! call! the! Y!
chromosome!a!"hall!of!mirrors."!Although!this!sequence!repetition!created!great!challenges!
in! the! sequencing! of! the! Y! chromosome,! the! complex! structure! also! serves! an! important!
purpose.!Multiple!copies!of!essential!spermatogenesis!genes!ensure!that!in!spite!of!deletion!
events,!which!may!result! in!the!loss!of!a!single!copy!of!an!essential!gene,!spermatogenesis!
can!still!proceed!via!proteins!produced!by!remaining!copies.!
The! ampliconic! sequences! evolved! from! a! great! variety! of! genomic! sources,! and!
accumulated!in!the!MSY!region!through!two!main!molecular!mechanisms:!the!amplification!
of!XSdegenerate!genes!and!the!transposition/retroposition!and!subsequent!amplification!of!
autosomal!genes.!Such!an!accumulation!of!SDs!(amplicons)!in!the!MSY!region!is!considered!
an!evolutionarily!conserved!strategy!of!the!Y!chromosome!to!counteract!the!accumulation!
of!deleterious!mutations,!in!the!absence!of!conventional!recombination!with!a!chromosome!
partner.! The! presence! of! massive! nearSidentical! amplicons! allows! indeed! two!
recombinationSbased!DNA!repair!mechanisms!to!occur! in!the!MSY!region:!gene!conversion!
and!nonSallelic!homologous!recombination! (NAHR).!The! first! is!a!nonSreciprocal! transfer!of!
sequence! information! from! one! DNA! duplex! to! another! (Szostak! et! al.,! 1983),! which! can!
occur!between!duplicated!sequences!on!a! single!chromosome!and! in!mitosis! (Jackson!and!
Fink,! 1981).! Gene! conversion! (nonSreciprocal! recombination)! in! the!MSY! is! as! frequent! as!
crossing!over!(reciprocal!recombination)!is!in!ordinary!chromosomes,!and!occurs!routinely!in!
30%! of! the! MSY! (Skaletsky! et! al.! 2003).! This! conversionSbased! system! of! gene! copy!
“correction”! permits! the! preservation! of! YSlinked! genes! from! the! gradual! accumulation! of!
deleterious! mutations! ensuring! their! continuity! over! time.! ! As! stated! above,! NAHR! is! a!
homologySbased!mechanism!of!accurate!DNA!repair,!which!can!also!lead!to!the!generation!
of! largeSscale! AZF! structural! rearrangements! such! as! inversions! and! CNVs! affecting! the!
dosage!of!a!number!of!YSlinked!genes.!
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Figure!2.9.!MSY!genes,!transcription!units!and!palindromes.!a)!Localization!of!the!8!palindromes!(P1S
P8)!in!the!MSY!region.!b)!MSY!region!as!represented!in!Figure!2.8.!Solid!black!triangles!denote!coding!
genes!and!transcription!units!which!are!classified!as!follow:!c)!Nine!families!of!proteinScoding!genes;!
d)! singleScopy!protein!coding!genes!and!e)! singleScopy! transcription!units!which!give! rise! to! spliced!
but!apparently!nonScoding!transcripts.!f)!Fifteen!families!of!transcription!units.!g)!Merged!map!of!all!
genes!and!transcription!units.!Figure!from!Skaletsky!et!al.!2003.!
!
The! MSY! is! flanked! on! both! sides! by! pseudoautosomal! regions! (PAR1! and! PAR2)! short!
regions!of!homology!between!the!mammalian!X!and!Y!chromosomes.!Being!present!on!both!
sex!chromosomes,!the!PARs!act!like!autosomes!and!recombine!during!meiosis.!Thus,!genes!
in!this!region!characterized!by!autosomal!inheritance!rather!than!a!strictly!sexSlinked!fashion.!
PAR1!comprises!2.6!Mb!of!the!shortSarm!tips!of!both!X!and!Y!chromosomes!and!is!required!
for!pairing!of!the!X!and!Y!chromosomes!during!male!meiosis.!All!characterized!genes!within!
PAR1!escape!X! inactivation.!XSY!pairing! in! the!PAR! is! thought! to!serve!a!critical! function! in!
spermatogenesis,! at! least! in! humans! and! mouse! (Burgoyne! et! al.,! 1983;! Matsuda! et! al.,!
1992;! Mohandas! et! al.,! 1992).! PAR2! is! located! at! the! tips! of! the! long! arms! and! is! much!
shorter,! spanning! only! 320! kb! (Freije,! 1992).! PAR2! exhibits! a! much! lower! frequency! of!
pairing!and! recombination! than!PAR1!and! is!not!necessary! for! fertility! (Helena!Mangs!and!
Morris,!2007).!
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Thanks!to!the!first!sequencing!of!the!human!X!chromosome!(Ross!et!al.,!2005),! it! is!known!
that!PAR1!contains!at! least!24!genes,!of!which!16!have!been!hitherto!characterized! (Table!
2.1),!whereas!4!genes!(SPRY3,9SYBL1,9IL9R9and9CXYorf1)!have!been!identified!on!the!PAR2.!
!
Table!2.1.!PAR1!Genes!and!Protein!Function.!Only!characterized!genes!are!showed.!
Gene! Description! Function!
PLCXD19 PhosphatidylinositolSSpecific! Phospholipase! C,!
X!Domain!Containing!1!
Ubiquitously! expressed;! diverse! biological! functions!
including! roles! in! inflammation,! cell! growth,! signaling!
and! death! and! maintenance! of! membrane!
phospholipids.!
GTPBP69 GTP!Binding!Protein!6!(Putative)! Ubiquitously!expressed.!Undefined!function.!
PPP2R3B& Protein!Phosphatase!2,!Regulatory!Subunit!B! Exerts! regulatory! control! over! the! initation! of! DNA!
replication.!Overexpression!causes!G1!cell!cycle!arrest.!
SHOX& Short!Stature!Homeobox! HomeoboxScontaining! gene,! thought! to! be! a!
transcription!factor!related!to!short!stature!syndromes.!
CRLF29 Cytokine!receptorSlike!factor!2! Receptor! for! TSLP,! a! cytokine! that! enhances! the!
maturation!process!of!dendritic!cells!and!promotes!the!
proliferation!of!CD4+!T!cells.!
CSF2RA99 ColonySstimulating!factor!2!receptor,!alpha! Alpha! subunit! of! the! receptor! for! the! granulocyteS
macrophage! colonySstimulating! factor! (GMSCSF).! GMS
CSF! is! important! for! the! growth! and! differentiation! of!
eosinophils!and!macrophages!in!the!bone!marrow,!and!
also!regulates!cell!viability!in!human!embryos.!
IL3RA9 Interleukin!3!receptor,!alpha! Alpha!subunit!of!the!receptors!for!interleukin!3.!
SLC25A699 Solute!carrier!family!25,!member!A6! Member!of!the!ADP/ATP!translocase!family,!which!has!
a! potential! role! in! Th! cell! survival! and! immune! cell!
homeostasis.!
ASMTL9 Acetylserotonin!OS!methyltransferaseSlike! Undefined!function.!
P2RY89 Purinergic!receptor!P2Y,!GSprotein!coupled,!8! Member! of! the! purine! nucleotide! GSprotein! coupled!
receptor!gene!family!
AKAP17A9 A!Kinase!(PRKA)!Anchor!Protein!17A! Splice! factor! regulating!alternative! splice! site! selection!
for! certain! mRNA! precursors.! Mediates! regulation! of!
preSmRNA!splicing!in!a!PKASdependent!manner!
ASMT9 Acetylserotonin!OSmethyltransferase! Catalyzes! the! final! reaction! in! the! synthesis! of!
melatonin.!
DHRSXY9 Dehydrogenase/reductase! (SDR! family)! XS
linked!
Encodes! an! oxidoreductase! of! the! shortSchain!
dehydrogenase/reductase!family.!
ZBED19 Zinc!finger,!BEDStype!containing!1! Binds! to! 5'STGTCG[CT]GA[CT]AS3'!DNA!elements! found!
in! the!promoter! regions!of! a!number!of! genes! related!
to!cell!proliferation.!Binds! to! the!histone!H1!promoter!
and!stimulates!transcription.!
CD999 CD99!molecule! Cell! surface! molecule! involved! in! TScell! adhesion!
processes.! Activation! of! a! distinct! domain! of! CD99!
activates! a! caspaseSindependent! death! pathway! in! TS
cells.!
XG9 Xg!blood!group! Encodes!the!XG!blood!group!antigen.!
Genes!in!bold!were!object!of!investigation!of!this!thesis.!
!
Disturbances!of!PAR1!have!been!linked!to!clinical!conditions,!such!as!isolated!short!stature,!
Leri–Weill!dyschondrosteosis!and!Langer!mesomelic!dysplasia,!all!associated!with!mutations!
in!the!SHOX!gene.!
!
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PAR19and9Disease:9the9SHOX9gene9
The! SHOX! (Short! stature! HOmeoboXScontaining)! gene,! for! the! first! time! isolated! by!
positional!cloning!(Rao!et!al.),!covers!a!genomic!region!of!40!kb!and!resides!in!the!PAR1!of!
human! sex! chromosomes! at! Xp22! and! Yp11.3,! within! a! 170Skb! region,! 500! kb! from! the!
telomeres.! Because! genes! residing! in! the! PAR1! escape! XSinactivation,! two! copies! of! the!
SHOX9gene!are!normally!expressed! in!males!as!well!as! in! females.!The!SHOX!gene!has!one!
nonScoding!and!six!coding!exons!(ranging!from!58!to!1166!bp! in!size)!and!encodes!for!two!
isoforms!of! a! homeodomainScontaining! transcription! factor,! SHOXa! (293! amino! acids)! and!
SHOXb!(225!amino!acids),!which!differ!in!the!CSterminal!region.!These!two!different!isoforms!
are!expressed!in!differential!tissues:!SHOXa!is!expressed!at!low!levels!in!many!tissues,!while!
SHOXb!has!a!more!restricted!expression,!displaying!the!highest!expression!in!bone!marrow!
fibroblasts! (ClementSJones! et! al.,! 2000;! Rosenfeld,! 2001;! Munns! et! al.,! 2004).! The!
involvement!of!the!SHOX!protein!in!bone!development!is!further!supported!by!two!studies!
reporting! its!expression! in!hypertrophic!chondrocytes!of! the!growth!plate! (Marchini!et!al.,!
2004;!Munns!et!al.,!2004).!Furthermore,!Marchini!and!colleagues!(2004)!provided!evidence!
that! the! expression! of! SHOX! also! induces! cell! cycle! arrest! and! apoptosis! in! osteosarcoma!
cells! as!well! as! in! primary! chondrocytes,! suggesting! an! involvement! of! the! protein! in! the!
processes!regulating!chondrocyte!differentiation.!
SHOX9haploinsufficiency!S!a!condition!that!results!when!one!copy!of!a!dosageSsensitive!gene!
has!been!deleted!S!was!suggested!for!the!first!time!to!be!involved!in!idiopathic!short!stature!
(ISS;! OMIM#! 604271)! and! the! short! stature! in! Turner! syndrome! (TS)! by! two! consequent!
publications!(Ellison!et!al.,!1997;!Rao!et!al.,!1997),!whereas!homozygous!loss!of!the!gene!has!
been!correlated!with!the!Langer!type!mesomelic!dysplasia!(OMIM#!249700).!It!has!also!been!
shown!that!SHOX!haploinsufficiency!can!cause!not!only!short!stature!but!also!Turner!skeletal!
abnormalities! such! as! short! fourth!metacarpals,! cubitus9 valgus! and! characteristics! of! LériS
Weill! dyschondrosteosis! (LWD;! OMIM! #127300)! (Kosho! et! al.,! 1999).! Subsequently,!
heterozygous!SHOX!mutations!were!also!shown!to!cause!LériSWeill!dyschondrosteosis!(Belin!
et!al.,!1998).!It!is!overall!estimated!that!the!incidence!of!SHOX!deficiency!is!between!1/2000S
1/5000! in! the! general! population! and! 1/40S1/150! among! short! people.! In! contrast! to! the!
clear!picture!existing!concerning!the!loss!of!one!(haploinsufficiency)!or!both!copies!of!SHOX!
and!its!deleterious!effects!on!stature,!poor!and!unclear!information!is!available!with!respect!
to!SHOX!overSdosage,!reported!in!association!with!normal!to!tall!stature!(Ogata!et!al.,!2001;!
Adamson!et!al.,!2002)!as!well!as!to!more!severe!conditions!such!as!LWD!and!idiopathic!short!
stature!(ISS)!(Roos!et!al.,!2009;!Thomas!et!al.,!2009;!D’haene!et!al.,!2010;!BenitoSSanz!et!al.,!
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2012).!SHOX! duplications!apparently!are!quite! rare,!with!only! few!cases!hitherto! reported!
(Grigelioniene! et! al.,! 2001;! Tachdjian! et! al.,! 2008;! Roos! et! al.,! 2009;! Thomas! et! al.,! 2009;!
D’haene! et! al.,! 2010;! Gervasini! et! al.,! 2010)! and! no! direct! relationship! with! any! specific!
phenotype!has!yet!been!defined.!To!date,!there!is!only!one!study!in!the!literature!reporting!
an!association!between!spermatogenic! impairment!and!SHOX!CNVs!(Jorgez!et!al.,!2011),! in!
which! the! authors! propose! that! the!mechanism!underlying! YSchromosome!microdeletions!
(paragraph!2.3.2)!might!also! lead!to!the!formation!of!PAR!rearrangements,! including!SHOX9
deletions!and!duplications.!
2.3.2.9Y9chromosome[linked9CNVs9
The!Y!chromosome!is!peculiar!for!its!haploid!nature!that!precludes!recombination!with!the!X!
chromosome! for! most! of! its! length.! This! unique! characteristic! led! to! YSY! recombination!
events!between!homologous!sequences!within!the!Y!chromosome.!This!phenomenon!led!to!
the! accumulation! of! a! relevant! number! of! segmental! duplications! (also! called! amplicons),!
which!constitute!a!favorable!substrate!for!CNV!formation!because!of!their!susceptibility!to!
both!NAHR!and!gene!conversion,!previously!described!in!paragraph!2.3.1.!
Since!that! the!Y!chromosome!does!not!undergo!recombination!during!the!crossingSover,!a!
phylogenetic! approach! was! used! to! study! the! dynamics! of! YSlinked! CNVS! and! their!
mechanisms!of!formation!(Jobling,!2008).!This!study!showed!that!determining!the!frequency!
of!a!given!CNV!in!different!Y!lineages!allows!deducing!the!minimum!number!of!independent!
mutation!events!accounting!for!the!CNV!distribution.!As!illustrated!in!Fig.!2.10,!the!dynamics!
of!the!YSlinked!CNVs!can!be!ascribed!to:!
• Unique! CNVs:! these! are! present! in! all! the!members! of! a! given! Y! haplogroup! but!
absent!in!other!lineages!(CNV1!in!the!Fig.2.10).!In!this!case,!the!mutation!is!a!unique!
event!that!has!occurred!in!the!ancestral!Y!chromosome!of!that!specific!haplogroup.!
• Recurrent! CNVs:! distributed! among! different! branches,!may! arise! through! several!
independent!mutation!events!reflecting!the!highly!mutagenic!nature!of!the!involved!
region!(CNV2!and!CNV3!in!the!Fig.2.10).!In!the!case!of!recurrent!CNVs!showing!high!
prevalence! in!Y!haplogroups! (CNV2),!belonging! to!more!than!one! lineage! indicates!
that!the!mutation!has! likely!occurred! in!the!ancestral!Y!chromosome!of!more!than!
one! lineage;! though,! in!some!members!of! the!same!haplogroup!“reversion”!of! the!
mutation! has! occurred.! This!mainly! occurs! in! cases! of! CNVs!with! a! high!mutation!
rate.! Finally,! CNVs! that! occur! with! very! high! recurrence! can! also! form! as!
independent!events!in!different!Y!lineages!(CNV3).!
!
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Figure! 2.10.! Phylogenic! approach! used! for! the! study! of! the! dynamics! of! YS
linked!CNV!formation.!Figure!from!Joblin!et!al!2008.!
!
Furthermore,!making!an!estimate!of!the!number!of!generations!encompassed!by!a!sampled!
chromosome!during!evolution!allows!inferring!the!mutation!rate!of!a!certain!CNV!(Hammer!
and!Zegura,!2002;!Repping!et!al.,!2006;!Karafet!et!al.,!2008).!
YSlinked!CNVs!have!been!object!of! investigation! in!several! fields!of!research,! from!forensic!
and!population!genetics!studies!to!molecular!reproductive!genetics,!the!latter!being!mainly!
focused! on! the! investigation! the! AZF! region! in! men! with! altered! spermatogenesis.! The!
comprehensive!and!objective!picture!nowadays!available!in!relation!to!YSlinked!CNVs!is!the!
fruit!of!groundbreaking!studies!that!provided!systematic!genomeSwide!CNV!surveys!(Redon!
et!al.,!2006;!Perry!et!al.,!2008)!and!reSsequencing!data!of! the!entire!whole!Y!chromosome!
(Levy!et!al.,!2007).!The!largest!scale!study!(Redon!et!al.!2006)!employed!CGH!to!explore!104!
distinct!Y!chromosomes!from!the!HapMap!sample!(n=270),!revealing!that!the!AZFc!region!is!
the! most! variable! euchromatic! portion! in! terms! of! CNVs! (Fig.! 2.11.).! In! the! following!
paragraph!the!more!common!known!AZFSlinked!CNVs!will!be!described.!
!
Figure! 2.11.! Representation! of! the! log2! ratio! from! comparative! genomic! hybridization! to! BAC!
clones! spanning! the! Y! euchromatin.! The!most!dynamic! region! corresponds! to! the!AZFc! region.!
(Figure!by!Jobling!et!al.!2008).!
AZF9microdeletions9
The! first!association!between!azoospermia!and!microscopically!detectable!deletions! in! the!
long!arm!of!the!Y!chromosome!(Yq),!was!reported!by!Tiepolo!and!Zuffardi!in!1976!(Tiepolo!
and!Zuffardi,!1976).!The!authors!proposed!the!existence!of!an!AZoospermia!Factor!(AZF)!on!
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Yq,! representing! a! key! genetic! determinant! for! spermatogenesis,! since! its! deletion! was!
associated!with!the!lack!of!spermatozoa!in!the!ejaculate.!Due!to!the!structural!complexity!of!
the! Y! chromosome,! the!molecular! characterization! of! the! AZF! took! about! 30! years! to! be!
achieved.!With!the!development!of!molecular!genetic!tools!and!the!identification!of!specific!
markers!on!the!Y!chromosome!(Sequence!Tagged!Sites,!STSs),!it!was!possible!to!circumscribe!
the!AZF! region.!Three!AZF! subSregions!were! identified! in!proximal,!middle!and!distal!Yq11!
and!designated!AZFa,!AZFb!and!AZFc,!respectively.!It!was!later!demonstrated!that!AZFb!and!
AZFc!overlap,!being!1.5!Mb!of!the!distal!portion!of!AZFb!interval!part!of!the!AZFc!region!(Fig.!
2.12).!
!!
Figure! 2.12.! Structure!of!AZF! region!of! the!Yq.!Schematic! representation!of! the!Y!chromosome!
showing!the!three!AZF!regions!(A)!with!each!specific!STSs!(B).!
!
SubSmicroscopic! deletions! involving! the! AZF! regions,! regarded! to! as! YSchromosome!
microdeletions,!occur!in!1/4000!males!in!the!general!population.!They!are!now!considered!a!
wellSestablished! genetic! cause! of! male! infertility! being! exclusively! found! in! men! with!
impaired!sperm!production.!The!AZF!microdeletion!screening! is!now!part!of!the!diagnostic!
workSup!of!severe!male! factor! infertility! (Krausz!et!al.,!2014).! Indications! for!AZF!deletions!
screening!are!based!on!sperm!count!and! include!azoospermia!and!severe!oligozoospermia!
(<5!million!spermatozoa/ml).!Thanks!to!the!EAA!guidelines!and!EAA/EMQN!external!quality!
control!program!(http://www.emqn.org/emqn/)!Yq!testing!has!become!more!homogeneous!
and! reliable! in! different! routine! genetic! laboratories.! The! EAA! guidelines! provide! a! set! of!
primers!(two!markers!for!each!region),!which!is!able!to!detect!virtually!all!clinically!relevant!
deletions.! Deletion! frequency! increases! with! the! severity! of! spermatogenic! impairment!
amounting! to! 5S10%! among! nonSobstructive! azoospermic! men,! 2S4%! among! severe!
oligozoospermic!men!with! less! than! 5!million! spermatozoa/ml! and! less! than! 0.5%! among!
men!with! sperm!concentration!between!5!and!10!million!spermatozoa/ml.!YSchromosome!
microdeletions! have! never! been! found! among! men! with! normal! sperm! parameters!
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(normozoospermic! men).! In! addition! to! the! semen! phenotype,! also! ethnic! background! is!
likely! to! influence! the! occurrence! of! this! genetic! anomaly! as! suggested! by! the! different!
deletion! frequency! observed! even!within! similar! semen! categories! amongst! infertile!men!
from! different! populations.! In! this! regard,! the! lowest! deletion! frequency! (1.8%)! was!
reported! in! German! and! Danish! idiopathic! severely! oligozoospermic! men! (Cruger! et! al.,!
2003;! Simoni! et! al.,! 2008),!whereas! the! highest! in! an! ethnically! admixed! population! from!
France!(13.7%)!(Krausz!et!al.,!1999)!and!in!Romanians!(10%)!(Raicu!et!al.,!2003).!In!most!of!
the! cases!Y!microdeletions!arise!as!de9novo! event! and!are!associated!with!heterogeneous!
seminal!and!testicular!phenotypes.!
Y!microdeletions!arise! through!NAHR!and,!according!to! their! recombination!hotSspot,! they!
can!be!classified!as!AZFa,!P5Sproximal!P1! (AZFb),!P5Sdistal!P1! (AZFbc),!P4Sdistal!P1! (AZFbc)!
and!b2/b4!(AZFc)!deletions.!
The!AZFa!region!spans!792!Kb!and!unlike!either!AZFb!or!AZFc,! is!exclusively!constituted!by!
singleScopy! DNA.! The! complete! deletion! of! AZFa! interval! results! from! nonSallelic!
homologous! recombination! between! two! flanking! HERV! elements! (human! endogenous!
retroviral!elements),!spanning!10!Kb!each!and!displaying!an!overall!94%!of!sequence!identity.!
Two!ubiquitously!expressed!genes!map!inside!the!AZFa!region!and!are!thus!involved!in!the!
deletion:!USP9Y! and!DDX3Y.! The!AZFa!deletion! is! a! rather! rare!eventS! less! than!5%!of! the!
reported! Y!microdeletions! (Kamp! et! al.,! 2001;! Krausz! and! Degl’Innocenti,! 2006)S! and! it! is!
invariably! associated! with! azoospermia! due! to! the! complete! absence! of! germinal! cells! in!
seminiferous! tubules,! a! condition! known! as! pure! Sertoli! Cells! Only! Syndrome! (SCOS)!
(Kleiman! et! al.,! 2012).! The! low!prevalence!most! likely! depends! on! both! limitations! of! the!
deletion!mechanism!(it!is!characterized!by!a!relatively!short!recombination!target),!and!the!
potential! negative! selection! of! the! deletion! due! to! its! deleterious! effect! on! fertility.! The!
corresponding! NAHR! product,! the! AZFa! duplication,! is! detected! at! a! fourfold! higher!
frequency! when! compared! to! that! of! the! deletion! indicating! that! increased! AZFa! gene!
dosage!does!not!affect!fertility!(Bosch!and!Jobling,!2003).!
The!AZFb!region!spans!a! total!of!6.23!Mb!and!contains! three!singleScopy!regions,!a!DYZ19!
satellite!repeat!array!and!14!ampliconic!elements!organized!in!palindromes!(from!P2!to!P5!
and!the!proximal!part!of!P1)!of!which!P5/P4!and!P1!are!the!NAHR!targets!giving!rise!to!the!
complete! and! partial! AZFb! deletion,! respectively.! AZFb! deletion! carriers! are! azoospermic!
with! testicular!histology!of!maturation!arrest!at! the! spermatocyte/spermatid! stage.!Unlike!
the!AZFa!deletion,!no!evidence!for!reciprocal!duplications!have!been!reported!for!the!AZFb!
deletion,!so!far.!
! 37!
The!AZFc!deletion!spans!3.5!Mb!and!results!from!the!NAHR!between!the!flanking!b2!and!b4!
amplicons.! The! deletion! removes! 21! genes! and! transcriptional! units! belonging! to! 8!
multicopy! gene! families! (Fig.19).! These! include! 3! protein! coding! gene! families! (BPY2,9 CDY!
and! DAZ)! specifically! expressed! in! the! testis.! The! AZFc! deletion,! accounting! for!
approximately!60%!of!all!recorded!AZF!deletions!(NavarroSCosta!et!al.,!2010a),!is!associated!
with!severe!spermatogenic!impairment!phenotype!(azoospermia!or!severe!oligozoospermia)!
related! to! variable! testicular! pictures! ranging! from! pure! and! mixed! SCOS! to!
hypospermatogenesis!and!maturation!arrest.!A!deterioration!of!semen!quality!over!time!has!
been!suggested!for!AZFc!deleted!oligozoospermic!men!based!on!indirect!observations!such!
as! the! difference! in! age! between! carriers! with! azoospermia! and! oligozoospermia! or! the!
increase!of!FSH!concentrations!over!time!in!some!subjects.!However,!this!issue!is!nowadays!
still!debated.!
Within!the!AZFc!region!three!different!patterns!of!partial!deletions!have!been!identified,!the!
gr/gr,!b2/b3!and!b1/b3!deletions!(Repping!et!al.,!2006)!(Fig.!2.13)!but!only!the!gr/gr!deletion!
is!of!potential!clinical!interest.!Four!metaSanalyses!are!published!on!this!topic!and!all!report!
that!the!gr/gr!deletion!confers!on!average!a!2S!to!2.5Sfold! increased!risk!of!reduced!sperm!
output/infertility! (Tüttelmann!et!al.,! 2007;!Visser!et! al.,! 2009;!NavarroSCosta!et! al.,! 2010a;!
Stouffs! et! al.,! 2011)! making! this! deletion! a! unique! example! in! andrology! of! a! confirmed!
significant! genetic! risk! factor! for! impaired! sperm! production.! The! gr/gr! deletion! removes!
half! of! the! genetic! content! (1.6! Mb)! of! the! AZFc! region.! Eight! testisSspecific! gene! and!
transcription!unit!families!are!affected!by!this!deletion!pattern.!In!particular,!it!removes!two!
copies!of! the!DAZ!gene!and!1!copy!of!CDY1!gene,!which!are!the!two!most! important!AZFc!
candidate!infertility!genes.!
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Figure! 2.13.!AZF! deletion! patterns.!Recombining!amplicons! /palindromes! responsible! for! each!AZF9
deletions!and!genes!involved!are!shown.!AZFa!is!flanked!by!two!human!endogenous!retrovirus!(HERV)!
elements! that!mediate! the!occurrence!of!AZFa9deletions!via!nonSallelic!homologous!recombination.!
AZFb! and! AZFb+c! deletions! are! caused! by! P5/proximal! P1! yel3/yel1)! and! P5Sdistal! P1! (yel3/yel2)!
recombination,!respectively.!NAHR!between!b29and!b4!amplicons!lead!to!AZFc9deletion.!Figure!from!
Navarro9–Costa92010a.9!
!
The! identification! of! Yq! microdeletions,! which! explain! the! etiology! of! the! impaired!
spermatogenesis,! is! not! only! relevant! from! a! diagnostic! standpoint,! but! it! also! has! a!
prognostic!value!prior!testicular!biopsy!(TESE)!(Brandell!et!al.,!1998;!Krausz!et!al.,!2000b).!In!
this! regard,! in! case! of! complete!AZFa! and!AZFb! deletions! of! the! Y! chromosome! testicular!
biopsy!is!not!advised!because!the!chance!of!finding!spermatozoa!is!virtually!zero.!The!AZFc!
deletion!is!compatible!with!the!presence!of!spermatozoa!in!the!testis!or!in!the!ejaculate,!and!
is!obligatorily! transmitted! to! the!male!offspring.!Therefore,!genetic! counseling! for! infertile!
couples! willing! to! undertake! ART! treatment! is! mandatory.! The! severity! of! spermatogenic!
failure!in!the!son!may!vary!considerably,!although!given!the!strict!cause–effect!relationship!
between!AZF!deletions!and! impaired!spermatogenesis,!normal!spermatogenesis!cannot!be!
warranted.!When! it! comes! to! the!exact! testicular!phenotype,!predictions! cannot!be!made!
because! of! the! different! genetic! background! and! environmental! factors! that! will! have!
impacted!on!the!reproductive!functions!and!fertility!potential!of!the!father!and!his!son.!
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Concerns! have! been! raised! about! the! potential! risk! for! Turner’s! syndrome! (45,X)! in! the!
offspring! and! other! phenotypic! anomalies! associated! with! sex! chromosome! mosaicism,!
including! ambiguous! genitalia.! Data! on! men! with! Y! microdeletions! (Siffroi! et! al.,! 2000;!
RajpertSDe!Meyts!et!al.,!2011)!and! in!patients!bearing!a!mosaic!46,XY/45,X!karyotype!with!
sexual! ambiguity! and/or! Turner! stigmata! (Patsalis! et! al.,! 2005)! suggest! that! some! Yq!
microdeletions!are!associated!with!an!overall!YSchromosomal! instability!which!might!result!
in!the!formation!of!45,X!cell!lines.!A!recent!study!(Jorgez!et!al.,!2011)!reported!that!5.4%%!of!
men! with! AZF! deletions! and! a! normal! karyotype! also! carried! SHOX! haploinsufficiency.!
Indeed,! this! study! raised! the!question! about! the! importance!of! screening! for!SHOXSlinked!
CNVs!in!men!carrying!YSchromosome!microdeletions,!which!constitutes!one!of!the!objects!of!
this!thesis.!!
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2.4.!The!X!chromosome!
2.4.1.9General9features9and9structure9
The!X!chromosome! is!a! subSmetacentric! chromosome! representing!almost!5%!of! the! total!
DNA!in!women,!whereas!in!men,!who!are!hemizygous!for!the!X!chromosome,!it!represents!
about!2.5%!of!the!total!DNA.!The!reference!sequence!of!the!human!X!chromosome!has!been!
recently!reassembled!(Mueller!et!al.,!2013)!and!accordingly! its!total!size!amounts!to!about!
155.3!Mb.!It!displays!a!low!(G+C)!content!(39%)!compared!with!the!genome!average!(41%)!
and! it! is! highly! enriched! in! repetitive! sequences.! These! regions! account! for! 56%! of! the!
euchromatic!XSchromosome!sequence!and!are!represented!by:!
• Short! Interspersed! Nuclear! Elements! (SINEs)! belonging! to! the! Alu9 family,! the!
content!of!which!in!the!X!chromosome!is!below!the!genome!average.!
• Long!Terminal!Repeats!(LTRs)!the!coverage!of!which!is!above!average.!
• Long! Interspersed! Nuclear! Elements! (LINEs)! of! the! L1! family,!which! are! the!most!
represented!class!of!repetitive!elements!of!the!X!chromosome,!accounting!for!29%!
of!the!chromosome!sequence!compared!to!a!genome!average!of!only!17%!(Ross!et!
al.,!2005).!
• Ampliconic! sequences! (segmental!duplications!of!>10!Kb!sharing!>!99%!nucleotide!
identity)!represent!approximately!2%!(3.15!Mb)!of!the!chromosome!length!(Mueller!
et!al.,!2013).!!
The! crossSspecies! alignment! of! orthologous! XSlinked! genes! allowed! defining! two!
evolutionary!domains!that!are!characteristic!of!the!X!chromosome:!
• The!XOconserved! region! (XCR),! an! ancestral! region! including! all! the! long! arm! and!
PAR1,!which!would!descend!from!the!protoSX!chromosome,!one!of!two!‘proto’!sex!
chromosomes! evolved! from! the! ancestral! autosome! pair! according! to! the! Ohno’s!
theory! (Ohno,! 1967).! All! mammals! share! this! evolutionary! domain! (placental! and!
not).!
• XOadded!region!(XAR)!including!the!short!arm!and!the!PAR2,!which!established!on!X!
chromosome! by! translocation! from! a! second! autosome.! This! region! is! exclusively!
present!in!placental!mammals.!!
The!gene!density!of! the!X! chromosome! is!among! the! lowest! in! the!genome! (7.1!gene!per!
Mb)! (Ross! et! al.! 2005).! This! unusually! low! gene! density! is! probably! a! consequence! of! the!
! 41!
massive! expansion! of! nonScoding! intergenic! sequences! that! during! evolution! have! been!
interposing!between!genes!(Bellott!et!al.,!2010).!
2.4.2.9X[linked9genes9
A! total! of! 1551! genes! have! been! hitherto! annotated! in! the! genomic! databases!
(www.ensembl.org/biomart)! and,! of! these,! 800! are! proteinScoding! genes.!With! the! more!
accurate! assembly! and! consequent! recalibration! of! the! human! X! chromosome’s! gene!
content,! Mueller! et! al.! tested! Ohno’s! law! S! which! states! that! the! gene! content! of! X!
chromosomes! is! conserved! among! placental! mammalsS! by! systematically! comparing! the!
gene! contents! of! the!human!and!mouse!X! chromosomes.! They! found! that! 18%! (144/800)!
proteinScoding!genes!violate!Ohno’s!law,!since!they!were!not!shared!by!the!two!species.!The!
majority!of!them!(76/144;!52.7%)!were!acquired!independently!on!the!X!chromosome!since!
the! two! lineages! began! to! diverge! from! a! common! ancestor! 80! million! years! ago;! such!
independent! acquisition! apparently! occurred! through! transposition! or! retroposition! from!
autosomes,! or! having! arisen! de9 novo.! Among! the! independently! acquired! XSlinked! genes,!
approximately! twoSthirds! (48/76)!are!ampliconic! (i.e.!embedded! in!duplicated!segments!of!
>10! kb! in! length! and! exhibiting! >99%! nucleotide! identity),! whereas! the! remaining! are!
multicopy! (only! the! gene! structure! is! duplicated)! or! single! copy! genes.! Interestingly,!
ampliconic!genes!are!predicted!to!have!a!function!in!male!fitness.!Overall,!only!31%!of!the!
human!XSampliconic!genes!had!orthologs!in!the!other!species.!!
Mueller!et!al! (2013)!also!reported!that!most! independently!acquired!human!and!mouse!XS
linked!genes!exhibit!high!expression!in!the!testis!and!little!or!no!expression!in!other!tissues.!
In!mice,!this!prevalent!testis!expression!is!related!to!the!male!germ!cellSrestricted!expression!
of!these!genes!regardless!of!whether!they!are!single,!multiScopy!or!ampliconic!(Mueller!et!al!
2013).! These! novel! findings! are! in! line! with! previous! genomic! studies! reporting! an!
enrichment! on! the! mammalian! X! chromosomes,! compared! to! the! autosomes,! for! maleS
specific! single! and! multiScopy! genes! showing! testisSrestricted! or! predominant! expression!
(Wang!et!al.,!2001;!Lercher!et!al.,!2003;!Mueller!et!al.,!2009;!Zheng!et!al.,!2010).!Given!that!
the!independently!acquired!genes!are!expressed!predominantly!in!spermatogenic!cells,!one!
might! anticipate! that! lossSofSfunction! mutations! affecting! these! genes! or! gene! families!
would!perturb!male!gametogenesis.!
Given!that!the!X!chromosome!is!enriched!with!single!copy!genes!expressed!during!the!early!
stages!of!murine!spermatogenesis,!it!was!originally!suggested!that!mainly!preSmeiotic!genes!
were! located! on! the! X! chromosome! (Wang! et! al! 2001).! Accordingly,! X! chromosome! is!
transcriptionally! active! only! in!mitotically! dividing! spermatogonia! and! in! the! early!meiotic!
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(preSpachytene)!spermatocytes.!During!meiosis!XSlinked!genes!undergo!the!soScalled!meiotic!
sex! chromosome! inactivation! (MSCI)! and! thus! are! transcriptionally! silenced! (Zheng! et! al.,!
2010).!However,!evidence!shows!that!many!microRNAs!are!expressed!also!at!the!pachytene!
stage,!when!MSCI!occurs,!suggesting!that!a!transcriptional!activity!coSexists!also!during!and!
after!meiosis!(Song!et!al.,!2009).!The!escape!from!MSCI!silencing!by!XSlinked!mRNA!suggests!
that! they! may! contribute! to! MSCI! or! be! involved! in! postStranscriptional! regulation! of!
autosomal!mRNA!during!meiotic!and!postSmeiotic!stages!of!spermatogenesis.!In!addition,!a!
postSmeiotic! transcription! reactivation!has! been! reported! for! several!multiScopy!mouse!XS
linked! gene! families! (Wang! et! al.,! 2005;! Mueller! et! al.,! 2008)! showing! higher! expression!
levels! compared! to! single! copy! genes! (Fig.! 2.14).! It! was! therefore! hypothesized! that!
increasing!copy!number!may!be!a!mechanism!to!counteract!transcriptional!repression!of!the!
X!chromosome!in!postSmeiotic!germ!cells.!
!
!
Figure!2.14.!MultiScopy!genes!evade!the!effects!of!X!chromosome!postSmeiotic!repression!in!the!mouse.!
SingleScopy!and!multiScopy!XSlinked!genes!exhibit!similar!average!levels!of!expression!during!preSmeiotic!
spermatogenesis.!All!XSlinked!genes!are!subsequently!silenced!during!MSCI.!Following!MSCI,!singleScopy!
XSlinked! genes! exhibit! low! reactivation! levels! whereas! multiScopy! XSlinked! genes! exhibit! expression!
levels! similar! to! autosomal! genes,! thus! evading! the! effects! of! postSmeiotic! repression.! Figure! from!
Mueller!et!al.!2008.!
!
The!most!represented!XSlinked!testis!specific!gene!families!are!the!Cancer!Testis!(CT)!genes!
which!have!been!suggested!to!account!for!10%!of!human!XSchromosome!gene!content!(Ross!
et!al!2005).!CT!genes!are!defined!by!a!unique!expression!pattern:!amongst!normal!tissues,!
they! are! expressed! exclusively! or! predominantly! in! male! germ! cells! and! in! embryonic!
trophoblasts,! but! their! gene! products! are! also! found! in! a! significant! number! of! human!
tumors! of! different! histological! origin.! At! least! 70! families! of! CT! genes! with! over! 140!
members! have! been! identified! so! far! and! recently! listed! in! a! database! established! by! the!
Ludwing!Institute!for!Cancer!Research!(http://!www.cta.Incc.br/)!(Almeida!et!al.,!2009).!The!
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XSlinked!CT!genes!(XSCT)!represent!more!than!half!of!all!CT!genes!and!often!constitute!multiS
copy!gene! families!organized! in!wellSdefined!clusters!along! the!X! chromosome,!where! the!
different! members! are! arranged! into! complex! direct! and! inverted! repeats! (segmental!
duplications)!(Fratta!et!al.,!2011).!This!feature!account!for!the!susceptibility!of!CT!genes!to!
CNVs!even!though!their!multiScopy!gene!status!may!be!a!strategy!to!increase!the!chance!to!
escape!MSCI!during!meiosis,! as!observed! for!mouse!XSlinked!multiScopy!genes.!The!MAGE9
(Melanoma! antigen)! and! GAGE! (G! antigen)! are! the! largest! and! bestSknown! XSCT! gene!
families! containing! at! least! 24! and! 16! members,! respectively! (Stouffs! et! al.,! 2009).! The!
biological! function! of! most! XSCT! genes! is! still! largely! unknown.! However,! evidence! is!
emerging! that! the! best! studied! of! these,! the!MAGE! genes,! can! act! as! signal! transducing!
transcriptional! modulators.! Moreover,! MAGE! genes! appear! to! be! able! to! mediate!
proliferative! signals! (Park! and! Lee,! 2002;!Duan! et! al.,! 2003;!Glynn! et! al.,! 2004).! In! normal!
testis,!XSCT!genes!are!expressed!primarily! in!the!spermatogonia.!According!to!the!soScalled!
Rice’s! theory,! such! enrichment! of! maleSspecific! genes! on! the! X! chromosome! would! be!
related! to! the! accumulation! of! recessive! alleles/genes! with! beneficial! effect! for! men!
(masculinization!of!the!X!chromosome).!Indeed,!recessive!alleles!that!are!beneficial!to!males!
will! expectedly! become! fixed! more! rapidly! on! the! X! chromosome! than! on! an! autosome!
(Hurst,! 2001)! and! if! these! alleles! were! detrimental! to! females,! their! expression! could!
become!restricted!to!male!tissues.!!
Why9studying9the9X9chromosome?9
Being!the!“male“!chromosome,!the!Y!chromosome!has!been!for!decades!the!main!focus!of!
most! of! the! research! related! to! the! genetics! of! male! infertility.! However,! the! constant!
discoveries!that!throughout!time!allowed!the!fine!characterization!of!the!sequence!and!gene!
content!of!the!X!chromosome!encouraged!researchers!to!expand!their!investigation!to!this!
chromosome!as!well.!
Two!main!features!make!the!X!chromosome!an!undeniably!attractive!object!for!the!study!of!
male!infertility.!As!thoroughly!explained!in!paragraph!2.4.2,!this!chromosome!is!full!of!genes!
specifically!expressed!in!the!testis,!thus!potentially!involved!in!spermatogenesis.!Moreover,!
with!the!exception!of!PARSlinked!genes,!men!are!hemizygous!for!most!of!the!genes!located!
on!this!chromosome!and!any!de9novo!mutation!might!have!an!immediate!impact,!since!no!
compensation!is!exerted!by!another!normal!allele.!Considering!that!deleterious!mutations!in!
crucial! spermatogenesis! genes! cannot! be! transmitted! to! future! generations,! it! is! highly!
probable! that! they! arise! de9 novo9 and! at! a! low! frequency.! For! this! reason,! also! private!
mutations! S! found! only! in! one! infertile! patientS! might! cause! infertility.! Furthermore,!
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considering! the! low! prevalence! of! single! gene! mutations! in! candidate! spermatogenesis!
genes,! it! is! currently! postulated! that! infertility! should! be! regarded! as! a! polygenic! disease!
(Cram!et!al.,! 2004).! In! this! view,! the! classical! candidate!gene!approach,! focusing!on! single!
genes! of! interest,! is! a! definitely! inefficient! strategy! as! shown!by! the! paucity! of!mutations!
hitherto! identified! in! the! seven!XSlinked!candidate!genes! studied! so! far! (AR,9SOX3,9USP26,9
NXF2,9 TAF7L,9 FATE9 e9 AKAP);! for! instance,! potentially! causative! mutations! have! been!
reported!only!in!the!AR!gene.!
As! mentioned! in! paragraph! 2.1.2,! discovery! research! has! now! shifted! to! wholeSgenome!
approaches.!HighSthroughput!technologies!such!as!microarrays,!including!SNP!arrays!and!aS
CGH,!and!nextSgeneration!sequencing!(NGS)!provide!the!coverage!necessary!to!identify!new!
genetic! associations! and!allows! the! simultaneous! screening!of! a! large!number!of! carefully!
phenotyped!samples,!which!is!a!very!important!requirement!for!the!successful!identification!
of! novel! genetic! associations! with! infertility.!While! the! application! of! NGS! approaches! to!
male!infertility!is!still!dawning!and!literature!is!still!very!poor!in!this!regard,!microarrays!have!
already!been!successfully!employed!in!the!last!years!for!the!study!of!CNVs!(Tüttelmann!et!al.,!
2011;! Krausz! et! al.,! 2012a;! Stouffs! et! al.,! 2012;! Lopes! et! al.,! 2013)! and! allowed! the!
identification! of! novel! genetic! factors,! including! a! number! of! XSlinked! CNVs! of! potential!
clinical!relevance!in!the!etiology!of!male!infertility.!
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3.!AIM!OF!THE!THESIS!
The!general!objective!of!this!thesis!was!to!investigate!on!the!genetic!and!epigenetic!factors!
potentially!involved!in!idiopathic!male!infertility.!For!this!purpose,!a!thorough!research!was!
performed! in! order! to! determine! the! role! of! sex! chromosomesSlinked! CNVs! and! a! highS
resolution! methylation! microarray! was! employed! in! order! to! provide! a! comprehensive!
overview!of!the!“normal”!human!sperm!methylome.!
!
The! first! part! of! this! thesis!was! aimed! to! the! analysis! of! not! yet! identified! genetic! factors!
related!to!the!X!chromosome,!by!addressing!the!following!specific!issues:!
1. To! provide! an! X! chromosomeSspecific! outline! of! CNVs!mapping! to! the! genome! of!
infertile!patients!and!to!evaluate!their!potential!association!with!male!infertility.!
2. To! investigate! the! role! of! three! recurrent! XSlinked! deletions! in! the! etiology! of!
spermatogenic!failure.!
3. To! investigate! the! role! of! five! selected! XSlinked! duplications! in! the! etiology! of!
spermatogenic!failure.!
!
The!second!part!of!this!thesis!was!dedicated!to!the!analysis!of!genetic!factors!related!to!the!
Y!chromosome!and!addressed!the!following!specific!issue:!
• To! investigate! whether! AZF! microdeletions! on! the! Y! chromosome! are! associated!
with!SHOX!haploinsufficiency.!
!
The!third,!and!last,!part!of!this!thesis!regards!the!study!of!male!infertility!from!the!epigenetic!
standpoint,! which! provides! a! comprehensive! description! of! the! methylation! profile! of!
spermatozoa!from!normozoospermic!subjects;!furthermore,!the!following!specific!questions!
were!addressed:!
• Is! there! a! difference! in! the! DNA! methylation! pattern! between! qualitySfractioned!
sperm!populations!deriving!from!the!same!individual?!
• Is! there! an! interSindividual! variability! between! the! methylation! profiles! of! whole!
sperm! populations! and! qualitySfractioned! sperm! subpopulations! deriving! from!
different!normozoospermic!subjects?!
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4.!RESULTS!
Considering! the! aforementioned! objectives,! the! results! presented! in! this! thesis! can! be!
divided!accordingly.!
To!fulfill!the!objectives!related!to!the!first!part!of!this!thesis,!the!initial!step!consisted!in!
the!application!of!an!innovative!approach!based!on!a!high!resolution!arrayS!CGH!platform!
specific! for! the! X! chromosome,! which! provided! the! first! detailed! analysis! of! XSlinked!
losses!and!gains! in! several!hundred! subjects!with!known!sperm!parameters.!This! study!
led!to!the!identification!of!73!CNVs!(29!losses!and!44!gains)!S!detected!in!men!with!both!
abnormal! and!normal! spermatogenesis! –! and! to! the! finding! that! infertile! patients!with!
impaired! spermatogenesis! have! a! significantly! higher! burden! of! CNVs! compared! to!
normozoospermic!controls!(Krausz!et!al.,!2012a).!These!preliminary!data!served!then!for!
the! analysis! of! selected! patientSspecific! CNVs! with! potential! clinical! interest! in! larger!
caseScontrol! settings.! Basically,! two! separate! studies! were! subsequently! performed! in!
order!to!define!the!clinical! implication!of!selected!XSlinked!losses!and!gains.!The!former!
study!allowed!the!identification!and!characterization!of!three!recurrent!CNVs,!exclusively!
(CNV67)!or!predominantly!(CNV64,!CNV69)!found!in!patients,!providing!the!first!evidence!
of! a! significant! association! between! recurrent! XSlinked! deletion! and! spermatogenic!
failure! (Lo! Giacco,! Chianese! et! al.! 2013).! Similarly,! the! latter! study! allowed! the!
identification!of!novel!spermatogenesis!candidate!genes!linked!to!the!five!selected!gains!
and! the! discovery! of! the! first! recurrent,! XSlinked! gain! with! potential! clinical! relevance!
(Chianese!et!al.,!2014).!
With! respect! to! the! second! purpose! of! this! thesis,! the! SHOX! copy! number! status! was!
analyzed! in!a! large!collection!of!men!carrying!all! type!of!AZF!deletions,! including!partial!
deletions! and! giving! special! focus! to! YSchromosome! microdeletions! carriers! with! a!
normal! karyotype.! Results! from! this! study! showed! that! both! partial! and! complete! YS
chromosome!microdeletions! in!men!with! 46,XY! karyotype! are! unlikely! associated!with!
SHOX!haploinsufficiency,!since!of!177!carriers!none!had!SHOX9deletions.!
Finally,!to!accomplish!the!third!purpose!of!this!thesis,!the!highSresolution!Infinium!450K!
methylation!array!was!used!to!obtain!the!sperm!DNA!methylation!profile!at!the!towering!
number!of!487,517!CpGs!sites!in!a!group!of!eight!normozoospermic!subjects,!the!largest!
number! of! subjects! ever! considered! by! that! time.! Data! from! this! study,! on! one! hand,!
allowed! defining! that! the! DNA! methylation! profile! is! highly! conserved! among!
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normozoospermic! subjects;! on! the! other! hand,! the! examination! of! different! qualityS
fractioned! sperm!populations!deriving! from! the! same! individual! also!demonstrated! the!
stability!in!the!sperm!DNA!methylation!pattern!(Krausz!et!al.,!2012).!
!
The!results!briefly!resumed!above!will!be!presented! in!detail! in!the!following!published!
articles:!
!
OBJECTIVE!1.!
1 High! resolution! X! chromosomeOspecific! arrayOCGH! detects! new! CNVs! in! infertile!
males.!Krausz!C,!Giachini!C,!Lo!Giacco!D,!Daguin!F,!Chianese!C,!Ars!E,!RuizSCastane!E,!
Forti!G,!Rossi!E.9PLoS9One.!2012!7(10):e44887.!
2 Recurrent! X! chromosomeOlinked! deletions:! discovery! of! new! genetic! factors! in!
male!infertility.!Lo!Giacco!D!and!Chianese!C,!Ars!E,!RuizSCastañé!E,!Forti!G,!Krausz!C. 
J9Med9Genet.920149May;51(5):340[4.9
3 X! chromosomeOlinked! CNVs! in!male! infertility:! discovery! of! overall! duplication!
load! and! recurrent,! patientOspecific! gains! with! potential! clinical! relevance. 
Chianese!C,!Gunning!AC,!Giachini!C,!Daguin!F,!Balercia!G,!Ars!E,!Lo!Giacco!D,!RuizS
Castañé!E,!Forti!G,!Krausz!C. PLoS9One.920149Jun910;9(6):e97746.9
9
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• YOchromosome microdeletions!are!not!associated!with!SHOX!haploinsufficiency.9
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!
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Abstract
Context: The role of CNVs in male infertility is poorly defined, and only those linked to the Y chromosome have been the
object of extensive research. Although it has been predicted that the X chromosome is also enriched in spermatogenesis
genes, no clinically relevant gene mutations have been identified so far.
Objectives: In order to advance our understanding of the role of X-linked genetic factors in male infertility, we applied high
resolution X chromosome specific array-CGH in 199 men with different sperm count followed by the analysis of selected,
patient-specific deletions in large groups of cases and normozoospermic controls.
Results: We identified 73 CNVs, among which 55 are novel, providing the largest collection of X-linked CNVs in relation to
spermatogenesis. We found 12 patient-specific deletions with potential clinical implication. Cancer Testis Antigen gene
family members were the most frequently affected genes, and represent new genetic targets in relationship with altered
spermatogenesis. One of the most relevant findings of our study is the significantly higher global burden of deletions in
patients compared to controls due to an excessive rate of deletions/person (0.57 versus 0.21, respectively; p = 8.78561026)
and to a higher mean sequence loss/person (11.79 Kb and 8.13 Kb, respectively; p = 3.43561024).
Conclusions: By the analysis of the X chromosome at the highest resolution available to date, in a large group of subjects
with known sperm count we observed a deletion burden in relation to spermatogenic impairment and the lack of highly
recurrent deletions on the X chromosome. We identified a number of potentially important patient-specific CNVs and
candidate spermatogenesis genes, which represent novel targets for future investigations.
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Introduction
Male factor infertility affects about 7% of men in the general
population and the etiology of altered spermatogenesis remains
unknown in about 40% of cases (‘‘idiopathic infertility’’) and it is
likely that a large proportion of them are caused by still unknown
genetic factors [1]. Nevertheless, besides abnormal karyotype and
Y chromosome microdeletions no other recurrent genetic anom-
alies have been identified in men with primary testicular failure,
raising questions about the appropriateness of the investigative
approaches used so far [2–4]. The first innovative study applying
whole-genome analysis of SNPs and the successive follow-up study
failed in leading to the identification of recurrent genetic factors
with large effect size [5,6]. Recently, high resolution array
Comparative Genomic Hybridisation (array-CGH) studies identi-
fied new spermatogenesis candidate genes on autosomes and on
the X chromosome and some recurring and private patient-
specific CNVs with potential clinical interest [7,8].
Both sex chromosomes are enriched with genes prevalently or
exclusively expressed in the testis [9,10]. Nevertheless, only Y
chromosome-linked Copy Number Variants (CNVs) and Y-linked
genes have been demonstrated as important contributors to
impaired sperm production in humans [for review see [11,12]). In
particular, the so called AZoospermia Factor (AZF) regions on the
Yq have been found deleted in about 5–10% of azoospermic men
(absence of spermatozoa in the ejaculate) and 2–5% of severe
oligozoospermic men (,5 millions spermatozoa in the ejaculate).
Data on the potential role of X-linked gene products in
spermatogenesis derive mainly from model organisms and a
higher than expected number of X-linked spermatogenesis genes
have been identified [10,13]. The apparent paucity of information
in humans is probably related to the scarcity of X-linked genes
studied (only eight), none of which yet described as causative,
except for the AR gene [14]. Similarly, the question whether the X
chromosome contains AZF-like regions has not been sufficiently
explored so far.
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e44887
In order to advance the understanding of the role of X-linked
CNVs and genes in male infertility, we applied an innovative
approach based on high resolution X chromosome specific array-
CGH. Given that such a detailed analysis of the X chromosome
has not been published until now and the testicular function of
subjects included in the Genomic Variant Database is unknown
(except for 30 X-linked CNVs (23 duplications and 7 deletions)
reported in the recent paper by Tuttelmann et al. [7]), ours is the
first study providing a detailed analysis of X-linked losses and gains
in several hundred subjects with known sperm parameters.
Materials and Methods
Subjects
The local Ethical Committees of the University Hospital
Careggi and the Fundacio´ Puigvert approved the study. All
participants signed an informed consent. We analyzed with array-
CGH 96 idiopathic infertile subjects with different grade of
spermatogenic impairment (49 azoospermic, 25 cryptozoospermic
and 22 oligozoospermic men) and 103 normozoospermic men.
Infertile patients were selected on the basis of a comprehensive
andrological examination including medical history, semen
analysis, scrotal ultrasound, hormone analysis, karyotype and Y
chromosome microdeletion screening. Patients with mono- or
bilateral cryptorchidism, varicocele grades 2 and 3, obstructive
azoospermia, recurrent infections, iatrogenic infertility, hypogo-
nadotrophic hypogonadism, karyotype anomalies, Y chromosome
microdeletions including partial deletions of the AZFc region, and
partial AZFc duplications and patients with non-Italian or non-
Spanish origin were excluded. Testis histology was available for 47
men. Controls in the Spanish cohort were fertile normozoospermic
men undergoing pre-vasectomy, whereas the Italian control cohort
included normozoospermic volunteers not belonging to infertile
couples (60% with proven fertility). The ethnic/geographic
composition was similar in the control and patient groups (40%
Spanish and 60% Italians).In the second part of the study, we
performed a case-control association study reaching a total of 359
patients and 370 normozoospermic controls on 13 selected CNVs
which appeared to be specific to infertile men based on the array-
CGH analysis. Detailed phenotypic data relative to the study
populations are provided in Table 1.
Methods
Germline DNA was extracted from peripheral blood samples in
all the participants with standard methods.
Array-CGH. Customized array-CGH platforms (custom
8660 K, Agilent Technologies, Santa Clara, CA, USA) were
generated using the eArray software (http://earray.chem.agilent.
com/); 53069 probes (60-mer oligonucleotides) were selected from
those available in the Agilent database and cover the whole
chromosome X, including Xp and Xq pseudoregions, with a
medium resolution of 4 Kb. Four replicate probe groups, with
every probe present in two copies on the platform, were designed
in regions containing mouse infertility-associated genes i.e. sperm
protein associated with the nucleus, X-linked family members
(SPANX); testis expressed 11 TEX11, TAF7-like RNA polymerase
II, TATA box binding protein (TBP)-associated facto (TAF7L)
and). In these regions, the medium resolution is 2 Kb. The array
also included, for the normalization of copy number changes,
Agilent control clones spread along all autosomes (6842 probes).
As a reference DNA, we used the same normozoospermic subject
for all the study population. This control DNA was already
characterized for CNV content in previous array-CGH experi-
ments against eight different normospermic controls and presented
one private gain of 27 Kb mapping to Xcentr which was not
considered for the frequency analyses. 300 ng of test DNA and
control DNA were double-digested with RsaI and AluI (Promega)
for 1 hour at 37uC. After digestion, samples were incubated at
65uC for 20 minutes to inactivate the enzymes, and then labeled
by random priming (Agilent Technologies) for 2 hours using Cy5-
dUTP for the test DNA and Cy3-dUTP (Agilent Technologies) for
the control DNA. Labeled DNAs were incubated at 65uC for
10 minutes and then purified with Microcon YM-30 filter units
(Millipore, Billerica, USA). Every purified sample was brought to a
total volume of 9.5 ml in 1xTE (pH 8.0, Promega), and yield and
specific activity were determined for each sample using a
NanoDrop ND-1000 UV-VIS Spectrophotometer (Labtech Inter-
national LTD). The appropriate cyanine 5- and cyanine 3-labeled
samples were combined in a total volume of 16 ml. After sample
denaturation and pre-annealing with 5 ul of Human Cot-1 DNA
(Invitrogen, Carlsbad, CA), hybridization was performed at 65uC
with shaking for 24 hours. After two washing steps, the array was
analyzed through the Agilent scanner and the Feature Extraction
software (v10 1.1.1). Graphical overview was obtained using the
DNA Analytics (v4.0.73). All the array experiments were analysed
using the ADM-2 algorithm at threshold 5. Aberrant signals
including 3 or more adjacent probes were considered as genomic
CNVs (Figure S1). The positions of oligomeres refer to the Human
Genome March 2006 assembly (hg18). All experimental data was
submitted to GEO repository with the following Series accession
number: GSE37948.
Molecular genetic analyses for confirmation of array-CGH
data and for the case-control study
Molecular analysis of deletions. For the first step screening
as for the confirmatory step, we performed PCR protocol in a final
volume of 10 ml containing 70 ng of genomic DNA, 3 mM
MgCl2, 400 mM deoxynucleotides triphosphates, 10 pmol of
specific primers, 50 U/ml of Taq DNA Polymerase (Promega
PCR MASTER MIX 2X). All the primers for the first step
screening had an optimal annealing temperature between 58–
60uC and suspected deletions were further confirmed by i)
lowering the annealing temperature (55uC); ii) performing
additional PCRs with alternative primers (see details in the Table
S1).
Molecular analysis of gains and the loss CNV31. Gains
and loss CNV31 screening were performed using pre-designed
TaqManH Copy Number Assays or Custom TaqManH Copy
Number Assays (Applied Biosystems). All assays were conducted
using three or four replicates for each sample (on the basis of the
assay quality), in a final volume of 20 ul according to the
manufacturer’s instructions. The reaction mix components were:
1X TaqManH Genotyping Master Mix, 1X TaqManH Copy
Number Assay, 1X TaqManH Copy Number Reference Assays,
10 ng of genomic DNA. Briefly, the TaqManH Copy Number
Assay – containing two specific primers and a FAMTM dye-
labeled MGB probe to detect the genomic DNA target sequence –
is run in duplex with the TaqManH Copy Number Reference
Assays – containing two primers and a VICH dye-labeled
TAMRATM probe to detect the genomic DNA reference
sequence. On each plate the same normozoospermic control used
as reference DNA for array-CGH experiments (calibrator sample),
the DNA sample of the CNV carrier and the No Template
Control (NTC) were run. The CopyCaller SoftwareTM was used
for post-PCR data analysis for all the copy number quantitation
experiments. Information about qPCR probes are provided in
Table S2.
X Chromosome Deletions and Male Infertility
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Statistical analysis
Statistical analyses were performed using the statistical package
SPSS (version 17.0.1, Chicago, IL, USA). Non-parametric Mann-
Whitney U test was performed for comparisons of: i) median
values of CNV number and DNA change between patients and
controls; ii) median values of sperm concentration and total sperm
count in relationship with CNV number. Frequencies were
compared by Fisher exact test.
Results
Characterization of X-chromosome linked CNVs
We performed a high resolution array-CGH analysis using a
microarray containing probes densely covering the complete
human X chromosome (average resolution: 4 kb). Of the 199
subjects analyzed (96 idiopathic infertile subjects and 103
normozoospermic men), 97 (36 patients and 61 controls) showed
the lack of CNVs, whereas the remaining 102 samples were found
to carry 73 CNVs (44 gains and 29 losses) (Tables 2, 3, and 4).
Thirty-two CNVs intersected genes/transcription units based on
data available in genomic databases. As shown in Figure 1, CNVs
were evenly distributed along the X chromosome with higher
density in the PAR1.
Since homologous sequences at the border of a CNV may act as
a substrate for non-allelic homologous recombination (NAHR), we
checked the nature of regions flanking (between the minimum-
maximum size of the CNV and approximately up to 1 Mb from
the maximum size) the identified CNVs in order to understand
whether NAHR is likely to occur (UCSC Genome Browser).
Highly homologous sequences were identified only in 19% of
CNVs, indicating that NAHR is not involved in the majority of
observed CNVs. This figure was concordant with other observa-
Table 1. Clinical description of the study population.
A
SPERM COUNT PATIENTS (n =359) CONTROLS (n=370)
Total sperm count (106) median (25th–75th percentile) 2.6 (0.00–13.62) 263.20 (159.00–405.50)
mean 6 SD 8.77612.72 311.796199.99
Sperm concentration (106/ml) median (25th–75th percentile) 0.90 (0.00–4.40) 76 (50.00–117.50)
mean 6 SD 2.5663.27 91.32659.64
B
GEOGRAPHIC ORIGIN SEMEN PHENOTYPE
ARRAY-CGH STUDY
(n=96)
CASE-CONTROL
STUDY (n=263)
TOTAL
(n =359)
ITALIAN (n=233) azoospermic 15 42 57
cryptozoospermic 20 17 37
oligozoospermic 22 117 139
severe oligozoospermic (,56106/ml) 17 47 -
moderate oligozoospermic(,206106/ml) 0 12 -
SPANISH (n=126) azoospermic 34 15 49
cryptozoospermic 5 36 41
oligozoospermic 0 36 36
severe oligozoospermic (,56106/ml) 0 24 -
moderate oligozoospermic(,206106/ml) 0 12 -
C
HORMONAL PARAMETERS ARRAY-CGH STUDY (n=96) CASE-CONTROL STUDY (n=263) TOTAL (n =359)
FSH (U/L)
Mean 6 SD 13.4069.09 11.13610.08 11.7469.84
Median (25th–75th percentile) 11.38 (5.30–19.0) 8.10 (4.27–14.30) 8.70 (4.40–15.0)
LH (U/L)
Mean 6 SD 5.0262.34 5.4664.02 5.3663.72
Median (25th–75th percentile) 4.45 (3.30–6.21) 4.60 (3.20–6.75) 4.60 (3.20–6.70)
TESTOSTERONE (ng/ml)
Mean 6 SD 5.1862,.94 4.4962.08 4.6462.30
Median (25th–75th percentile) 4.80 (3.51–6.40) 4.20 (3.40–5.20) 4,.20 (3.40–5.40)
TESTIS VOLUME (ml)
Mean 6 SD 11.5564.55 12.8964.32 12.5464.42
Median (25th–75th percentile) 11.50 (8.0–14.0) 13.0 (9.0–14.87) 13.0 (9.0–14.50)
A) Semen phenotype of the entire study population (array-CGH and case-control study); B) Description of all analyzed patients (array-CGH and case-control study)
according to their geographic origin and semen phenotype; C) Hormonal levels and testis volumes of all analyzed patients (array-CGH and case-control study).
doi:10.1371/journal.pone.0044887.t001
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tions reporting a similar frequency of potential NAHR targets
[15]. It is interesting to note that in some areas (Xp11.12-q21.1)
only duplications were found, whereas from Xq27.1-q27.3 only
deletions were detected. One of the PAR1-linked losses (CNV15)
was found in 23 patients and only once in controls (Figure 1b).
This small CNV has already been described in the Database of
Genomic Variants (DGV) both as loss and gain. This CNV was
situated inside a 3914 bp Simple Tandem Repeat which included
two Segmental Duplications (respectively of 1498 bp and 1444 bp)
that therefore may act as substrate for NAHR. This mechanism
may have lead also to reciprocal duplication and in fact CNV14,
identified in our study, is the reciprocal duplication of CNV15. No
genes were identified inside or nearby CNV14/15 which made it
difficult to attribute a pathogenic role to this loss. Moreover, the
same sequence was present also on the Y chromosome which
further complicated the interpretation of the results.
Considering the size of detected CNVs, which ranged from
1.4 Kb to 1609 Kb (Tables 2, 3, and 4), we noticed that losses
were typically of small/medium size and only 17% of them were
large (Figure 2). Conversely, large gains represented 48% of the
total CNVs and the difference between frequencies of losses and
gains of .100 Kb was statistically significant (p = 0,012). Small
Table 3. List of the 33 control-specific (not found in idiopathic patients) CNVs detected by array-CGH and their description
according to type, gene location (NO=no gene found within) and occurrence in the Database of Genomic Variants (DGV).
CNV type
CNV
code Region Size (Kb) Start position End position
Coding
sequences
within the CNV* DGV Frequency
LOSSES 5.B Xp22.33 12.63 701,071 713,696 NO 1
25.A Xp21.2 9.69 31,282,923 31,292,613 DMD 1
25.B Xp21.1 28.26 33,953,232 33,981,492 NO Variation_7783 2
33.A Xp11.21 58.89 56,403,390 56,462,278 NO 1
53.A Xq24 170.73 118,278,913 118,449,646 SLC25A43 1
58.A Xq25 12.68 125,198,109 125,210,792 NO 1
60.A Xq26.3 50.84 134,801,361 134,852,198 SAGE1 1
60.D Xq27.1 217.83 140,175,103 140,392,930 NO 1
66.A Xq28 37.12 147,393,583 147,430,698 AFF2 1
71.A Xq28 (PAR) 122.36 154,755,542 154,877,901 VAMP7 1
GAINS 4.A Xp22.33 (PAR) 237.08 153,373 390,452 PLCXD1 GTPBP6
PPP2R3B
1
5.A Xp22.33 (PAR) 241.98 674,222 916,206 NO 1
5.C Xp22.33 (PAR) 420.72 747,358 1,168,080 NO 1
12.A Xp22.33 (PAR) 6.61 1,693,897 1,700,511 ASMT 1
12.B Xp22.33 (PAR) 683.74 1,716,023 2,399,766 ASMT DHRSX 1
15.A Xp22.33 (PAR) 27.94 2,382,699 2,410,643 DHRSX Variation_83270 1
15.B Xp22.33/22.32 280.09 4,206,493 4,486,580 NO 1
16.A Xp22.31 1609.42 6,487,238 8,096,662 HDHD1 STS VCX
PNPLA MIR651
1
19.A Xp22.31 129.96 7,961,788 8,091,751 MIR651 Variation_9337 1
19.B Xp22.31 177.54 8,411,159 8,588,699 KAL1 1
20.A Xp22.2 665.88 14,590,604 15,256,487 GLRA2 FANCB
MOSPD2 ASB9
ASB11 PIGA
1
20.B Xp22.13 13.34 18,018,894 18,032,238 NO 1
25.C Xp21.1 185.02 34,931,807 35,116,827 NO 1
25.D Xp21.1 215.00 35,269,628 35,484,626 NO 1
31.A Xp11.23 78.87 48,021,982 48,100,848 SSX3 1
34.A Xp11.12 48.06 56,870,427 56,918,489 NO 1
36.A Xq11 716.03 63,925,948 64,641,977 ZC4H2 ZC3H12B 1
38.A Xq13.2 192.04 74,375,875 74,567,915 UPRT ZDHHC15 Variation_74012 1
38.B Xq13.3 153.23 75,123,387 75,276,621 NO 1
55.A Xq25 53.80 120,385,787 120,439,584 NO 1
59.A Xq26.3 24.69 134,151,039 134,175,725 NO 1
60.B Xq26.3 13.45 136,050,422 136,063,872 NO 1
60.C Xq26.3 91.26 137,089,527 137,180,783 NO 1
*CNV minimum size.
doi:10.1371/journal.pone.0044887.t003
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CNVs (,10 Kb) were more frequently found in patients in respect
to controls whereas large gains have been found mainly in controls
(Figure 2).
According to the Database of Genomic Variants (DGV)
website, losses/gains were divided into ‘‘known’’ and ‘‘novel’’,
identifying 21 novel losses and 34 novel gains (Tables 2, 3, and 4).
Among the 73 CNVs, 31 (15 losses and 16 gains) were found only
in patients, ‘‘patient-specific’’ (Table 2) and 33 (10 losses and 23
gains) were found only in the control group, ‘‘control-specific’’
(Table 3). Of the remaining 9 CNVs, only one gain (CNV12) was
found more frequently among controls whereas those resulting
more frequent among patients (‘‘patient-enriched’’) were deletions.
The rest (4 gains and 1 deletion) were found to equally occur in
both patients and controls (Table 4). These data suggest that gains
are less likely to affect spermatogenesis since 63% of them (28/44)
were found also in normozoospermic controls. On the contrary,
deletions were less frequent in controls (11/29; 38%) indicating
that in the presence of a deletion an abnormal sperm phenotype is
more likely to occur. A general outline of the array-CGH findings
with phenotypic description is provided in Table S3.
CNV burden
In order to assess the potential impact of CNVs in cases versus
controls, we used two primary measures of CNV burden: the
mean size and the mean number of CNVs/individual (Table 5A).
The mean value of losses bp was significantly higher in patients
than in controls (11.79 Kb and 8.13 Kb, respectively;
p = 3.43561024). All losses were confirmed by PCR plus/minus
or Real Time PCR, except for PAR-linked losses (n = 4), for which
no suitable assay could be designed. The number of CNVs/person
was significantly higher in patients compared to controls
(p = 0.002) and depended on the overrepresentation of losses in
the former group (0.57 versus 0.21; p= 8.78561026) (Table 5).
CNV15, the most frequently found loss appears to be the major
contributor to the deletion burden, however even without this loss
the number of losses/person is significantly higher in the patient’s
group (p = 0.041). Phenotypic description of patients (loss-carriers
and no CNV-carriers) is provided in Table S4. Although the
frequency of patients with more than one CNV (n= 19; 19.8%)
was nearly twice that of controls (n = 11; 10.7%), the difference did
not reach statistical significance (p= 0.078). On the other hand,
comparing the frequencies of subjects with $1 CNV in cases
versus controls, we observed a highly significant difference when
considering the total number of CNVs (p = 0.003) and of losses
(p,0.001) (Table 5B).
CNVs and semen parameters
A significant association with sperm concentration and total
sperm number was observed among patients when considering the
total CNV number (Table 6). Patients with more than 1 CNV had
a significantly lower sperm concentration and total sperm count
than those with #1 CNV (0.260.66106/ml versus 1.062.06106/
ml; p,0.022; 2.364.66106 versus 1.063.36106; p,0.032). The
maximum number of CNVs/subject was three, and of the five
patients with three CNVs four were azoospermic and one was
severely oligozoospermic with ,1 million spermatozoa/ejaculate
(Table S6). All of them had at least one private CNV (uniquely
found in this patient), and only one patient (07-170) shared two
recurrent CNVs with two others (07-13, 07-30). Given that the
selection of patients was based on the absence of known causes of
spermatogenetic failure, subjects with multiple CNVs did not show
any additional andrological anomaly or other relevant diseases.
Semen parameters and testis histology of patients and controls
with .1 CNVs are reported in Table S5, 6.
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Screening for selected deletions
To further investigate the potential clinical implications of
losses, 13 patient-specific deletions were subsequently screened in a
large group of infertile and normozoospermic men: excluding
CNV66, they all remained patient-specific (Table 7). Due to the
rarity of the 12 patient-specific losses, statistically significant
Figure 1. Schematic representation of the distribution of the 73 CNVs (44 gains and 29 losses) along the X chromosome identified
by high resolution X chromosome specific array-CGH analysis. A) The histogram shows that the 73 CNVs were evenly distributed along the X
chromosome but displayed a higher density in the pseudoautosomal region 1, PAR1 (Xp22.33). B) The frequency of gains (upwards) and losses
(downwards) per X chromosome region in patients and controls are indicated.
doi:10.1371/journal.pone.0044887.g001
X Chromosome Deletions and Male Infertility
PLOS ONE | www.plosone.org 7 October 2012 | Volume 7 | Issue 10 | e44887
differences were not observed in their frequencies compared to the
control group. In fact, 8/12 were private (found in a single
individual) whereas only 4 were recurrent with a still relatively low
frequency (0.5–1.1%).
Recurrent patient-specific CNVs. Among the patient-
specific recurrent CNVs, three deletions are of major interest.
CNV67, observed in 1.1% of patients may remove (considering its
maximum size) the melanoma antigen family A, 9B (MAGEA9B),
which belongs to the Cancer Testis Antigens (CTAs) gene family,
Figure 2. Array-CGH study.: distribution of the 73 CNVs according to their size: small (,10 Kb), medium (10–100 Kb) and large (.100 Kb) referred
to A) all CNVs (44 gains and 29 losses); B) losses; C) gains. Losses were typically of small/medium size (52%) whereas gains are generally of larger size
(48%). On the side, tables display the number of A) all CNVs; B) losses; C) gains of different size and categorized according to their occurrence in
patients/controls: i) ‘‘patient-specific’’ when found only in patients; ii) ‘‘control-specific’’ when found only in controls; iii) ‘‘patient-enriched’’ when
found predominantly in patients; iv) ‘‘control- enriched’’ when found predominantly in controls; v) ‘‘common’’ when found at a similar frequency in
patients and controls.
doi:10.1371/journal.pone.0044887.g002
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expressed exclusively in the testis with the highest expression level
in spermatocytes and in some tumour cell lines [16]. This deletion
may also affect additional genes with prevalent or exclusive
expression in the testis such as other CTAs and the following:
transmembrane protein 185A (TMEM185A), chromosome X open
reading frame 40A (CXorf40A), X linked heat shock transcription
factor family (HSFX) all situated at ,1 Mb from the deletion.
Phenotypes of patients with this deletion ranged from azoospermia
due to Sertoli Cell Only Syndrome (SCOS, [17]) to oligozoos-
permia. CNV 31 presents a reciprocal duplication (CNV30,
Table 2) and was observed in 4 patients (two found by array-GH
and two by qPCR) and 0/325 controls. CNVs 30/31 affect the
dosage of zinc finger protein 630 (ZNF630), a gene with unknown
function; however, considering their maximum extension, addi-
tional genes with exclusive expression in the testis such as the
sperm acrosome associated 5 SPACA5,/SPACA5b) are also
involved. CNV32 does not remove any gene directly, but it is
situated within an area abundant in CTA genes. In order to define
whether the underlying mechanism of these deletions is NAHR we
analyzed the flanking regions. Only CNV 30/31 showed
Segmental Duplications (SD) which may explain the recurrence
of deletion/duplication events. Although also CNV67 was found
in 4 patients, this deletion does not have a reciprocal duplication
and it is not flanked by SDs. An alternative mechanism for the
formation of CNV67 could be Non Homologous End Joining
(NHEJ), since substrates for this mechanism are highly represented
in this area (many LINE and Alu elements). However this
hypothesis requires further confirmation by the fine mapping of
the breakpoints.
Private patient-specific CNVs. Concerning private patient-
specific deletions, which were found only in single patients, we
observed two deletions directly affecting gene dosage. CNV50
removes the ARMCX5-GPRASP2 read-through (ARMCX5-
GPRASP2) genes for which no testis expression data are available.
The carrier of this deletion suffers from azoospermia due to
SCOS. CNV61, observed in one azoospermic man, removes
another CTA family member, the melanoma antigen family C, 3
MAGEC3. This deletion may also affect other neighbouring CTA
genes, such as the melanoma antigen family C, 1 MAGEC1 and
Sperm protein associated with the nucleus, X-linked, family
Table 5. Array-CGH study: Comparison between patients and controls of the mean number and mean extension of CNVs (A) as
well as the number of all subjects bearing more than one CNV (B).
A PATIENTS (n =96) CONTROLS (n=103) p
Mean CNV
number ± sd
Mean CNV extension
(Kb) ± sd
Mean CNV
number ± sd
Mean CNV extension
(Kb) ± sd p1 p2
LOSSES+GAINS 0.8760.85 36.21685.4 0.5460.76 73.876222.08 2.09561023 0.113
LOSSES 0.5760.64 11.79638.43 0.2160.46 8.13632.30 8.7856106 3.43561024
GAINS 0.3060.54 24.42676.50 0.3360.62 65.746220.07 0.862 0.733
B PATIENTS (n=96) CONTROLS (n=103) p OR (95% CI)
$1 CNV/subject 60 42 0.003 1.5 (1.2–2.0)
$1 loss/subject 47 20 ,0.001 2.5 (1.6–3.9)
$1 gain/subject 25 28 0.874 -
sd = standard deviation. OR =odds ratio. CI = confidence interval. p1 refers to the mean number of CNV/subject. p2 refers to the mean DNA change/subject.
doi:10.1371/journal.pone.0044887.t005
Table 6. Array-CGH study: comparison of patients’ semen parameters according to the number of CNVs.
PATIENTS (n=96)
SPERM CONCENTRATION (n6106/ml) p TOTAL SPERM NUMBER (n6106) p
0 CNV (n=36) 1.262.4 (0.01; 0.0–12.0) 2.965.7 (0.01; 0.0–30)
$1 CNV (n=60) 0.661.3 (0.0; 0.0–6.2) 0.068 1.663.4 (0.0; 0.0–17.4) 0.075
0 LOSS (n=49) 1.062.1 (0.01; 0.0–12.0) 2.765.0 (0.01; 0.0–30.0)
$1 LOSS (n =47) 0.661.5 (0.0; 0.0–6.2) 0.053 1.463.6 (0.0; 0.0–17.4) 0.051
0 GAIN (n =71) 1.062.1 (0.0; 0.0–12.0) 2.464.9 (0.0; 0.0–30.0)
$1 GAIN (n =25) 0.460.7 (0.0; 0.0–2.3) 0.185 1.362.3 (0.0; 0.0–6.4) 0.215
#1 CNV (n=77) 1.062.0 (0.0; 0.0–12.0) 2.364.6 (0.0; 0.0–30.0)
.1 CNV (n=19) 0.260.6 (0.0; 0.0–2.0) 0.022 1.063.3 (0.0; 0.0–13.4) 0.032
#1 LOSS (n =88) 0.961.9 (0.0; 0.0–12.0) 2.164.4 (0.0; 0.0–30.0)
.1 LOSS (n =8) 0.260.6 (0.0; 0.0–1.8) 0.230 1.764.7 (0.0; 0.0–13.4) 0.309
#1 GAIN (n =92) 0.861.9 (0.0; 0.0–12.0) 2.264.5 (0.0; 0.0–30.0)
.1 GAIN (n =4) 0.060.0 (0.0; 0.0–0.01) 0.293 0.060.0 (0.0; 0.0–0.01) 0.29
Sperm concentration and total sperm number are expressed as: mean 6 standard deviation (median; range). Significance is depicted by a p value,0.05.
doi:10.1371/journal.pone.0044887.t006
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member E (SPANXE). Four deletions (CNV22, 54, 56 and 57)
contained several (from 4–32) conserved transcription factor
binding sites, but the neighbouring genes were relatively distant
(from 8 Kb to 400 Kb).
Discussion
The diffusion of assisted reproductive techniques as a thera-
peutic option in severe male factor infertility raised several
questions about the short and long-term consequences on the
offspring, since infertile men are at higher risk of being carriers of
genetic anomalies in both their genomic DNA and gametes.
Although the importance of diagnosing genetic factors in this
category of future fathers is fully recognized, the diagnostic workup
of infertile men is still limited to a few genetic tests. Our working
hypothesis was that, similarly to Y chromosome-linked CNVs
(AZF and gr/gr deletions), we would be able to identify recurrent,
pathogenic deletions on the X chromosome. First, an X-
chromosome specific high resolution array-CGH analysis was
carried out in 199 men with known sperm count and was followed
by a screening of selected CNVs in several hundred infertile
patients and normozoospermic controls. Our array-CGH analysis
showed that 50% of subjects presented at least one CNV, and the
majority of these CNVs (55/73) were not reported in currently
available databases of genomic variants. Among the few X-linked
CNVs reported in subjects with known sperm count [7] only six
partially or completely overlapping CNVs were found. This can be
due to both technical issues (different array resolution, different
criteria used for the interpretation of data, lack of validation in the
Tuttelmann paper) and/or due to the patient selection criteria
(azoospermic men were selected for a specific histology, called
SCOS, in the Tuttelmann et al paper [7]). Interestingly, a small
deletion, CNV 69 on Xq28 was observed in 7 patients and 3
controls and it maps inside a CNV reported by Tuttelmann et al
[7] as patient-specific, present in a single oligozoospermic German
man (‘‘private’’). This discrepancy is likely due to the larger size
(34 Kb) of the patient-specific deletion in the German patient
compared to our 10 subjects (11.7 kb). On the contrary, a
reciprocal deletion/duplication (CNV31/CNV30) was observed
exclusively in patients (n = 4) in our study, whereas Tuttelmann et
al. found two normozoospermic carriers of the duplication and
one carrying the deletion [7]. However, the deletion encountered
in the above German study was 25 Kb smaller than CNV31/30.
An other interesting finding concerns two partially overlapping
gains detected in both studies, which affect the dosage of two genes
(H2BFWT and H2BFM). In our study this CNV (CN51) has been
found both in controls (n = 4) and patients (n = 5), whereas in the
German study [7] it was found only in an oligozoospermic patient.
Given that the larger CNV reported in the German study [7]
duplicates also two other genes (TMSB15B, H2BFXP), the
combined analysis of the results suggests that it is more likely
that the not shared genes, situated in the larger duplication, are
responsible for the observed oligozoospermic phenotype.
The further analysis of patient-specific deletions (n = 13)
revealed that .90% of them are unique or rare (frequency
,1%). These data are in line with the previous whole genome
array-CGH study [7] in which among the 27 patient-specific
CNVs only one recurrent duplication was found in two
oligozoospermic men. Similarly in the paper by Stouffs et al,
among the 10 patient specific autosomal CNVs only two were
recurrent [8]. The role of rare CNVs has already been established
for other multifactorial diseases [18,19] and since mutations
causing spermatogenic failure are unlikely transmitted to the next
generation, we can predict that de novo mutations probably play a
major role in primary testicular failure. It remains difficult to
ascertain the importance of rare patient-specific CNVs in
spermatogenesis through family analysis, since analysis on
maternal X-chromosome would not be informative and brothers
(with a 50% chance of sharing the same X chromosome) were not
available for analysis. The difficulty to obtain DNA from relatives
in relationship with infertility studies is related to the delicate
nature of this condition and for this reason the two previous array-
CGH studies were also unable to define the de novo nature of the
identified CNVs. As an alternative way to explore their potential
clinical relevance, we performed a search for functional genomic
regions (protein coding genes, microRNAs, conserved transcrip-
tion binding sites) mapping inside or nearby the 13 deletions of
interest. Since men are hemizygous for X-linked genes, their
CNV-dependent altered expression cannot be compensated by a
normal allele and could potentially lead to a direct pathological
effect. Ours is the first study suggesting that X-linked CTA family
members are recurrently affected and their dosage variation may
play a role in CNV-related spermatogenic failure. CTA genes
comprise more than 240 members from 70 families and are
generally divided into two broad categories: X-linked (mostly
multicopy genes) and non-X CTA genes (mainly single copy genes
located on autosomes) [for review see [16,20]]. These genes are
normally expressed only in germ cells but aberrant activation has
also been reported in a number of malignant tumors. The
exclusive physiological expression in germ cells strongly suggests a
role in spermatogenesis hence human CTA gene family members
are largely unexplored and no clinical data is available.
Interestingly, by tracing the evolutionary history of CTA genes,
it has been demonstrated that CTA genes in general and the X
chromosome linked CTA genes in particular are under strong
diversifying pressure and amongst the fastest-evolving genes in the
human genome [21]. Consequently, many of the human X-linked
CTA genes do not have easily identifiable orthologues in the
mouse or rat genomes, which makes it difficult to study the role of
these genes in animal models. Clues regarding functionality of
CTAs for many of these proteins point to a role in cell cycle
regulation or transcriptional control [for review see [22]]. Data
obtained in the 103 controls (array-CGH analysis) indicates that in
this group only one control-specific deletion contained a CTA
gene, the sarcoma antigen 1 SAGE1, which indicates that this gene
is unlikely a spermatogenesis candidate gene. In support of such a
statement, the expression of this gene is extremely low in the testis.
On the contrary, for the patient-related CTA genes expression
levels in the testis and germ cells were substantially higher. Apart
from CTA family members we identified other potential candidate
genes in the patient group which deserve further genetic screening.
On the contrary, we can conclude that those genes which are
deleted in control subjects, are unlikely to be spermatogenesis
candidate genes since their absence is compatible with normal
spermatogenesis. Among the 6 gene-containing control–specific
losses, with the exception of vesicle-associated membrane protein 7
(VAMP7), the level of testicular expression is either absent or very
low. VAMP7 is situated in PAR2 and it has been described as
strongly expressed in the testis, especially in spermatids. Our data
indicates that VAMP7 haploinsufficiency (i.e. one copy of the gene
is still retained on the Y-linked PAR2) does not impair
spermatogenesis.
One of the most stimulating findings of our article is related to
the CNV burden observed in the patients’ group in relationship
with loss of genetic material. The relatively high frequency of Y
chromosome deletions (4–7% in severe spermatogenic failure)
already suggested that infertile men are more prone to the loss of
genetic material [11]. The mechanism by which Y chromosome
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deletions lead to spermatogenetic failure is not fully clarified and
they may act either by removing genes involved in spermatogen-
esis or by affecting meiosis. Here we found an excess of X-linked
CNV number and DNA loss in patients with reduced sperm
count, which was only partially related to direct gene removal,
hence the majority of deletions mapped close to gene-rich areas.
We also found a significant association between CNV number and
sperm count in the infertile group, which further reinforces the
potential link between deletion burden and spermatogenic failure.
Similarly to our data, in the paper by Tuttelmann et al [7] a
significant inverse correlation has been found between sperm
count and CNV number at the whole genome level.
Whether the observed deletions are directly responsible for the
phenotype (either affecting gene expression or interfering with sex
chromosome pairing for those mapping to the PAR regions) or
simply arise due to increased genomic instability, remains a
puzzling question. Some previous observations suggest a possible
relationship between genomic instability and male infertility and
are related to microsatellite instability [23] as well as to the
presence of multiple CNVs on the Y chromosome in men with
AZF deletions [24] and an excessive CNV number in azoospermic
men with SCOS [7]. Previously, we also observed a significant
effect of multiple rearrangements in the AZFc region on sperm
production, suggesting a potential link between a less stable
genome and spermatogenic efficiency [25]. Additionally, epide-
miological observations showing a higher incidence of morbidity
(including cancer) and lower life expectancy [22,26] in infertile
men would support a potential link between altered spermatogenic
function and genomic instability. Our study suggests a potential
involvement of increased X-linked deletion burden in the aetiology
of impaired spermatogenesis and stimulates further research to
better define its implication in primary testicular failure and on
general health issues for both the patient and his future offspring.
In conclusion, by the analysis of the X chromosome, at the
highest resolution available to date, in a large group of subjects
with known sperm count we were able to provide evidence about
the lack of highly recurrent deletions, which suggest that an AZFc-
like region does not exist on this sex chromosome. Our
investigation gives an important contribution both to the field of
genetics and reproductive medicine since we identified a large
number of novel CNVs, and by our second step analysis, we
confirmed 12 deletions as being specific to men with impaired
spermatogenesis. The analysis of gene-containing CNVs in
patients and in controls allows to discern between those that
merit future research and those which are unlikely to be involved
in spermatogenesis.
Supporting Information
Figure S1 Array-CGH profiles of two CNVs detected by
customed oligonucleotide-based X microarray.Magnified
view of CNV 30 (left) and CNV 50 (right) in cases 08-79 and 07-
22, respectively. The shaded areas indicate a gain in DNA copy
number (duplication, average log2 ratios: +1) detected by red dots
(left) and a deletion (average log2 ratios: 24) detected by green
dots (right). Arrows indicate the first and the last oligonucleotide
duplicated (left) or deleted (right), respectively.
(TIF)
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Table S3 A general outline of the array-CGH findings
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Table S4 Phenotypic features according to the pres-
ence/absence of losses in patients, including the
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both the array-CGH and case-control studies (B).
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ABSTRACT
Background The role of X-linked genes and copy-
number variations (CNVs) in male infertility remains
poorly explored. Our previous array-CGH analyses
showed three recurrent deletions in Xq exclusively
(CNV67) and prevalently (CNV64, CNV69) found in
patients. Molecular and clinical characterisation of these
CNVs was performed in this study.
Methods 627 idiopathic infertile patients and 628
controls were tested for each deletion with PCR+/−. We
used PCR+/− to map deletion junctions and long-range
PCR and direct sequencing to define breakpoints.
Results CNV64 was found in 5.7% of patients and in
3.1% of controls (p=0.013; OR=1.89; 95% CI 1.1 to 3.3)
and CNV69 was found in 3.5% of patients and 1.6% of
controls (p=0.023; OR=2.204; 95% CI 1.05 to 4.62). For
CNV69 we identified two breakpoints, types A and B, with
the latter being significantly more frequent in patients than
controls (p=0.011; OR=9.19; 95% CI 1.16 to 72.8).
CNV67 was detected exclusively in patients (1.1%) and
was maternally transmitted. The semen phenotype of one
carrier (11-041) versus his normozoospermic non-carrier
brother strongly indicates a pathogenic effect of the
deletion on spermatogenesis. MAGEA9, an ampliconic
gene reported as independently acquired on the human
X chromosome with exclusive physiological expression in
the testis, is likely to be involved in CNV67.
Conclusions We provide the first evidence for X
chromosome-linked recurrent deletions associated with
spermatogenic impairment. CNV67, specific to
spermatogenic anomaly and with a frequency of 1.1% in
oligo/azoospermic men, resembles the AZF regions on the
Y chromosome with potential clinical implications.
INTRODUCTION
The aetiology of altered spermatogenesis remains
unknown in about 40% of cases (so-called ‘idio-
pathic infertility’), of which a large proportion are
probably related to still unknown genetic factors.1
During recent years, copy-number variations
(CNVs) have been shown to be an interesting aspect
also in andrology. To date, the only known CNVs
that actually cause spermatogenic failure are Y
chromosome microdeletions; however, high-
resolution whole genome approaches have enabled
the identification of new spermatogenesis candidate
genes as well as recurrent and private patient-
specific CNVs with potential clinical interest also on
autosomes and the X chromosome.2–4 In a previ-
ously published study,4 based on high-resolution X
chromosome-specific array-CGH platforms (average
resolution 4 kb), we provided the largest collection
of X-linked CNVs related to spermatogenesis and,
more interestingly, we observed a deletion burden in
relation to spermatogenic impairment as men with
idiopathic infertility had an excessive rate of dele-
tions compared with normozoospermic controls.
Among the 29 deletions identified by array-CGH,
three recurrent deletions (frequency >1%) on Xq
were of interest for their exclusive (CNV67) or
prevalent (CNV64 and CNV69) presence in
patients. Our previous publication also included a
case–control follow-up study in which only ‘patient-
specific’ CNVs were incorporated, and CNV67 was
found in 4/359 (1.1%) patients and 0/370 controls.
To evaluate the potential role of these recurrent
X-linked CNVs in male infertility, we screened more
than 1200 men with known sperm parameters in
two Mediterranean populations. All three deletions
have been confirmed as significant risk factors for
impaired spermatogenesis. In particular, CNV67 was
confirmed as ‘patient-specific’, being the first
X-linked deletion with potential clinical implications.
METHODS
Subjects
Germline DNA from 1255 subjects (627 strictly
selected patients with idiopathic infertility and 628
normozoospermic controls) from Spain (36.6%)
and Italy (63.4%) was analysed (for patient selec-
tion criteria see also online supplementary materi-
als). The ethnic/geographical composition was
similar between the control and patient groups.
The clinical features of the patients are presented in
online supplementary table S1.
Molecular analysis of deletions
A multistep Sequence Tagged Site (STS) PCR+/−
protocol was optimised in order to identify and
confirm reliably the presence of deletions (see
online supplementary table S2). PCR+/− was also
used to further restrict the deletion interval for
CNV67 and CNV64.
Pedigree analysis
Segregation analysis in relatives was possible for
CNV67 carriers 11-041 (Spanish) and MMP704
(Italian). To understand whether CNV67 occurred
de novo, we analysed each patient’s mother and sib-
lings (11-041’s brother and MMP704’s sister).
Screening of the female relative of CNV67 carriers
was performed by quantitative PCR (qPCR) using a
TaqMan Copy Number Assay (hs03323870_cn).
CNV69 deletion breakpoint definition
Conventional PCR+/− using primers mapping to
the flanking regions of the minimum CNV69 size
Lo Giacco D, et al. J Med Genet 2014;0:1–5. doi:10.1136/jmedgenet-2013-101988 1
Copy-number variation
 JMG Online First, published on January 13, 2014 as 10.1136/jmedgenet-2013-101988
Copyright Articl  author (or their employer) 2014. Produced by BMJ Publishing Group Ltd under licence. 
 group.bmj.com on April 7, 2014 - Published by jmg.bmj.comDownloaded from 
was performed to confine breakpoints to smaller intervals.
Long-range (LR) PCR was subsequently performed to amplify
the junction fragment including the breakpoint (figure 1A; see
online supplementary table S3). Additional primers were then
designed to sequence the obtained LR-PCR product (figure 1B).
To easily classify the type of breakpoint in all CNV69 carriers
and to provide a tool for a potential diagnostic screening,
another pair of deletion-specific primers was designed (see
online supplementary table S3).
Analysis of sequence family variants (SFVs)
In order to understand whether CNV67 caused the deletion of
the MAGEA9 or CXorf40A gene copy mapping within the CNV
maximum size, we tested carriers for a number of STSs,
mapping within the MAGEA9 and CXorf40A ampliconic
regions. Each of these markers amplifies two homologous
sequences containing sequence family variants (SFVs) that
would allow, prior to sequencing, the distinction between the
copies inside and outside the maximum size (see online supple-
mentary tables S4 and S5).
Statistical analysis
Statistical analysis was performed using SPSS software V.17.0.
Significance was tested using the Fisher exact test and corrected
by the Holm test for multiple testing (see online supplementary
methods).
RESULTS
Physical mapping and bioinformatic characterisation
All three deletions map to the long arm of the X chromosome
in q27.3 (CNV64) and q28 (CNV67 and CNV69).
CNV64
This deletion, described in the Database of Genomic Variants
(nsv829407), removes between 3.923 and 6.382 kb of DNA,
considering its minimum (chrX: 143 436 346–143 440 268)
and maximum (chrX: 143 434 786–143 441 167) CNV size,
respectively. The presence of highly repetitive sequences in this
region prevented fine mapping of the deletion breakpoints.
Nevertheless, based on the +/− STS pattern, we localised prox-
imal and distal breakpoints within a region of 0.6 kb upstream
and 0.3 kb downstream of the proximal and distal edges of the
minimum CNV size, respectively. No genes and regulatory ele-
ments were directly removed by this deletion. Nevertheless, a
number of functional elements are located at <0.5 Mb from the
deletion and may be affected (table 1).
CNV69
This deletion removes between 11.770 and 22.141 kb of DNA,
considering its minimum (chrX: 154 044 876–154 056 645)
and maximum (chrX: 154 037 065–154 059 205) CNV size,
respectively. Sequencing showed the existence of at least two
Figure 1 Fine mapping of copy-number variation 69 (CNV69) deletion breakpoint. (A) Schematic representation of the minimum and maximum
CNV size. Triangles (+) depict the first and last positive array-CGH probes, delineating the maximum CNV size, and triangles (−) depict the first and
last negative array-CGH probes, delineating the minimum CNV size. Primers used for chromosome walking are indicated in bold. Prox, primers
located upstream of the proximal edge of the minimum CNV size; Dist, primers located downstream of the distal edge of the minimum size; Int,
primers inside the minimum CNV size. Primers used for junction amplification and sequencing are indicated in italic and red, respectively. (B)
Sequencing of deletion junction in type A and type B breakpoints. Sequences shown were obtained with LR.R5 reverse primer. Insertions compared
with the reference sequence at the deletion junction are highlighted in green and the alignment of the sequences flanking the breakpoint is shown
in the lower panel of each electropherogram. (C) Type of deletions. Breakpoint-specific primers used for screening of CNV69 carriers are indicated in
bold. Dotted lines depict the amplification product obtained for each type of deletion. (D) PCR product using breakpoint-specific primers.
Electrophoresis of the two fragments obtained, each mirroring the deletion sizes. No amplification was obtained in male and female controls. MC,
male control; FC, female control; NTC, no template control.
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different deletion patterns referred to as type A and type B
(figure 1C). The alignment of the flanking sequences indicates
that none of the deletion types originates from homologous
recombination, so the most likely mechanism is
Non-Homologous End Joining (NHEJ). This hypothesis is
further supported by the presence of different additional
nucleotides (NHEJ ‘molecular scars’) compared with the refer-
ence sequence at the deletion junction (figure 1B). For instance,
type A breakpoint was characterised by the insertion of a TAA
tract (InsTAA), implying a deletion length of 16.06 kb, whereas
type B breakpoint displayed the insertion of a
CATTCCATGTCCCC tract (InsCATTCCATGTCCCC) and the
deletion measured 18.53 kb. Breakpoint-specific primers
allowed the detection of two fragments, each mirroring the
deletion sizes: 700 bp for type A and 450 bp for type B (figure
1C,D). Of 32 subjects (22 patients and 10 controls) carrying
CNV69, 17 displayed type A (10 patients and 7 controls) and
10 displayed type B (9 patients and 1 control). In the remaining
five subjects (3 patients and 2 controls), the deletion could not
be classified as either type A or type B and was thus referred to
as type C.
No genes are mapping within the deletion. However, the
region at <0.5 Mb surrounding the maximum CNV size
includes a number of regulatory elements and several genes, of
which BRCC3 was reported as being associated with reproduct-
ive phenotypes (tables 1 and 2).5
CNV67
Based on array-CGH analysis, we previously reported that this
deletion removes between 5.417 and 25.513 kb of DNA, con-
sidering its minimum (chrX: 148 456 473–148 461 889) and
maximum (chrX: 148 452 726–148 478 238) CNV size based
on array-CGH, respectively.4 Although the exact deletion break-
points could not be defined, chromosome walking allowed us to
better define the deletion extension, estimated to be 11.664 kb.
It is worth noticing that the highly repetitive nature of this
region may predispose to inversions,6 and thus we propose two
possible scenarios (see online supplementary figure S1). Also, in
this case the most likely mechanism for deletion formation is
NHEJ. The molecular characterisation also highlighted that the
proximal maximum size has been underestimated with
array-CGH, probably due to the repetitive nature of the region.
The distal deletion breakpoint was restricted to a 15.261 kb
region downstream of the distal edge of the minimum size,
which includes the proximal copy of MAGEA9 and is 3.7 kb
from the proximal copy of HSFX1/2. Furthermore, the region at
<0.5 Mb from the proximal and distal edges of the maximum
CNV size also includes other genes and regulatory elements
(tables 1 and 2). The results of the SFV analysis in the CXorf40A
ampliconic region are shown in online supplementary figure S2.
Carrier 10-314 was homozygous for units 1 and 2, the more
proximal to the CNV minimum size. Homozygosity was also
detected in unit 3 inside the CXorf40A gene whereas the SFV
Table 1 Regulatory elements detected within CNV64, CNV67 and CNV69
Number of regulatory elements*
CNV
code Position
Weak
enhancer
Strong
enhancer
Weak
promoter
Active
promoter
Weak transcribed
region
Transcription
elongation Insulator
64 Upstream proximal edge 10 – – – 2 – 4
Inside the deletion – – – – – – –
Downstream distal edge 11 3 1 – 2 – 7
67 Upstream proximal edge 57 19 7 3 11 4 8
Inside the deletion 6 2 – – 1 – –
Downstream distal edge 70 17 10 4 16 1 16
69 Upstream proximal edge 110 38 21 7 28 7 16
Inside the deletion – – – – – – –
Downstream distal edge 68 9 25 7 8 2 4
Only regulatory elements located at <500 kb from the proximal/distal maximum CNV size border are considered.
*Predicted functional elements in normal four human cell lines from ENCODE (cell lines: GM12878-B lymphocyte, lymphoblastoid, International HapMap Project, H1-hESC-embryonic
stem cells, HUVEC-umbilical vein endothelial cells, NHER-epidermal keratinocytes).
CNV, copy-number variation.
Table 2 Case–control study and list of genes mapping inside and within the flanking regions of CNV64, CNV67 and CNV69
X chromosome
band
CNV
code
Patients
(frequency)
Controls
(frequency) p Value (OR; 95% CI) Genes inside and nearby
Xq27.3 64 36/627 (5.7%) 19/628 (3.03%) 0.013 (1.89; 1.10 to 3.27) –
Xq28 67 7/627 (1.1%) 0/628 (0.0%) 0.008 IDS; LINC00893; CXorf40A*; MAGEA9B; HSFX2†; HSFX1†;
TMEM185A; MAGEA11; HSFX1; HSRX2; MAGEA9B; MAGEA;
CXorf40B
Xq28 69 22/627 (.5%) 10/628 (1.59%) 0.033 (2.2; 1.05 to 4.62) GAB3; DKC1; SNORA36A; SNORA56; MPP1; SMIM9; F8;
H2AFB3FUNDC2;CMC4; MTCP1; BRCC3*; VBP1†; RAB39B;
CLIC2; TMLHE-AS1; H2AFB3; F8A1;F8A1;H2AFB1; TMLHE-AS1
Type A 10/615 (1.6%) 7/624 (1.1%) 0.301 (NS)
Type B 9/614 (1.5%) 1/619 (0.2%) 0.011 (9.19; 1.16 to 72.8)
Type C 3/608 (0.5%) 2/620 (0.3%) 0.491 (NS)
Genes potentially removed by the deletion are highlighted in bold. Only genes located <500 kb from the proximal/distal maximum CNV size border are considered.
*First proximal flanking gene.
†First distal flanking gene.
NS, not significant.
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pattern changed to heterozygosis for the outer units (ie, units 4/
5 and 6). Interestingly, of the five SFVs mapping within this
unit, 10-314 never displayed the variant mapping inside the
CNV maximum size. The rest of the carriers were heterozygous
for different SFVs and, accordingly, different types of deletion
have been defined (see online supplementary figure S2). As for
the analysis of the MAGEA9 ampliconic region, carriers were
mostly homozygous for the analysed SFVs; however, the major-
ity of SFVs were uninformative due to the fact that homozygos-
ity was also observed in female and male controls. However, the
comparison of MAGEA9 SFVs between carrier 11-041 and his
non-carrier brother showed that the carrier was homozygous for
all SFVs analysed whereas his brother was heterozygous for all
SFVs except one (see online supplementary table S6).
Genotype–phenotype correlation
All three deletions were significantly more frequent in patients
than in controls (table 2). The phenotype of the carriers is
shown in online supplementary table S7. Estimating CNV69
deletion frequencies according to the type of breakpoint, we
observed that type B breakpoint was significantly more frequent
in patients (9/614, 1.5%) than in controls (1/619, 0.2%)
(p=0.011; OR=9.19, 95% CI 1.16 to 72.8). No statistically
significant difference was found between patients (10/615,
1.6%) and controls (7/624, 1.1%) (table 2) with regard to type
A breakpoint.
CNV67 was found in 1.1% of patients and in no controls
(p=0.008 (significant p<0.017 after correcting by the Holm
test; table 2).
All CNV carriers displayed a significantly lower total sperm
count and total motile sperm count compared with non-carriers,
considering the whole study population (see online supplemen-
tary table S8A), but not when comparison was performed in the
two phenotypic groups separately (see online supplementary
table S8B). A comparison of the clinical features of carriers and
non-carriers is presented in online supplementary table S9.
Pedigree analysis
CNV67 was maternally inherited, and neither of the patients’
mothers nor MMP704’s sister (who also carried CNV67) had
premature ovarian failure or anovulation. Interestingly, patient
11-041’s brother did not carry CNV67 and was normozoosper-
mic, different from his oligozoospermic brother who did carry
CNV67 (see online supplementary figure S3).
DISCUSSION
In this study we provide evidence for an association of CNV64,
CNV67 and CNV69 with spermatogenic failure through (1) a
case–control study on a large study population; (2) molecular
characterisation of deletions; (3) a search for functional ele-
ments in the region of interest; and (4) genotype–phenotype
correlation analysis.
Concerning the patient-enriched CNVs CNV64 and CNV69,
two clues support their association with impaired spermatogen-
esis: (1) deletion carriers had an increased probability of
impaired spermatogenesis compared with non-carriers (OR=1.9
and 2.2, respectively); and (2) semen quality in terms of total
sperm count and total motile sperm count was significantly
impaired in carriers compared with non-carriers. Type B
CNV69 (the larger one) was significantly more represented in
patients than in controls, suggesting that this deletion pattern
may account for the potential deleterious effect of CNV69 on
sperm production. This may be related to the closer position of
type B deletion (7.8 kb) to an upstream insulator compared with
type A, the proximal breakpoint of which maps to 2.6 kb down-
stream (see online supplementary figure S4). Importantly,
through the breakpoint definition we developed a simple diag-
nostic tool for type B deletion, allowing other laboratories to
further explore the role of this deletion in other ethnic groups.
We confirmed in more than 1200 subjects the recurrent
(1.1%) and ‘patient-specific’ feature of CNV67. Unfortunately,
it was impossible to obtain a fine mapping of CNV67 break-
points because of the presence of highly repetitive sequences
and the incomplete assembly of the currently available reference
sequence of the human X chromosome derived from 16 differ-
ent individuals.6 SFV analysis provided a more accurate estimate
of the minimum and maximum deletion size of CNV67—for
instance, when heterozygosis is observed, deletion is surely not
present. Specifically, SFV analysis in the CXorf40A ampliconic
region suggests that different deletion breakpoints might exist at
the proximal edge of the CNV minimum size (see online supple-
mentary figure S2), determining the involvement of the
CXorf40A copy mapping inside the maximum size. Accordingly,
one of our patients (carrier 10-314) displays the extent of the
larger deletion that would remove part of the CXorf40A coding
sequence. With regard to SFV analysis in the MAGEA9 amplico-
nic region, the variants are not fully informative. However, the
homozygous pattern observed for most variants in our carriers
allows speculation that the proximal copy of the MAGEA9 gene
might be involved. It is especially evident in the case of the two
brothers, given that the deletion carrier showed homozygosity
whereas his brother was heterozygous for the SFVs mapping to
the MAGEA9 copy. Although we were unable to formally dem-
onstrate the removal of the proximal copy of the MAGEA9 gene
on the basis of the above results, we can speculate that this gene
is directly affected or the deletion affects its regulatory elements.
For instance, large-scale CNVs might change the three-
dimensional structure of chromatin, which is seemingly crucial
for correct gene regulation.7–9
We previously suggested that Cancer Testis gene dosage vari-
ation may play a role in CNV-related spermatogenic failure4;
accordingly, MAGEA9 belongs to this gene family. MAGEA9 is
an ampliconic gene reported as independently acquired on the
human X chromosome, since no orthologs could be detected in
the murine X chromosome.6 Independently acquired X-linked
genes are predominantly expressed in the testis with a specific
expression of multi-copy genes in male germ cells.6 It can there-
fore be speculated that the loss of MAGEA9 copies would affect
spermatogenesis. Moreover, according to gene ontology,
MAGEA9 is mainly involved in the regulation of gene expres-
sion, DNA methylation, reproduction and spermatogenesis,
reflecting its potential involvement in transcriptional and epi-
genetic regulatory mechanisms of gametogenesis.5 Finally,
CNV67 may also affect the regulation of HSFX1/2, another
independently acquired X-linked multi-copy gene with testis-
specific expression.
Pedigree analyses of two CNV67 carriers indicated that this
deletion is maternally inherited, thus not affecting female fertil-
ity. This is in accordance with the lack of expression of
MAGEA9 in the ovary. The family of patient 11-041 is espe-
cially informative since the pathological semen phenotype of the
carrier (11-041) versus his normozoospermic non-carrier
brother is a strong indicator for a pathogenic effect of the dele-
tion on spermatogenesis.
For the first time we provide evidence for a significant associ-
ation between recurrent X-linked deletions and impaired sperm
production. Strikingly, CNV67, which is specific to spermato-
genic failure, resembles AZF deletions on the Y chromosome.
4 Lo Giacco D, et al. J Med Genet 2014;0:1–5. doi:10.1136/jmedgenet-2013-101988
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This finding merits further investigations in order to elucidate
the structural complexity of this region and to provide a feasible
substrate for fine molecular characterisation and large-scale diag-
nostic testing.
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Abstract
Introduction: Spermatogenesis is a highly complex process involving several thousand genes, only a minority of which have
been studied in infertile men. In a previous study, we identified a number of Copy Number Variants (CNVs) by high-
resolution array-Comparative Genomic Hybridization (a-CGH) analysis of the X chromosome, including 16 patient-specific X
chromosome-linked gains. Of these, five gains (DUP1A, DUP5, DUP20, DUP26 and DUP40) were selected for further analysis
to evaluate their clinical significance.
Materials and Methods: The copy number state of the five selected loci was analyzed by quantitative-PCR on a total of 276
idiopathic infertile patients and 327 controls in a conventional case-control setting (199 subjects belonged to the previous
a-CGH study). For one interesting locus (intersecting DUP1A) additional 338 subjects were analyzed.
Results and Discussion: All gains were confirmed as patient-specific and the difference in duplication load between
patients and controls is significant (p = 1.6561024). Two of the CNVs are private variants, whereas 3 are found recurrently in
patients and none of the controls. These CNVs include, or are in close proximity to, genes with testis-specific expression.
DUP1A, mapping to the PAR1, is found at the highest frequency (1.4%) that was significantly different from controls (0%)
(p = 0.047 after Bonferroni correction). Two mechanisms are proposed by which DUP1A may cause spermatogenic failure: i)
by affecting the correct regulation of a gene with potential role in spermatogenesis; ii) by disturbing recombination
between PAR1 regions during meiosis. This study allowed the identification of novel spermatogenesis candidate genes
linked to the 5 CNVs and the discovery of the first recurrent, X-linked gain with potential clinical relevance.
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Introduction
Infertility is a multi-factorial disorder affecting approximately
15% of couples – half of these can be attributed to the male.
Currently known causes of male-factor infertility account for only
60% of cases and known genetic factors contribute to about 15%
of severe male factor infertility [1]. The most frequent molecular
genetic cause is related to the Y chromosome and concerns the
AZF deletions [2]. These deletions are the first example in
andrology of functionally-relevant CNVs and can be easily studied
with plus/minus PCR. Recently, the development of high-
throughput analytical techniques such as a-CGH have allowed
the screening of large numbers of loci and have been used with the
principal aim of identifying novel spermatogenesis candidate
genes. These studies have also been useful in identifying a CNV
burden in infertile men, mainly involving the sex chromosomes
[3–5].
Considering the high complexity of spermatogenesis, which
requires more than 2,000 genes, it is highly likely that a proportion
of the 40% ‘missing’ aetiology is linked to yet unknown genetic
factors [1]. CNVs may induce a pathogenic effect in a number of
ways: structural changes to regulatory regions or a numerical
increase or decrease in protein-coding regions may have a direct
effect on mRNA levels [6]; large-scale CNVs may cause changes
to the well-regulated 3D structure formed by chromatin [7],
leading to downstream effects on the regulation of protein-coding
regions. Finally, large CNVs may also disturb chromosome pairing
at the PAR regions during meiosis [8,9].
While the AZF region-linked genes have been extensively
studied in respect to male infertility [10] very few studies have
focussed on the X chromosome, despite its predicted enrichment
in genes expressed in the testis [11,12]. Only a single X-linked
gene has been shown to definitively contribute to an infertility
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phenotype, the androgen receptor (AR) [1], leaving huge scope for
further experiments on this chromosome. Recently, evolutionary
models demonstrated that the X chromosome progressively
accumulating testis-expressed genes [11]. Accordingly, 18% of
the 800 protein-coding genes on the human X chromosome do not
show orthologs in other placental mammals. Of these, the majority
have been acquired by the human X chromosome de novo or
through transposition from the autosomes. Two-thirds of these are
ampliconic, possessing duplicated 10 Kb segments with .99%
homology and are predicted to be involved in male fitness [12].
In our previous study [3], we analyzed the CNV status of 96
infertile patients and 103 controls using a custom-designed
8660 K microarray targeting the X chromosome (Agilent
Technologies, Santa Clara, CA, USA). Of the 44 gains identified,
16 were patient-specific and the five most promising CNVs
(DUP1A, DUP5, DUP20, DUP26 and DUP40) were selected for
testing in an enlarged study population.
Materials and Methods
The local Ethics Committees of the University Hospital Careggi
and the Fundacio´ Puigvert approved the study and consent
procedure. All participants gave written, informed consent. The
consent forms are stored locally at the University Hospital
Careggi. All data were analysed anonymously.
CNV Selection and Bioinformatic Analysis
Five CNVs (DUP1A, DUP5, DUP20, DUP26 and DUP40)
were selected from the 16 patient-specific gains identified in our
previous study [3]. CNVs underwent several selection steps.
Initially, this focused on the frequency at which CNVs were
identified in the a-CGH study. CNVs found in control samples
were excluded. Online data-sources, such as OMIM, gene
ontology terms, and literature review were used to find candidate
features within 0.5 Mb of the CNV minimum. Information about
expression data was obtained from microarray and RNA-seq
experiments deposited in the GermOnline database [13,14].
CNVs containing genomic features with a potential involvement
in spermatogenesis were selected. At this regard, DUP1A resulted
of particular interest and therefore it was subjected to a deepened
investigation. All genomic loci, in the previous study reported in
Hg18 genome assembly [3], have been converted to Hg19
assembly and all loci in the current study are reported according
to Hg19.
Study Population
Patients with non-Italian or non-Spanish origin were excluded.
Patients were recruited after a comprehensive clinical examination
in both centres using the same clinical protocol, according to
WHO guidelines [15]. Exclusion criteria included all known
causes of infertility: history of mono- or bilateral cryptorchidism,
varicocele (grades 2 and 3), obstructive azoospermia, recurrent
infections, iatrogenic infertility, hypogonadotrophic hypogonad-
ism, karyotype anomaly and Y-chromosome microdeletions.
Control samples were recruited from pre-vasectomy patients with
proven fertility, male partners of infertile women (tubal factor,
anovulation and endometriosis) and male volunteers from the
general population. Given that the aim of the study was to define
the effect of CNVs on spermatogenesis, the control group
contained only subjects presenting with normal sperm parameters
(according to the WHO manual). Additional information about
sperm parameters is provided in the supplementary material and
methods S1 in File S1.
In addition to the previous study population of 199 samples (96
patients and 103 controls) [3], 404 new subjects (180 patients and
224 controls) were analyzed at the 5 selected loci. The total patient
group (n= 276) used in this study consisted of 96 azoospermic, 83
cryptozoospermic (,1.06106 spermatozoa. ml21) and 97 severe
oligozoospermic subjects (between 1.06106 and 5.06106 sperma-
tozoa. ml21) of which 130 were Spanish and 146 Italian. The
control group (n= 327) consisted of 107 Spanish and 220 Italian
normozoospermic subjects. For DUP1A only, the further enlarge-
ment of the study population with additional 158 patients (27
azoospermic, 59 cryptozoospermic and 72 severe oligozoospermic)
and 180 controls ensured the analysis of a total of 941 subjects.
qPCR Analysis
The copy number state of each locus was determined by qPCR.
Primer sequences are reported in Table S2 in File S1. Before
testing, all samples were put through rigorous quality control to
ensure that DNA quality and concentration was sufficient. DNA
samples that showed contamination were re-precipitated, using
ethanol precipitation. DNA samples were diluted to 50 ng.mL21 in
ddH20. Each sample was analyzed in triplicate in a 96-well plate.
The SYBR Select Master Mix produced by Invitrogen (REF:
4472908) was used. For each sample, PMP22 was amplified as a
reference gene for analysis purposes. The reaction conditions were
as follows: 20 ng DNA; 200 nM Primer (forward and reverse);
SYBR Green SELECT Master mix (1x concentration) in a total
reaction volume of 20 mL. In the case of DUP1A, an additional
qPCR was performed in order to test the LINC00685/PPP2R3B
gene dosage ratio. For this purpose, we tested the PPP2R3B copy
number state in DUP1A carriers using a pair of primers solely
mapping to the PPP2R3B gene. We used the same reaction
conditions, but optimal concentration for these primers was
400 nM (forward and reverse). qPCR was performed on TaqMan
7900 HT on ‘Absolute Quantification’, using the pre-set ‘Stan-
dard’ cycle conditions. The annealing temperature was 60uC. A
non-targeting control and a ‘duplicated’ control (a Klinefelter 47,
XXY man) was included on each plate. For Dup1A, we
simultaneously analysed sample 08–373 (carrying DUP4A) and
A800 (carrying DUP1A) for whom CNVs had previously been
identified by a-CGH (3). Threshold cycle and baseline were
calculated automatically and relative quantification was deter-
mined using the DDCt analysis method.
All samples from the original a-CGH experiment (96 patients
and 103 controls) were re-tested using the qPCR method
validating a-CGH results. A single ‘normal’ result (absence of
duplication in the triplicate) was required to denote a normal gene
copy number. In case duplication was found, the analysis was
repeated once for confirmation. A ‘borderline’ range was also
possible and samples within this range were repeated; if a
borderline result turned into duplication, another experiment
was performed for confirmation.
Statistical Analysis
SPSS software (version 20.0, Chicago, IL, USA) was used. CNV
frequencies were analysed for significance using Fisher’s Exact
Test in the ‘R’ software package and corrected using Bonferroni-
Holm step-down correction for multiple testing.
Results
Case-control Association Study
The 5 selected CNVs (DUP1A, DUP5, DUP20, DUP26 and
DUP40) were confirmed as patient-specific. Among the 276
patients analyzed, DUP5 was found in two (0.72%), DUP20 and
X-Chromosome Duplications in Male Infertility
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DUP26 in one (0.36%), DUP40 in 3 (1.09%) and DUP1A in 4
patients (1.44%). Given the higher frequency of DUP1A,
additional samples were tested for this CNV. In this enlarged
study population, we found DUP1A in a further two patients (2/
158; 1.26%) and in none of the additional 180 controls.
Considering the total study population used for DUP1A only
(434 patients and 507 controls), the difference in duplication
frequency between patients and controls for this CNV reached
statistical significance after Bonferroni-Holms correction for
multiple testing (6/434 patients versus 0/507 controls; p = 0.047)
(Table 1). DUP1A carriers displayed a heterogeneous semen
phenotype ranging from azoospermia to severe oligozoospermia
(Table 2). A phenotypic description of carriers of all CNVs is
shown in Table 2.
A comparison of sperm parameters between all CNV carriers
and non-carriers was performed and is shown in Table S1 in File
S1. The most relevant results concern the Total Motile Sperm
count, which resulted significantly lower in carriers of DUP1A
(p= 0.008), DUP26 (p= 0.003) and DUP40 (p = 0.03) compared
to non-carriers.
Bioinformatic Analysis for Physical Characterization of
CNVs
The physical characteristics of the selected CNVs are shown in
Table 3. DUP1A and DUP5 were of special interest because of
their large size and location on the PAR1. Locations of DUP20,
DUP26 and DUP40 are Xp22.2, Xp21.1 and Xq21.1, respec-
tively. No homology of sufficient size for non-allelic homologous
recombination (NAHR) was found between the upper and lower
boundaries of all CNVs indicating that a mechanism other than
NAHR might have led to the formation of these recurrent gains.
We checked for other types of repeated elements that could
contribute to genome instability, such as Alu elements, and found
that, for DUP1A, DUP5, DUP20 and DUP26, the flanking
regions are filled with short interspersed nuclear elements (SINEs),
which include Alus, and long interspersed nuclear elements
(LINEs). As for DUP40, two LINE elements, belonging to the
L1PA3 family1, are located at the extremities of the CNV. Hence,
we propose that the presence of SINEs and LINEs might underlie
the generation of recurrent duplications.
Gene Content of Interest and Search in the Database of
Genomic Variants (DGV)
DUP1A fully duplicates the following genes: PLCXD1, GTPB6
and LINC00685 (Table 3). Apparently, the most interesting is a
long non-coding RNA, (LINC00685) predicted to act as a negative
regulator of a gene (PPP2R3B) with a potential role in
spermatogenesis (Figure 1). According to the a-CGH data, the
PPP2R3B gene is affected by DUP1A only for an 11.7 Kb span,
thus it is not duplicated but disrupted at intron 7–8 by the CNV
(considering the minimum size). Similarly, qPCR data confirm the
lack of complete duplication of this gene in all CNV carriers.
Through DGV search within DUP1A, several CNVs (30
duplications and 25 deletions referring to the variant esv27600)
were found intersecting the PLCXD1 and GTPBP6 loci (located in
the proximal part of the duplication), and all of them were
identified only in females without further notification on the
phenotype. Four variants are reported in close proximity to the
most interesting genes, LINC00685 and PPP2R3B. As for
LINC00685, two distal variants are reported in DGV (4 Kb
downstream), esv2219721 and esv266687: the former refers to a
549 bp deletion found in only one man, whereas the latter refers to
a 560 bp loss found in 82/1151 (7.1%) subjects (including men
and women) analyzed. As for the PPP2R3B gene, three variants
are reported in DGV and none of them affects the entire gene.
The first (esv27923) refers to a 548 bp loss mapping to intron 10–
11 of the gene found in one woman over a total of 451 subjects
(0.22%); the second (esv25834) refers to a 2.12 Kb region mapping
to intron 7–8 of the gene, where both gains (n = 7) and losses
(n = 4) were found in 11 women over a total of 451 subjects
(2.24%); the third (esv2758560) refers to 3 gains (218.7 Kb)
mapping to intron 1–2 of the gene, found in three men over 271
subjects totally analysed (1.1%). All these CNVs seemingly do not
disturb the ratio between LINC00685 and PPP2R3B copy number,
as with DUP1A.
Within the CNV minimum of DUP5 there is a single predicted
microRNA element, AL732314.1 (Table 3). For DUP5, the
already described esv2758560 variant is reported in DGV as well
as a large number of small CNVs; one variant (nsv508745),
describing three insertions (one in a woman and the other two in
one man out of 270 belonging to the HapMap project), overlaps
with the AL732314.1. No information about fertility of the single
male carrier could be found.
Within the CNV minimum of DUP20, two protein-coding
genes are duplicated entirely (Table 3). Of interest is MSL3, an
homologue of the Drosophila melanogaster homonymous gene, which
is involved in X-chromosome dosage compensation [16]. A
number of CNV annotations can be found in DGV. Of the 3
merged variants (nsv523223: 2.4 Kb; nsv524154: 74.9 Kb;
nsv526302: 140.8 Kb) representing 3 gains spanning the MSL3
locus, no CNVs were found in males. The ten (nsv515163,
esv2739963, esv270995, nsv6797, esv271693, nsv510814,
nsv6799, esv2739964, nsv436626, nsv499329) common CNVs
found upstream of MSL3 are all found at a much higher frequency
in females than in males (28 women (1.66%) versus 10 men (0.59%)
over a total of 1,682 subjects reported in the DGV).
Both DUP26 and DUP40 do not contain any protein-coding
genes but of interest is the presence of FAM47C, located 200 Kb
downstream of DUP26, and HMGN5, located 139 Kb upstream of
Table 1. CNV frequency and statistical analysis of case-control association study.
CNV Frequency Patients Frequency Controls Raw p-value Corrected p-value1
DUP1A 6/434 (1.38%) 0/507 0.01 0.047
DUP5 2/276 (0.72%) 0/327 0.21 0.63
DUP20 1/276 (0.36%) 0/327 0.45 0.45
DUP26 1/276 (0.36%) 0/327 0.45 0.45
DUP40 3/276 (1.09%) 0/327 0.097 0.39
1Corrected using Bonferroni-Holm Step-down correction for multiple testing.
doi:10.1371/journal.pone.0097746.t001
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DUP40 (Table 3). Both these genes show testis-specific expression
[14]. Concerning DUP26, three variants are reported to overlap
with this CNV: esv1007820 (6.9 Kb), describing a gain found in a
man without information on semen parameters; esv28598 (6.3
Kb), describing a gain found in a woman over a total of 451
subjects; esv2740093 (13.6 Kb), describing a loss found in one man
over 96 subjects totally analyzed. None of these CNVs intersect
the FAM47C directly but are located between 307.7–325.6 Kb
downstream. Two losses (esv23127, size: 380.5 Kb; nsv510839,
size: 74.4 Kb) and 1 gain (esv24190, size: 18.1 Kb) covered the
entire DUP40 CNV minimum, whereas one gain (nsv436916, size:
10.26 Kb) covered DUP40 for most of its size (3.8 Kb). Again,
these CNVs do not intersect HMGN5 directly but are located
between 238.3–281.1 Kb upstream. The 2 gains and the 2 losses
were found at the same frequency in 2 women and 2 men over a
total of 508 analyzed subjects (0.39%). No information on the
men’s fertility status was available.
Discussion
A recent study by Tu¨ttelmann et al [4] provides the first
statistically significant duplication burden on the X chromosome,
reporting a significantly higher number of gains in azoospermic
patients compared to both oligozoospermic patients and normal
controls. Our analysis of five X-linked CNVs also reveals a
significantly higher duplication load in infertile compared to
normozoospermic men.
While four of the five CNVs (DUP5, DUP20, DUP26 and
DUP40) studied did not individually reach statistical significance,
they remained patient-specific. It is worth noting that rare variants
have previously been predicted to play an important role in
spermatogenic failure [5] due to the strong selection against
highly-penetrant infertility-causing variants. All CNVs include, or
are in close proximity to, genes with testis-specific expression and
potential implication in spermatogenesis. DUP20 contains the
MSL3 gene, a homologue of Drosophila melanogaster homonymous
gene. Msl3 in D. melanogaster plays a critical role in the X-
chromosome dosage-compensation pathway by directing histone
H4 acetylation at lysine 16 (H4K16) and the human homologue is
thought to have a similar function [17]. Although no information
in humans is available, mice models provide evidence that this
specific chromatin modification is dramatically increased in
elongating spermatids and precedes histone replacement during
spermatogenesis, as an initial step of nucleosome removal [18].
Both DUP26 and DUP40 are within close proximity of genes
expressed exclusively in the testis. Inside and nearby DUP40 there
is a dense area with epigenetic features indicating that DUP40
may disrupt the epigenetic regulation of neighbouring genes.
DUP5 is of particular interest due to its large size and location on
the PAR1 as explained below.
Table 3. Physical Characteristics of CNVs selected for the study.
CNV
Start-end position
(CNV Min)1
Size
(Min)
Size
(Max)
Substrate
for NAHR2
Protein Coding within, or
nearby CNV minimum
(within 0.5 Mb)
Regulatory/RNA within, or nearby CNV
minimum (within 0.5 Mb)
DUP1A ChrX: 61544–3063721 245 Kb 247 Kb No PLCXD1, GTPBP6, PPP2R3B4,
SHOX
LINC00685, AL732314.1
DUP5 ChrX: 382644–5427401 160 Kb 168 Kb No3 PLCXD1, GTPBP6, PPP2R3B, SHOX LINC00685, AL732314.1, RP11–309M23.1
DUP20 ChrX: 11194597–117966931 602 Kb 608 Kb No3 MID1, HCCS, ARHGAP6, AMELX,
MSL3, FRMPD4, PRPS2, TLR7,
TLR8, TMSB4X, FAM9C.
RP11–120D5.1, AC002981.1, FRMPD4-AS1, TLR8-AS1,
RP11–791M20.1, GS1–600G8.5
DUP26 ChrX: 37283466–373720451 89 Kb 96 Kb No3 FAM47C, PRRG14, TM4SF24,
LANCL3, XK, CYBB, DYNLT3,
CXorf27, SYTL5.
RNU6–49
DUP40 ChrX: 80225590–802308701 5.3 Kb 28 Kb No BRWD3, HMGN5, SH3BGRL ACA64, U6, AL357115.1
1Genomic positions are in Hg19.
2Non-allelic Homologous Recombination (NAHR).
3Short regions (,300 bp) with 80% homology were found, but were not considered sufficient for NAHR.
4Gene crossed the minimum and maximum threshold, and is not fully duplicated.
doi:10.1371/journal.pone.0097746.t003
Figure 1. Position of DUP1A relative to LIN00685 and PPP2R3B on the X chromosome (PAR1). Diagram of the Xp22.33, showing the
presence of all known protein-coding genes (Red) and DUP1A (Blue). Enlarged is a 100 Kb region showing the location of PPP2R3B and LINC00685 in
relation to the DUP1A minimum and maximum. This gain will certainly duplicate the antisense element LINC00685, but does not fully duplicate
PPP2R3B – skewing the ration between the gene and its negative regulator.
doi:10.1371/journal.pone.0097746.g001
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DUP1A was found at a significantly higher frequency in
patients. This gain contains a long non-coding RNA (LINC00685)
that potentially acts as a negative regulator of a gene with potential
role in spermatogenesis, PPP2R3B. This proposed mechanism
could not be confirmed by functional studies because in vitro
human spermatogenic cell culture is not available and this
antisense is not present in easily accessible model organisms such
as mouse and Drosophila. However, expression data provides
evidence for an inverse relationship between PPP2R3B and
LINC00685 levels in a number of different tissues (see Figure S1
in File S1 and Figure 2) [13,14]. Concerning the testis, those
samples with a high expression of PPP2R3B show comparatively
low expression of LINC00685 [13,14].
Figure 2 shows the changing levels of PPP2R3B and
LINC00685 mRNA throughout spermatogenesis and the inverse
relationship between PPP2R3B and LINC00685. In tissues that
lack germ cells, PPP2R3B levels are low, and LINC00685 levels are
comparatively high (AdMinus, JS1 and JS2). PPP2R3B levels rise
with the presence of mitotically active cells (AdPlus, JS3), and are
highest in samples enriched in meiotically active cells (JS5).
Scoring system for testicular biopsies was obtained from Chalmel
et al [14] and is reported in Table S3 in File S1. Again, in these
tissues LINC00685 levels are decreased. Based on this observation,
we propose that the mechanism by which DUP1A could lead to
spermatogenic failure is through increased negative regulation,
caused by the duplicated LINC00685 that would decrease
PPP2R3B transcription in the developing germ cells. This
hypothesis is also supported by our qPCR analysis, which proved
that the six patients with DUP1A, thus carrying an over-dosage of
the antisense LINC00685, do not display a duplication of the entire
PPP2R3B gene.
Although the role of PPP2R3B in spermatogenesis has not been
explored, indirect functional evidence supports its involvement
both in mitosis and meiosis. PPP2R3B encodes for a subunit of the
protein phosphatase 2 (PP2) protein complex. PP2 is one of four
major Ser/Thr phosphatases and has been implicated in a wide
range of cellular activities. PP2 is a heterotrimeric protein,
composed of a structural A-subunit, a catalytic C-subunit and a
regulatory B-subunit. PPP2R3B belongs to this final group, giving
specificity to the PP2 complex [19]. In mice, PPP2R3B–PP2 was
demonstrated to maintain a pool of dephosphorylated CDC6 - a
replication-licensing factor [19]. CDC6 phosphorylation and
dephosphorylation is necessary for the mitotic G1 to S-phase
transition [20]. Accordingly, overexpression of PPP2R3B results in
mitotic arrest at G1 phase [19]. Unlike somatic cells, following
mitosis primary spermatocytes retain high levels of CDC6 [20],
indicating a possible further role for this protein in meiosis.
Expression analysis of testis biopsies with different histology
patterns supports the involvement of PPP2R3B in mitosis where
PPP2R3B levels are higher in samples containing mitotically active
cells compared to those lacking germ cells. More importantly, the
most pronounced expression is observed in biopsies with
spermatocytic arrest i.e. those enriched in meiotic cells, indicating
an additional role for this gene in meiosis [14]. As mentioned
above, LINC00685 levels show an opposite trend, strongly
suggesting a functional link between the two gene products
[13,14] (see supplementary discussion S2, Table S3 and Figure S1
in File S1).
Given that genes that have been recently incorporated into the
human X chromosome are involved in male reproductive fitness
[12] it is worth noting that PPP2R3B has been recently acquired
on this chromosome.
Although no CNVs were found in the database of genomic
variants (DGV) intersecting PPP2R3B or LINC00685, re-analysis
of raw data deposited in dbVar by Tu¨ttelmann et al. [4] shows that
a number of CNVs (5 gains and 2 losses) were found in the PAR1
of azoospermic men. Focusing on the gains, the variant nsv869733
(243.8 Kb), describing 3 gains mapping to the PPP2R3B locus, was
found exclusively in azoospermic patients (n = 4). The CNV
minimums of two of these gains (one mapping to chrX: 298, 292–
322, 672 and the other mapping to chrX: 298, 292–330, 801)
begin in PPP2R3B intron 1–2 and end in intron 12–13,
respectively. These CNVs are likely to lead to a non-functional
protein by causing an internal duplication. The other CNV
(mapping to chrX: 291, 285–336, 040) begins 3.4 Kb upstream of
the PPP2R3B locus and ends in intron 12–13, which would disrupt
the gene at exon 1 as well as the promoter. Moreover, the presence
of a predicted promoter 1Kb upstream of PPP2R3B and several
regions enriched in histone methylation suggests that these gains
may disrupt the correct regulation of PPP2R3B. The duplication of
the PPP2R3B locus has been reported also in men with abnormal
karyotype and AZF deletions and in a single man with normal
karyotype and AZFb deletion [21]. However, in these cases the
infertile phenotype is clearly related to the karyotype and Y
chromosome defects. The observations from Tu¨ttelmann, together
with ours, showing the relatively high frequency at which DUP1A
was found exclusively in patients and its potential link to PPP2R3B
gene expression, strongly indicate that PPP2R3B could be
considered a novel spermatogenesis candidate gene.
Large CNVs of the PAR1 region, like DUP1A and DUP5, may
lead to impaired spermatogenesis also through a structural effect
disturbing male meiosis i.e. altering the recombination event that
occurs between the PAR1 regions of the sex chromosomes [8,9].
PAR1 recombination becomes progressively more frequent
Figure 2. Relative expression of PPP2R3B and LINC00685 in testes biopsies in patients with different phenotypes (Johnsen Score)
(Chalmel, et al., 2012). Taken from EBI Expression Atlas. (http://www.ebi.ac.uk/gxa/home).
doi:10.1371/journal.pone.0097746.g002
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towards the distal telomeric boundary [22], where DUP1A and
DUP5 are located, showing the importance of this region during
meiosis. For instance, the merged analysis of data by Tu¨ttelmann
and our previous study shows that no PAR-linked CNVs were
found in the vicinity of these 2 CNVs in normozoospermic
controls, with the exception of one subject found by Krausz et al.
to be carrying DUP4A. However, this CNV only partially overlaps
with the DUP1A (at its distal boundary) and DUP5 (at its proximal
boundary). This observation may indicate that: i) the pathogenic
effect of DUP1A is more likely related to the misbalanced
LINC00685/PPP2R3B gene dosage effect; ii) the portions of
DUP1A and DUP5 that are not overlapping with DUP4A could
be affecting specific sites of importance for X-Y pairing during
meiosis.
Finally, the combination of all data discussed above supports the
importance of the PAR1–linked CNVs in male infertility. Our
most relevant finding is the identification of the first recurrent, X-
linked gain associated with spermatogenic failure, DUP1A. Two
possible mechanisms have been provided to explain the patho-
genesis of the associated infertile phenotype – one identifying and
regarding a novel spermatogenesis candidate gene and another
due to a potential structural effect in the PAR1. Both of these
scenarios are intriguing and prompt further research.
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studyquestion: Are Y-chromosomemicrodeletions associatedwith SHOX haploinsufficiency, thus representing a risk of skeletal anom-
alies for the carriers and their male descendents?
summaryanswer: The present study shows that SHOX haploinsufficiency is unlikely to be associated with Y-chromosome microdele-
tions.
what is known already: Y-chromosomemicrodeletions are not commonly known as amajormolecular genetic cause of any patho-
logical condition except spermatogenic failure. However, it has been recently proposed that they are associated not only with infertility but also
with anomalies in the pseudoautosomal regions (PAR), among which SHOX haploinsufficiency stands out with a frequency of 5.4% in microdele-
tion carriers bearing a normal karyotype. This finding implies that sons fathered by men with Y-chromosome defects will not only exhibit fertility
problems, but might also suffer from SHOX-related conditions.
study design: Five European laboratories (Florence, Mu¨nster, Barcelona, Padova and Ancona), routinely performing Y-chromosome
microdeletion screening, were enrolled in a multicenter study.
participants/materials, setting, methods: PAR-linked and SHOX copy number variations (CNVs) were analyzed in 224
patients carrying Y-chromosome microdeletions and 112 controls with an intact Y chromosome, using customized X-chromosome-specific
array-CGH platforms and/or qPCR assays for SHOX and SRY genes.
main results and the role of chance: Our data show that 220 out of 224 (98.2%) microdeletion carriers had a normal SHOX
copy number, as did all the controls. No SHOX deletions were found in any of the examined subjects (patients as well as controls), thus excluding
an association with SHOX haploinsufficiency. SHOX duplications were detected in 1.78% of patients (n ¼ 4), of whom two had an abnormal and
twoanormal karyotype.Thismight suggest thatY-chromosomemicrodeletions havea higher incidence for SHOXduplications, irrespectiveof the
patient’s karyotype. However, the only clinical condition observed in our four SHOX-duplicated patients was infertility.
limitations, reasons for caution: The number of controls analyzed is rather low to assess whether the SHOX duplications
found in the twomen with Y-chromosomemicrodeletions and a normal karyotype represent a neutral polymorphism or are actually associated
with the presence of the microdeletion.
wider implications of the findings: Men suffering from infertility due to the presence of Y-chromosome microdeletions can
resort to artificial reproductive technology (ART) to father their biological children. However, infertile couplesmust be aware of the risks implied
and this makes genetic counseling a crucial step in the patient’s management. This study does not confirm previous alarming data that showed an
association between Y-chromosome microdeletions and SHOX haploinsufficiency. Our results imply that deletion carriers have no augmented
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risk of SHOX-related pathologies (short stature and skeletal anomalies) and indicate that there is no need for radical changes in genetic counseling
of Yq microdeletion carriers attempting ART, since the only risk established so far for their male offspring remains impaired spermatogenesis.
study funding/competing interest(s): This work was supported by the Italian Ministry of University (grant PRIN 2010-2012
toC.K.), Tuscan Regional Health Research Program (‘Progetto Salute 2009’) toG.F., the SpanishMinistry ofHealth (grant FIS-11/02254) and the
European Union ‘Reprotrain’ Marie Curie Network (project number: 289880 to C.K.). The authors declare that no conflicting interests exist.
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Introduction
The Y chromosome displays a distinctive genomic landscape for most of
its extent, rich in repetitive elements that provide a favorable environ-
ment for the generation of copy number variations (CNVs). There is
ever-growing evidence that collocates CNVs among those genetic
factors that deserve prime attention when dealing with complex
human diseases. To date, the only CNVs unquestionably associated
with male infertility are the Y-chromosome microdeletions, which
involve the azoospermia factor (AZF) region on Yq and are thus
termed AZFa, AZFb and AZFc microdeletions (Krausz et al., 2011).
Each type of microdeletion is in a clear-cut cause–effect relationship
with a distinct abnormal semen phenotype, but until recently microdele-
tion carrierswith normal karyotypehavenot beenproven tobe at risk for
any condition other than infertility.
However, one recent study (Jorgez et al., 2011) reported that micro-
deletion carriers also displayed aberrations in the pseudoautosomal
regions (PAR1 and PAR2), short homologous regions sited at the ex-
tremities of the gonosomes. Therefore, the authors proposed that the
mechanism underlying Y-chromosome microdeletions might also be
associated with the occurrence of PAR rearrangements. The salient,
and alarming, finding of this study resided in the detection of haploinsuf-
ficiency of the PAR1-located SHOX (Short stature HOmeoboX-
containing) gene in 5.4% of men carrying Yq microdeletions and a
normal karyotype. It is widely ascertained that SHOX haploinsufficiency
leads to disproportionate short stature and diverse skeletal anomalies
such as Leri–Weill dyschondrosteosis (LWD) (Helena Mangs and
Morris, 2007). In contrast, theoccurrenceof SHOXduplications is appar-
ently rare, with only few cases reported so far (Grigelioniene et al., 2001;
Tachdjian et al., 2008; Roos et al., 2009; Thomas et al., 2009; D’Haene
et al., 2010;Gervasini et al., 2010) andnodirect relationshipwith anyspe-
cific phenotype has yet been defined. The finding by Jorgez et al. (2011)
raised the question whether microdeletion carriers might be at higher
risk of incurring PAR-related pathologies. If this were true, genetic
counselingwould radically change, since infertile couples undergoing arti-
ficial reproductive technology (ART) would need to be informed that
their sons not only will have fertility problems but also will be at risk of
developing PAR-related disorders. Moreover, screening for SHOX-
linked CNVs should then become compulsory for men carrying Yq
microdeletions.
Given the relevance and the potential clinical impact of this issue, we
performed a multicenter investigation on a large study population—
almost doubling that of the above mentioned study (Jorgez et al.,
2011)—in order to investigate whether the hypothesis of an association
between Yq microdeletions and SHOX haploinsufficiency could be
confirmed.
Materials andMethods
Subjects
The study population counted a total of 336 Caucasian men, comprising 224
patients carrying different types of Y-chromosome microdeletions (4 com-
plete AZFa; 6 AZFb,c; 153 complete AZFc; 4 AZFa,b,c; 57 partial AZF dele-
tions; 40gr/gr, 7 gr/gr-b2/b4duplication,3partialAZFadeletion, 5b2/b3,1
b1/b3, 1 b3/b4) and 112 men with an intact Y chromosome, referred to as
controls. The detection of Y-chromosome microdeletions was achieved by
screening patients according to the European Academy of Andrology
(EAA) guidelines (Simoni et al., 2004), in the followingparticipating laborator-
ies: Florence (n ¼ 66); Mu¨nster (n ¼ 56); Barcelona (n ¼ 43); Padova (n ¼
49); Ancona (n ¼ 10). Karyotype was available for 300 subjects, including
patients and controls.
GermlineDNAderiving fromperipheral blood lymphocyteswas originally
isolated in each participating center by standard methods. DNA quality was
assessed using a Nanodrop ND-1000 UV-VIS spectrophotometer (Nano-
drop Technologies, Wilmington, DE, USA) and samples showing a A260/
280 ratio .1.8 were used. All individuals gave informed consent for the
routine AZF analysis and further scrutiny.
Array-comparative genomic hybridization
Customized X-chromosome-specific array-comparative genomic hybridiza-
tion (CGH)platforms (8X60 K,Agilent Technologies, SantaClara,CA,USA)
were generated using the e-Array software (http://earray.chem.agilent
.com/); 53 069 probes (60-mer oligonucleotides) were selected from the
Agilent database and covered the whole X chromosome, including Xp and
Xq PARs, with a mean resolution of 4 kb. Four replicate probe groups,
with each probe present in two copies on the platform, were designed in
regions containing mouse infertility-associated genes, i.e. sperm protein
associated with the nucleus, X-linked family members (SPANX); testis
expressed 11 (TEX11), TAF7-like RNA polymerase II (TAF7L), TATA box
binding protein (TBP). In these regions, the medium resolution is 2 kb. For
the normalization of copy number changes, the array also included Agilent
control clones spread along all autosomes (6842 probes). As a reference
DNA, the same male subject with no Yq microdeletions and normal karyo-
typewas used.This controlDNAwasalready characterized forCNVcontent
in previous array-CGH experiments against eight different normozoosper-
mic controls and presented one private gain of 27 kb mapping to Xcentr
which was not considered for the frequency analyses. Three hundred nano-
grams of test DNA and control DNA were double-digested with RsaI and
AluI (Promega, Madison, WI, USA) for 1 h at 378C. After digestion,
samples were incubated at 658C for 20 min to inactivate the enzymes, and
then labeled by random priming (Agilent Technologies, Santa Clara, CA,
USA) for 2 h using Cy5-dUTP for the test DNA and Cy3-dUTP (Agilent
Technologies, Santa Clara, CA, USA) for the control DNA. Labeled DNAs
were incubated at 658C for 10 min and then purified with Microcon
YM-30 filter units (Millipore, Billerica, MA, USA). Every purified sample
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was brought to a total volume of 9.5 ml in 1xTE (pH 8.0, Promega, Madison,
WI, USA), and yield and specific activity were determined for each sample
using aNanoDropND-1000UV-VIS Spectrophotometer (Nanodrop Tech-
nologies, Wilmington, DE, USA). The appropriate cyanine 5- and cyanine
3-labeled samples were combined in a total volume of 16 ml. After sample
denaturation and pre-annealing with 5 ml of HumanCot-1DNA (Invitrogen,
Carlsbad, CA, USA), hybridization was performed at 658C with shaking for
24 h. After two washing steps, the array was analyzed through the Agilent
scanner and the Feature Extraction software (v10 1.1.1). Graphical overview
was obtained using the DNA Analytics (v4.0.73). All the array experiments
were analyzed using theADM-2 algorithm at threshold 5. Aberrant signals in-
cluding three or more adjacent probes were considered as genomic CNVs.
The positions of oligomers refer to theHumanGenomeMarch 2006 assem-
bly (hg18). Array-CGH calls for the detected CNVs are provided in Supple-
mentary data, Table SI and raw data are depicted in Supplementary data, Figs
A–D, referring to samples presented in Table I.
Quantitative real-time PCR
To estimate SHOX copy number (CN), a quantitative real-time PCR (qPCR)
assay targeting exon2of the genewasdesigned (AppliedBiosystem). Primers
and probes were designed with the Primer Express v2.0 software (Applied
Biosystems, Foster City, CA, USA) and tested for specificity using the
NCBI’s BLAST software. To estimate SRYCN,weused a commercially avail-
able qPCR assay (Roche, Mannheim, Germany). Reactions were performed
in triplicate in a 10 ml final volume. The target gene (FAM-labeled) and the
reference gene RNAseP (VIC-labeled) were co-amplified in a duplex
qPCR. Four internal controls were always included in each experiment: (i)
a subject with normal karyotype (calibrator); (ii) a subject with SHOX dele-
tion; (iii) a 47,XXY subject and (iv) a no-template negative control. All runs
were performed using 7900HT Fast System. Target genes CN was deter-
mined by relative quantification using the Copy-Caller-Software, v1.0
(Applied Biosystems, Foster City, CA, USA), based on the comparative
ddCt method (Fig. 1). qPCR profiles are shown in Supplementary data, Figs
E–G.Assay reproducibilitywas validated by calculating the coefficient of vari-
ation (Cv) between fivedifferent experiments, inwhichCNwas estimated for
the three positive controls (normal man, deleted man and 47,XXY man).
Standard deviations (S) and mean values (M ) were calculated and Cv was
computed as: Cv ¼ (S/M ) × 100, denoting a very low inter-assay variability
ranging between 0.4 and 2%.
Results
Array-CGH indicates that PAR-linked CNVs
are mainly related to the individual’s
karyotype
Array-CGHwas performed for twenty menwith Yqmicrodeletions and
twelve controls with an intact Y chromosome. Karyotype was available
for 18of theYqmicrodeletion carriers, 13with normal and5with abnor-
mal karyotypes. All controls displayed a normal karyotype. This prelim-
inary array-CGH analysis revealed that four of twenty carriers (20%)
displayed CNVs, both losses and gains, at the PAR level. Of these four
subjects, three carried an AZFb,c microdeletion and one carried a com-
plete AZFc microdeletion. However, the array-CGH results were not
unexpected since all the detected CNVs were explainable by the asso-
ciated abnormal karyotype (Table IA). None of the twelve controls dis-
playedCNVs in the PARs. Validation of array-CGH-detectedCNVswas
performed using predesigned SHOX and SRY TaqMan CN Assays.
SHOXCN evaluation by qPCR
Wescreened another set of 204men carrying various types of Yqmicro-
deletions (including partial AZFc deletions and duplications) with SHOX
qPCR alone, considering SHOXCNas a proxy of PAR1 rearrangements.
Karyotype was available for 170 men, of which 164 had a normal karyo-
type and 6 had karyotype anomalies. We found that almost all subjects
analyzed (201/204; 98.5%) had a normal SHOX CN, except for three
men that displayed an extra copy of the SHOX gene (1.47%): samples
D1056, P7806 (both carrying a complete AZFc microdeletion) and
Mmp1000 (carrying an AZFbcmicrodeletion) (Table IB). These patients
were then screened for the SRY gene, aswell.We found thatone also had
an extra copy of the SRY gene, whereas the other two had a normal SRY
CN (Table IB). Although Mmp1000’s case history reported a 46,XYq-
karyotype, the presence of two copies of the SRY gene clearly indicates
that this is a 46,X,idic(Yp) with potential breakpoint in P6/P7 (Lange
et al., 2009). No SHOX deletions were found in any of the Yqmicrodele-
tioncarriers. Ifweonly considermenwithcompleteAZFcmicrodeletions,
Table I Patients with PAR-linked CNVs detected by qPCR and/or array-CGH.
A. Array-CGH analysisa
Patient Center Deletion type Tot sperm count (×106) Karyotype CNV type
A416 Florence AZFb,c 0 46,X,idic(Y)(q11.22) Gain PAR1
A372 Florence AZFb,c 0 46,X,idic(Y)(q11.22)[31]/46,X,+mar[3]/45,X[16] Loss PAR2
A1389 Florence AZFb,c 0 45,X[19]/46,X,del(Y)(q11.2)[81] Loss PAR2
A116b Florence AZFc 0 45,X[90]/46,XY[10] Loss PAR2
B. qPCR screeningc
Patient Center Deletion type Tot sperm count (×106) Karyotype SHOX CN SRY CN
Mmp1000 Ancona AZFb,c 0 46,XYq- 3 2
P7806 Padova AZFc 0 46,XY 3 1
D1056 Muenster AZFc 0 46,XY 3 1
CGH, comparative genomic hybridization; CN, copy number; CNV, copy number variation.
aArray-CGH results were validated by subsequent qPCR.
bFor patient A116, qPCR was not performed due to DNA sample extinction.
cEach qPCR was performed in triplicate and each assay was repeated three times.
Y-chromosome microdeletions and SHOX 3157
 at Kainan University on January 21, 2015
http://humrep.oxfordjournals.org/
Downloaded from 
weobserve that samplesD1056andP7806are theonlyoneshavingSHOX
CNVs, accounting for 1.31% (2/153) of carriers.
SHOXCNVs in microdeletions carriers
and normal karyotype
If we solely considermenwithYqmicrodeletions and a normal karyotype,
we observe that, on a total of 177 subjects (15 analyzed by array-CGH/
qPCR and 164 analyzed by qPCR only), SHOX deletions were never
found, whereas only SHOX duplications were detected in samples
D1056 andP7806 (1.1%).Hence, 98.9% (175/177) ofmenwithmicrode-
letionsandanormal karyotypedidnotdisplayanySHOXCNVs.Asacoun-
terpart, we finally screened an extra set of 100 men, of two different
nationalities (Italian and Spanish), displaying an intact Y chromosome
and normal stature, and all resulted with a normal SHOX CN.
SHOX duplications and the associated
phenotype
Atotal of four patients, carrying both altered and normal karyotypes, dis-
played an extra copy of the SHOX gene. At the moment of consultation,
all these patients presented with neither stature abnormalities nor any
medical condition other than azoospermia (Table II). In the case of
patient P7806, testicular sperm extraction upon bilateral TESE allowed
the isolation of 13 fully maturated spermatozoa from the right side and
0.025 × 106 from the left side. ICSI performed with the patient’s cryo-
preserved spermatozoa resulted in the delivery of a healthy male child.
Discussion
Y-chromosome microdeletions represent the most frequent genetic
cause of spermatogenic failure in infertilemen, second only to Klinefelter
syndrome (Krausz et al., 2011). In order toovercome their condition and
father biological children, some carriers opt for treatment with ART.
However, Yq genetic defects will be inevitably transmitted to their
male offspring, whowill predictably suffer from fertility problems. There-
fore, genetic counseling for these couples is of inestimable importance.
Twenty years of interest in Y-chromosome microdeletions has pro-
duced a collection of numerous articles, but only a minority of these
studies aimed to definewhether Yq deletionsmight lead to other patho-
logical conditions, beside spermatogenic failure. Microdeletions were
reported in associationwith 45,X/46,XYmosaic karyotype and ambigu-
ous genitalia (Papadimas et al., 2001; Patsalis et al., 2002, 2005; Papani-
kolaou et al., 2003; Tian et al., 2012); consistently, our data provide
further evidence that Yq microdeletions do associate with mosaicism
(as four samples presented 45,X cell lines), supporting the hypothesis
that Y chromosomes bearing AZF deletions are more instable and
thus predispose to the formation of Y-chromosome nullisomic cell lines.
Recently, a paper by Jorgez et al. (2011) reported thatY-chromosome
microdeletions might not only cause spermatogenic failure but also in-
crease the risk for PAR-related pathologies, especially emphasizing
SHOX gene involvement. On a total of 87 men with Yq microdeletions,
they found SHOX haploinsufficiency in five samples, four carrying a
Figure 1 SHOX qPCR results. The figure represents data derived
from a single experiment and elaborated by CopyCallerTM software
v1.0. Deleted ¼ 1 copy of SHOX; Control ¼ 2 copies of SHOX;
Klinefelter ¼ 3 copies of SHOX.
.............................................................................................................................................................................................
Table II Phenotype characterization of Y-chromosomemicrodeletion carriers with an extra copy of SHOX.
Patient D1056 P7806 A416 Mmp1000
Age 32 39 44 38
Height (cm) 180 188 n.a. 174
Nationality German Italian Italian Italian
Mean testis (cc) 7 6 n.a. 12
Tot sperm count (x106) 0 0 0 0
Karyotype 46,XY 46,XY 46,X,idic(Y) 46,XYq-
FSH (UI/L) 29.9 21.9 17.9 13.9
LH (UI/L) 11.2 9.2 6.7 8.6
Testosterone (ng/ml) 3.77 3.54 5.75 4.61
Testis histology Bilateral SCOS Unilateral SCOS and hypospermatogenesisa – –
Other medical conditions None None None None
SCOS, Sertoli cell only syndrome; n.a., not available.
aQuantitative alteration in which a very small portion of seminiferous tubules containing fully maturated spermatozoa (13 in the right testis and 0.025 × 106 in the left testis) was found.
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normal karyotype and one carrying an idic(Y); however, information is
missing about these patients’ phenotype. Moreover, they found nine
men with SHOX duplications, all displaying abnormal karyotypes; still,
stature was available only for six patients and clinical data only for four
subjects, ofwhomonly twodisplayedothermedical conditions (congeni-
tal urological defects, diabetes and cataracts).
In this study, we provide the largest collection of men carrying
Y-chromosome microdeletions analyzed so far in association with
SHOXCN. A novelty of our study consisted in the inclusion of additional
Y-chromosome rearrangements, such as gr/gr deletions and gr/gr
deletion-duplications. Moreover, we included a very large number of
menwith complete AZFcmicrodeletion (4-fold higher than the previous
study) because they represent the more plausible candidates for ART
attempts. Our data seemingly indicate that SHOX CNVs are mainly
linked to the individual’s karyotype rather than the mere presence of
microdeletions. As a matter of fact, of 177 deletion carriers with a
normal karyotype only two (1.1%) displayed an abnormal SHOX CN:
both patients bore duplications of the SHOX gene, but apart from a rela-
tively high stature (though still within the normal range) themen’s clinical
work-up revealed no other pathological conditions than azoospermia.
Literature is poor and unclear about SHOX over-dosage, which has
been reported in association with normal to tall stature (Ogata et al.,
2001; Adamson et al., 2002) as well as to more severe conditions such
as LWD and idiopathic short stature (ISS) (Roos et al., 2009; Thomas
et al., 2009; D’Haene et al., 2010; Benito-Sanz et al., 2012). In our
study, the relatively low number of controls analyzed makes it difficult
to define whether the SHOX duplications found in the two men with
Yq microdeletions and a normal karyotype represent a polymorphism
commonly found in the general population or are actually associated
with the presence of the microdeletion. However, although we did not
find SHOX over-dosage in controls, a recent study (Lopes et al., 2013)
reported the presence of a duplication burden on the Y chromosome,
including PAR1, in men with no Yq microdeletions, suggesting that the
‘duplication events’ that we observed are unlikely to be related to the
presence of microdeletions.
Conversely, a clear picture exists concerning SHOX haploinsufficiency
and its deleterious effects on stature (HelenaMangs andMorris, 2007). In
our screening, noneof themenwithmicrodeletions had SHOXdeletions,
contrasting the aforementioned hypothesis that microdeletion carriers
are at a higher risk of developing pathologies causedby SHOXhaploinsuf-
ficiency.
The reasons underlying the discrepancy between our study and the
previous publicationmight be related tomethodological issues, although
the extremely succinct description of the method in the paper by Jorgez
et al. (2011) renders it difficult to make any meaningful comparison. In
our study, much care was taken to validate every step: template
quality, inter-assay variability and all technical aspects were thoroughly
addressed to avoid artifacts. Another potential bias might be ethnicity;
but again, the ethnic background was not specified in the previous pub-
lication and thus comparison with our study cannot be done.
In summary, our study confirms the previously reported association
between complete AZF microdeletions and 45,X/46,XY mosaicism.
Moreover, we show that both partial and complete microdeletions in
menwith 46,XY karyotype are unlikely to be associatedwith SHOX hap-
loinsufficiency, providing reassurance that the only established risk for
ART offspring born from men with Yq microdeletions remains sperma-
togenic impairment.
Supplementary data
Supplementarydata areavailable athttp://humrep.oxfordjournals.org/.
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Abstract
Data about the entire sperm DNA methylome are limited to two sperm donors whereas studies dealing with a greater
number of subjects focused only on a few genes or were based on low resolution arrays. This implies that information about
what we can consider as a normal sperm DNA methylome and whether it is stable among different normozoospermic
individuals is still missing. The definition of the DNA methylation profile of normozoospermic men, the entity of inter-
individual variability and the epigenetic characterization of quality-fractioned sperm subpopulations in the same subject
(intra-individual variability) are relevant for a better understanding of pathological conditions. We addressed these
questions by using the high resolution Infinium 450K methylation array and compared normal sperm DNA methylomes
against somatic and cancer cells. Our study, based on the largest number of subjects (n = 8) ever considered for such a large
number of CpGs (n = 487,517), provided clear evidence for i) a highly conserved DNA methylation profile among
normozoospermic subjects; ii) a stable sperm DNA methylation pattern in different quality-fractioned sperm populations of
the same individual. The latter finding is particularly relevant if we consider that different quality fractioned sperm
subpopulations show differences in their structural features, metabolic and genomic profiles. We demonstrate, for the first
time, that DNA methylation in normozoospermic men remains highly uniform regardless the quality of sperm
subpopulations. In addition, our analysis provided both confirmatory and novel data concerning the sperm DNA
methylome, including its peculiar features in respect to somatic and cancer cells. Our description about a highly polarized
sperm DNA methylation profile, the clearly distinct genomic and functional organization of hypo- versus hypermethylated
loci as well as the association of histone-enriched hypomethylated loci with embryonic development, which we now
extended also to hypomethylated piRNAs-linked genes, provides solid basis for future basic and clinical research.
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Introduction
Human spermatogenesis is an outstandingly complex biological
process which requires the concerted action of several thousands of
genes [1]. An interesting feature of this biological process is the
extremely large inter-individual variability of sperm production in
healthy fertile men. The entity of this variation is well illustrated by
a large recent study, reporting that total sperm number in the so
called normal range (defined as 5th -95th percentile), varies from
40 millions to several hundred millions [2]. While a few genetic
variants have been studied in relation to spermatogenic efficiency
in normozoospermic men [3–6], the epigenetic aspects of such
variations in the normozoospermic range is completely unex-
plored.
Apart from the large inter-individual variability of the above
mentioned quantitative traits of spermatogenesis, semen of
normozoospermic men contains a qualitatively (in terms of
motility and morphology) heterogeneous sperm population. With
the advent and diffusion of assisted reproductive techniques, a
number of sperm selection methods have been developed in order
to obtain sperm subpopulations enriched with highly motile and
morphologically normal spermatozoa to be used for in vivo or in
vitro insemination. The rationale behind selection is mainly related
to a predicted higher functional competency and a higher genomic
integrity of selected spermatozoa. Interestingly enough, despite the
same testicular environment, biochemical markers [7,8] as well as
DNA integrity [9–12] show differences in distinct sperm fractions
belonging to the same individual. It is still unknown whether these
fractions also show differences in their methylation level.
Given that epigenetic signals such as DNA methylation and
histone modifications are crucial for the proper functioning of the
genome, phenotypic differences in sperm production (quantitative
as well as qualitative traits) at both inter- and intra-individual level
may also be due to an epigenetic variation. This hypothesis seems
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e44479
to be plausible if we consider that the epigenome of mature
spermatozoa mirrors a series of sequential epigenetic reprogram-
ming events (demethylation and de novo methylation) which may
generate substantial epigenetic variability. The sole study address-
ing the question about intra- and inter-individual DNA methyl-
ation changes in normozoospermic men was based on a 12,198-
feature CpG island microarray [13]. The authors reported
significant variations for 6 genes both at the intra- and inter-
individual level, concluding that epigenetic variations may
contribute to the variable semen phenotype. On the other hand,
a limited inter-individual variability in DNA methylation was
observed in two recent studies comparing two sperm donors by
using a methylated DNA immunoprecipitation (MeDIP) proce-
dure and promoter arrays [14] and a genome-wide shotgun
bisulfite sequencing [15].
With respect to intra-individual variability of epigenetic marks
in quality-fractioned sperm populations from normozoospermic
and oligozoospermic men, data are available only for promoter
CpG islands of two spermatogenesis candidate genes, DAZ and
DAZL [16]. In this study, significant differences in the DAZL
promoter methylation were observed between normal and
defective germ cell fractions from the same individual. Other
evidences for a potential association of DNA methylation defects
and impaired sperm quality derives from studies based on the
comparison of men with different sperm parameters including
subjects with abnormally low sperm motility/morphology and
sperm number [16–25].
Given the paucity of data on intra- and inter-individual
variability of sperm DNA methylation, we aimed to provide a
detailed description based on the analysis of a total of 487,317
CpG sites. Our first question was whether different quality-
fractioned sperm populations deriving from the same individual
displayed differences at the DNA methylation level i.e whether
‘‘good’’ and ‘‘poor’’ quality spermatozoa differ not only in their
metabolic markers and genome integrity but also in their
methylation status. Our second aim was to assess the level of
inter-individual variability by comparing the genome-wide meth-
ylation profiles of whole sperm populations and quality-fractioned
sperm subpopulations of different normozoospermic subjects.
Finally, we aimed to get further insights into the sperm DNA
methylome through the investigation on loci with ‘‘variable’’ and
‘‘conserved’’ DNA methylation levels between individuals and
their relationship with chromatin modifications. In addition, in
this part of the study, we focused on a singular topic, not addressed
by others until now, that concerns the sperm methylation status of
piRNAs (PIWI-interacting RNAs). This peculiar class of small non
coding RNAs are specifically expressed in the testis and seem to be
involved in the maintenance of genomic stability and germ cell
function through the silencing, via DNA methylation, of mobile
genetic elements such as transposons (reviewed in Aravin et al.
[26]). In fact, knock-out mice models for the proteins involved in
the piRNA biogenesis (MIWI, MILI, MIWI2) revealed a
restoration of transposon activity, which is thought to be the
cause of the observed sterility due to meiotic arrest [27,28].
However, given that piRNAs have recently been identified also in
human cancer cells and somatic cells, it has been proposed that
piRNAs regulate gene expression more broadly than previously
predicted (for review see Juliano et al. [29] and Siddiqi and
Matushansky [29,30]. In order to provide new insights into this
largely unexplored topic, we investigated the piRNAs methylation
status in spermatozoa and performed a comparative analysis with
a differentiated somatic cell type (B cell) and a colorectal cancer
cell line (HCT-116).
Our study, based on the largest genome-wide DNA methylation
analysis available to date in a group of normozoospermic men,
allowed us to both define the ‘‘normal’’ sperm DNA methylome
with its peculiar features and discover a potential new role for
sperm piRNAs in embryonic development.
Materials and Methods
Subjects
Ethics statement: All participating subject signed an informed
consent and the project has been approved by the local Ethical
Committee of the University Hospital Careggi.
Eight healthy normozoospermic individuals of Italian origin
belonging to the upper normal range of sperm number were
analyzed in this study. Sperm parameters, age and relevant
phenotypic information are reported in Table S1. Considerable
care was taken for the selection of subjects in order to provide a
homogeneous group in terms of life style factors, age, BMI and
semen characteristics. Special attention was paid in selecting only
semen samples devoid of contaminating somatic cells in their
ejaculate. The absence of leucocytes or uroepithelial cells was
assessed by scoring 5 stained slides at the light microscope in all 8
samples. The purity of the swim-down fraction deriving from
contaminating cells was documented by checking additional 5
slides at light microscopy. This procedure based on a two-step
purity check granted a biologically irrelevant, if any, contamina-
tion in both whole semen and the swim-down fractions.
Three aliquots were obtained from each individual correspond-
ing to: 1) whole sperm population after 1 hour from semen
collection; 2) swim-up fraction; 3) swim-down fraction. For sample
EC7, the swim-down fraction has been excluded due to DNA
degradation. For 3 samples whole, semen at 2 Sperm DNA
methylation profile largely hours (corresponding to the time at
which the swim-up procedure ends) were also available for the
comparison with the other fractions.
Sperm selection
Whole semen has been centrifuged on a 25% Percoll gradient
(20 minutes) before the standard swim-up separation technique.
Although much care was taken for the selection of samples in
terms of lack of contaminating cells, this preliminary step further
ensured the purity of the sperm population. The swim-up
procedure allows spermatozoa with progressive motility to ‘‘swim
up’’ into the culture medium while hypomotile/immotile sperma-
tozoa remain behind. The upper fraction is denominated ‘‘Up’’,
whereas the fraction containing hypo/immotile spermatozoa is
indicated in this manuscript as ‘‘Down or Dn’’.
Sperm DNA extraction
Sperm DNA was extracted with an user-developed version of
the QIAampH DNeasy&Tissue Kit purification protocol. Fresh
washed (in PBS) sperm was incubated 1:1 with a lysis buffer
containing 20 mM TrisCl (pH 8), 20mM EDTA, 200 mM NaCl
and 4% SDS, supplemented prior to use with 100 mM DTT and
250 ug/ml Proteinase K. Incubation was performed for 4 hours at
55uC with frequent vortexing. Prior to processing in the columns,
200 ul of absolute ethanol and 200 ul of the kit-provided lysis
buffer were added to the samples. Then, purification was
performed according to kit instructions.
Microarray-based DNA methylation analysis
DNA was quantified by Quant-iTTM PicoGreen dsDNA
Reagent (Invitrogen) and the integrity was analyzed in a 1.3%
agarose gel. Bisulfite conversion of 600 ng of each sample was
Sperm DNA Methylation Profiling
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performed according to the manufacturer’s recommendation for
Illumina Infinium Assay. Effective bisulphite conversion was
checked for three controls that were converted simultaneously
with the samples. 4 ml of bisulfite converted DNA were used to
hybridize on Infinium HumanMethylation 450 BeadChip, follow-
ing Illumina Infinium HD Methylation protocol. Chip analysis
was performed using Illumina HiScan SQ fluorescent scanner.
The intensities of the images are extracted using GenomeStudio
(2010.3) Methylation module (1.8.5) software. Methylation score of
each CpG is represented as beta (b) value (b value ,0.2 is
considered as hypomethylated, .0.8 as hypermethylated). The
450K DNA Methylation array includes 485,764 cytosine positions
of the human genome. From these cytosine sites, 482,421 positions
(99.3%) are CpG dinucleotides, whilst only 3,343 sites (0.7%)
correspond to CNG targets. Thus, from this point on we will use
the term CpG, except when we refer specifically to putative CNG
methylation. A general depiction of the 450K platform design,
regarding functional genome distribution, CpG content and
chromosome location, is reported in a previous validation study
from our laboratory [31].
Data filtering
The 450K DNA methylation array by Illumina is an
established, highly reproducible method for DNA methylation
detection and has been validated in two independent laboratories
[31,32].
Every beta value in the 450 K platform is accompanied by a
detection p-value. We based filtering criteria on the basis of these
p-values reported by the assay. We examined two aspects of
filtering out probes and samples based on the detection p-values,
selecting i) a threshold and ii) a cut-off. Previous analyses indicated
that a threshold value of 0.01 allows a clear distinction to be made
between reliable and unreliable beta values [31]. We selected the
cut-off value as 10%. Following this criterion, we excluded all
probes with detection p-values .0.01 in 10% or more of the
samples and a total of 485,317 probes were included in the final
analysis. We expect similar methylation level in neighbouring CpG
sites given the strong correlation between CpG site methylation
levels up to 150 bp.
Statistical analysis
In order to identify differentially methylated CpG sites between
different quality fractioned sperm populations, a non parametric
test (Wilcoxon rank sum test) has been performed. Linear
regression coefficient has been calculated (Spearman’s rho) both
for intra and inter-individual variability of methylation levels. For
all comparisons of methylation levels between different subgroups
Fischer exact test was performed.
For the estimation of the degree of epigenetic dissimilarity
between individuals we measured the Euclidean distances between
two samples using the following equation:
d a,bð Þ~HSin~1 ai{bið Þ2
Where ai and bi represent the beta value for the i-essim CpG of
samples ‘‘a’’ and ‘‘b’’, and ‘‘n’’ the number of CpG sites selected.
In addition, to estimate the inter-individual variability of the
methylation status in the promoters of the 6 genes previously
described as highly variable, we calculated for each gene a 100,000
permutations test with the distances of the three groups, in order to
obtain a random distribution of possible mean distances and get a
p-value for the mean variability among individuals in a group (the
area below the distribution curve).
For the estimation of enrichment in biological processes we
performed a hypergeometric test on biological processes defined
by Gene Ontology [33].
Results
Comparison of genome-wide DNA methylation level in
different quality-fractioned sperm populations deriving
from eight normozoospermic men
The ejaculate of a normozoospermic man contains a qualita-
tively heterogeneous sperm population (in terms of different
motility, morphology, metabolic and genomic features). This part
of the analysis focused on intra-individual variation and addressed
the biological question whether there are significant differences in
methylation profiling between the ‘‘up’’ (enriched with highly
motile and morphologically normal spermatozoa) versus ‘‘down’’
(poorly motile/immotile and morphologically abnormal sperma-
tozoa) semen fractions in each subject.
Analysis of intra-individual variation in 485,317 CpG
loci. By performing linear regression analysis, we observed an
extremely high correlation (Pearson correlation coefficient ranging
from R2= 0.9896 to R2= 0.9982) between ‘‘good’’ and ‘‘poor’’
quality sperm suspensions in all subjects (Table S2A). A represen-
tative example is given for sample EC01 in Figure 1. Accordingly,
unsupervised hierarchical cluster analysis of the two tested groups
was unable to cluster the ‘‘up’’ and ‘‘down’’ fractions into two
distinct groups. Similarly, no significant differences were observed
following comparison of the methylation levels in the 485,317
CpG sites between different sperm fractions (‘‘up’’ versus ‘‘down’’,
whole sperm population versus ‘‘down’’, whole sperm population
versus ‘‘up’’). By comparing epigenetic distances between the ‘‘up’’
and ‘‘down’’ fractions of the same individual, we found no
significant differences except for one sample (EC12) with
p= 0.018. Interestingly, this sample showed the lowest sperm
count among the 8 normozoospermic individuals. Separately, we
analyzed the intra-individual variation in selected CpG loci
previously reported to be associated with poor sperm quality. To
begin with, a few imprinted loci were analyzed in previous studies
in relationship with a wide range of infertile phenotypes
(oligozoospermia, oligoasthenozoospermia, asthenozoospermia).
All previous studies reported methylation changes in a portion of
infertile men, suggesting that impaired sperm production may be
associated with methylation defects. A total of 2,386 CpGs
belonging to 45 imprinted genes are present on the 450K array
(24) and we analyzed the methylation status of their promoter
regions in the ‘‘up’’ and ‘‘down’’ fractions. Similarly, we
investigated on 289 CpGs belonging to 10 genes (DAZ, DAZL,
DAZAP, HRAS, KDM3A, MTHFR, NTF3, PAX8, RASGRF1, SFN)
showing DNA methylation changes in infertile men compared to
normozoospermic controls as well as in different quality-fractioned
sperm populations (such as DAZ and DAZL). In all cases, a
homogeneous methylation pattern was observed in the two
fractions derived from the same individual and, accordingly, the
two sperm fractions derived from all analyzed subjects did not
cluster separately (Figure 2 and 3).
Assessment of inter-individual variability in genome-
wide DNA methylation profile. Although all subjects be-
longed to the upper normal range of sperm number, the whole
semen fraction of each individual included a different proportion
of ‘‘good’’ and ‘‘poor’’ quality spermatozoa. The most homoge-
neous sperm population containing the best quality spermatozoa
was the ‘‘up’’ fraction. A slightly more pronounced inter-individual
variability in DNA methylation profile has been observed
compared to intra-individual variability between sperm fractions.
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However, the linear regression coefficients were always .0.98
(Table S2B). A representative scatter plot comparing two individ-
uals is shown in Figure 4 A–C.
In order to further explore inter-individual variability, we
analyzed each type of sperm fraction using two additional
approaches: i) we quantified the number of CpGs showing a
standard deviation .0.2 in the methylation level (beta value)
between individuals; ii) we measured the epigenetic distance (by
the use of the Euclidean distance formula reported in materials
and methods) between the methylation level of CpGs in different
subjects. The number of differentially methylated loci i.e. showing
a SD .0.2 between different subjects was 1,591 in the whole
semen, 1,207 in the ‘‘down’’ fraction and 1,675 in the ‘‘up’’
fraction. This implies that for all comparisons the number of CpGs
above the established threshold level was very low, representing
,0.3% of all loci tested. The GO analysis of genes related to the
1,675 differentially methylated sites did not show any germ cell
specific function. (data not shown).
By performing the comparison of DNA methylation distances
across individuals considering all 485,317 CpG sites, a significantly
higher variability has been observed in the swim-down sperm
fraction (p = 0.021) in respect to the swim-up fraction (Figure 4D).
However, it is worth noticing that the coefficient of variation is still
very low in the swim-down fraction, e.g. 14% which indicates that
the maximum epigenetic distance between individuals was limited
to 45, that is significantly lower than the maximum distance
possible e.g. 696.(see Table S3).
Assessment of methylation level in six gene promoters
previously reported as having the highest intra and inter-
individual variation. Significant DNA methylation variations
have been reported for promoters of the following 6 genes: BRCA1,
BRCA2, HTT (HD), DMPK (DM1), PSEN1, PSEN2 by Flanagan
et al. [13]. In order to evaluate the entity of inter-individual
variability, we calculated Euclidean distances for the beta values of
the CpG sites in the above gene promoters among individuals of
the three groups (Whole semen, ‘‘Down’’ and ‘‘Up’’), plots are
shown in Figure 5A–C. In addition, by performing permutation
test of the epigenetic distances we found significant inter-individual
differences for 4 out of 6 genes (HTT,DMPK, PSEN1, PSEN2) in
the swim-down sperm fraction (p values:2E-05; 0.00096; 0.00348;
0.02, respectively), while we observed no relevant variation in the
swim-up fraction. In the whole sperm population sample,
significance was reached only for BRCA1 (0.01136).
Sperm genome-wide methylome description and its
comparison with differentiated somatic cells
Sperm DNAmethylation profile: general features. Given
that the swim-up fraction, being enriched in the best quality
spermatozoa, is the one used for assisted reproductive techniques,
we aimed to provide a detailed description of genome wide DNA
methylation profile of these cells. The average DNA methylation
level of the 485,317 CpG sites was 45% (median value 35%).
However, an interesting feature of the sperm DNA methylome is
the polarization of DNA methylation level towards the two
extremes: 86% of all markers are either severely hypomethylated
(,20%) or strongly hypermethylated (.80%). Intermediate
methylation level (20–80%) was observed only for 14% of CpGs.
We defined, in each subject, the number of hypomethylated and
hypermethylated loci for the whole genome as well as for the sex
chromosomes and autosomes, separately (Table 1). The coefficient
of variation of DNA methylation levels was minimal between
subjects for the hypomethylated loci (0.9%) and slightly higher for
Figure 1. Scatter plots reporting CpGs methylation levels between different samples deriving from the swim-up sperm selection
procedure in the same individual EC01: (A) swim-up (Up) sperm fraction versus swim-down (Dn) sperm fraction; (B) whole sperm
population at1h (Ws 1 h) versus whole sperm population at 2 h (Ws 2h); (C) whole sperm population at 1h versus swim-down
sperm fraction; (D) whole sperm population at1h versus swim-up sperm fraction. R2 = Pearson coefficient.
doi:10.1371/journal.pone.0044479.g001
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hypermethylated loci (2.8%), suggesting a highly conserved profile
both for hypo and hypermethylated loci. Accordingly, we found
95.8% of all hypomethylated loci to be conserved between
individuals (n = 220,300 CpGs), whereas in the hypermethylated
loci the concordance was slightly lower, 86.1% (n= 161,542
CpGs).
The separate analysis of autosomal (a total of 473,681 CpGs),
X-linked (a total of 11,220 CpGs) and Y-linked CpGs (a total of
416 CpGs) revealed that X-linked loci are significantly more
frequently hypomethylated than autosomal loci (64.5% versus
45.8%; p,2.2 xE-16), as was the case also for the Y–linked loci
(65.2% versus 45.8%, p= 3.458xE-5) (Table 1). On the other
hand, autosomal loci were significantly more frequently hyper-
methylated than X-linked loci (38.1% versus 21.6%; p,2.2xE-16).
It is also worth noticing, that the highest percentage of
‘‘conserved’’ hypomethylated loci was found for the X-linked loci
(96.1%).
Sperm DNA methylation profile: comparative analysis of
regions with conserved hypo/hyper methylation and
differentially methylated loci between
individuals. Subsequently, we identified loci displaying the
same DNA methylation pattern in all subjects (‘‘conserved’’ hypo
or hyper) as well as loci showing different DNA methylation
patterns (‘‘variable’’ or ‘‘differentially methylated’’ loci). We
analyzed the functional genomic distribution (promoter, body,
39UTR, and intergenic), CpG content and neighborhood context.
For the latter, we referred to: i) ‘‘island’’ as a DNA sequence
(.200-bp window) with a GC content greater than 50% and an
observed: expected CpG ratio of more than 0.6.; ii) ‘‘shore’’ as a
sequence 0–2 Kb distant from the CpG island; iii) ‘‘shelf’’ as a
sequence 2–4 Kb distant from the CpG island; iv) ‘‘open sea/
Figure 2. Heatmap displaying the methylation status of CpG loci (n =2386) mapping in the promoters of 45 imprinted genes in
relation to quality-fractioned sperm populations (i.e. swim-up ‘‘up’’ and swim- ‘‘dn’’ sperm fractions). A) The dendrograms above the
heatmap show hierarchical clustering based on the methylation data alone. Sperm populations and CpG loci are represented by columns and rows,
respectively. Each cell indicates the CpG methylation level for one site in each sample. Methylation levels are represented in the scale on the right side
of the heatmap and are referred lowest to highest as green (0.0) to red (1.0). (B) List of the 45 imprinted gene available in the array.
doi:10.1371/journal.pone.0044479.g002
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others’’ as the remaining sequence. The methylation categories
were also analyzed in relationship with genomic locations related
to RNA transcription (coding, non-coding and intergenic). Sharp
differences were observed between the ‘‘conserved’’ hypo and
hyper-methylated loci according to the functional genomic
distribution as well as for the CpG and neighborhood context
(Figure 6). Among all ‘‘conserved’’ hypomethylated loci 63.6%
belonged to promoters, whereas this percentage was significantly
lower in the hypermethylated loci, 19.5% (p= 4,14E-05). A
significant difference was observed also in the methylation status
of gene body-linked CpGs which made up 47.7% of ‘‘conserved’’
hypermethylated loci and only a minority of the ‘‘conserved’’
hypomethylated loci (17.3%; p= 0.001357). Given the high
prevalence of promoters in the hypomethylated sites, almost
90% of the hypomethylated CpGs correspond to islands and
shores (58.7% and 29.9%, respectively). On the contrary, 80% of
‘‘conserved’’ hypermethylated sites are either in the CpG poor
island shelves or in ‘‘open sea’’ regions (18% and 63.3%,
respectively).
Differentially methylated loci (defined as .0.2 standard
deviation between individuals) have been identified only for
0.3% of all analyzed CpGs. Interestingly, the percentage of
‘‘variable’’ regions were lower in X-linked loci (0.2%) and were
completely absent in the 416 Y-linked loci. Intriguingly, the
pattern of ‘‘variable’’ CpGs was more similar to the ‘‘conserved’’
hypermethylated loci than to the ‘‘conserved’’ hypomethylated
ones, as a matter of fact the variation in DNA methylation
between individuals is more pronounced in CpG-poor regions
such as gene body, intergenic and ‘‘open sea’’ (Figure 6).
Gene Ontology analysis of ‘‘conserved’’ hypo and
hypermethylated loci. Our next question was whether hypo
and hypermethylated loci were linked to specific biological
processes. By performing GO analysis, we found that the two
methylation patterns are involved in completely distinct cellular
processes (Table S4A). An outstandingly high association has
been observed between hypomethylation and genes involved in
metabolic and biosynthetic processes (among the first 20
significant associations, 11 are linked to metabolic and 5 to
biosynthetic processes). On the contrary, hypermethylated sites,
while associated with several different biological processes, did
not show any association with metabolic and biosynthetic genes.
Analysis of DNA methylation levels in histone-enriched
loci and gene ontology analysis. In a previous study,
Hammoud et al.[14] defined the position of histone enriched loci
in the sperm genome. We crossed our list of ‘‘conserved’’ hypo and
hypermethylated loci with the list of histone positions referring to
Figure 3. Heatmap displaying the methylation status of CpG loci (n =297) mapping in 10 selected genes in relation to quality-
fractioned sperm populations (i.e. swim-up ‘‘up’’ and swim-down ‘‘dn’’ sperm fractions). A) The dendrograms above the heatmap show
hierarchical clustering based on the methylation data alone. Sperm populations and CpG loci are represented by columns and rows, respectively.
Each cell indicates the CpG methylation level for one site in each sample. Methylation levels are represented in the scale on the right side of the
heatmap and are referred lowest to highest as green (0.0) to red (1.0). B) Scatter plot reporting CpGs methylation levels between quality-fractioned
sperm populations (Up vs Dn) among different individuals. R2 = Pearson coefficient. C) List of the 10 analyzed genes, selected because previously
reported as differently methylated in infertile men compared to normozoospermic controls.
doi:10.1371/journal.pone.0044479.g003
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the top 9,841 regions (FDR 40 cut off) and found a total of 30,591
CpGs in our array. The large majority (98.9 %) of these CpGs
were hypomethylated (n= 30,244) whereas only 1.1% of all
histone-retained sites were hypermethylated (n= 347). Similarly
to the globally considered ‘‘conserved’’ hypo/hypermethylated
sites, we observed sharp differences in the distribution according to
functional genomic and CpG content criteria between hypo and
hypermethylated loci enriched in histones, since promoters and
islands are prevalent in the hypomethylated loci (74% and 90.5%,
respectively), and scarcely represented in the hypermethylated loci
(22.8% and 40.3%, respectively) (Figure 7). Hypermethylated loci
at the global level (including both histone-enriched and histone-
depleted i.e. protaminized segments) have been found mainly
outside of the islands as well as shore and shelf areas and involve
63.3% of the so called ’’open sea/others’’ genomic regions
whereas the same regions are present only in 21.6 % of
hypermethylated histone-retained CpGs. Moreover, in hyper-
methylated loci overlapping with histones, islands were represent-
ed almost seven times more than in hypermethylated regions at the
global level (40.3% versus 6.7%) (See Figure 6 and 7 ).
In agreement with Hammoud et al. [14] and Vavouri and
Lenher [34], we also found that histone-retained hypomethylated
regions were enriched with developmental genes (Table S4B)
indicating that genes mapping to histone enriched regions are
related to completely distinct biological processes compared to the
hypomethylated region at the global level (i.e. involved in
metabolism). Concerning histone enriched hypermethylated
regions the level of associations was much lower with specific
biological processes (below p,1024) and was more heterogeneous.
An additional datum supporting the link between hypomethyla-
tion and histone retention of developmental genes was that among
the 106 developmental genes available in the array, 62 presented
in their promoters CpGs with ,20% of methylation level as well
as histone retention. On the contrary, no overlap with histones was
observed in developmental gene promoters showing hypermethy-
lation.
Comparison of the sperm DNA methylome with a
differentiated somatic cell type. The average percentage of
hypomethylated loci was significantly higher in sperm cells of the 8
subjects at the global, autosomal and sex-chromosomal levels
(p,0.05 for all comparisons) compared to the differentiated
somatic cell (Figure 8). On the contrary, no differences were found
concerning the percentage of hypermethylated sites. The most
striking difference in hypomethylation concerned the X and Y
chromosomes (Figure 8 and Table 1). Next, we searched for the
number of equally methylated CpGs between spermatozoa and B
cells. We found that 4% showed a differentially methylated pattern
whereas 485,317 CpGs were equally methylated between the two
Figure 4. Representative scatter plots reporting CpG methylation levels between different individuals EC01 and EC10. (A) swim-up
(Up) sperm samples; (B) swim-down (Dn) sperm samples; (C) whole sperm population at 1 h (Ws 1 h) samples; (D) Box plot representing the inter-
individual variability of DNA methylation levels in total CpGs from the swim-up, swim-down and whole sperm population at1h samples. The median
value is shown. * corresponds to p value= 0.0213; R2 = Pearson coefficient. The boxes describe the lower quartile (Q1, 25%), median (Q2, 50%) and
the upper quartile (Q3, 75%); the whiskers extend 1.5 times the IQR from the box.
doi:10.1371/journal.pone.0044479.g004
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types of cells (96%). (Figure 9). Among the almost 20,000 CpGs
showing a sperm-specific differentially methylated pattern (either
hypo- or hypermethylation), those hypomethylated CpGs in
spermatozoa, which were found to be hypermethylated in B cells,
are the most represented proportion (76%). We analyzed the
functional genomic distribution, CpG content and the associated
RNA transcripts in the differentially methylated sites, separately
for hypo-and hypermethylated sperm specific CpGs. The only
significant difference consisted in the overrepresentation of ‘‘open
sea/others’’ elements in the category of CpG content/neighbor-
hood context of the sperm-specific hypermethylated CpGs
compared to the sperm-specific hypomethylated sites (71% versus
30%, p= 0.00086). The 15,799 CpGs showing a sperm-specific
hypomethylated pattern included 6,140 gene promoter CpGs
which belong to 3,344 distinct genes. The function of these genes is
mainly related to metabolic and biochemical processes, and
among the strongest associations resulted also DNA methylation
involved in gamete generation and piRNA metabolic processes
(Table S5A). Furthermore, we identified a total of 195 genes with
sperm-specific hypomethylated gene promoters which were
associated with histone-retained regions and involved in develop-
mental processes (organogenesis, especially neuronal development)
and in spermatogenesis (Table S5B).
piRNAs and DNA methylation status. We were interested
in providing a detailed description of the methylation status of
piRNA-linked CpGs in spermatozoa, B cells and cancer cells. To
accomplish this purpose, we crossed the position of 15,000
piRNAs with unique positions in the genome present in the
piRNABank (http://pirnabank.ibab.ac.in/) with the positions of
the 487,517 CpGs available in the array. In order to include
potential regulatory sequences, we extended the piRNA positions
to 62 Kb and through these criteria a total of 2,591 unique
piRNAs have been found to be covered by 7,528 CpGs on the
array. In spermatozoa, 80% of the total array-available piRNA-
linked CpGs (n= 6050) revealed either very high or very low
methylation levels. In fact, similarly to the global sperm DNA
methylome, sperm piRNA-linked CpGs showed a sharply
polarized methylation profile being 48.6% hypomethylated
(,20% methylation level) and 31.8% hypermethylated (.80%
methylation level). We found a significantly higher proportion of
piRNA-linked CpGs within the total hypomethylated loci (3,657
out of 220,300) compared to those found within the hypermethy-
lated loci (2,392 out of 161,542 ) (p = 1.585E-05). In order to
obtain more comprehensive characterization of sperm specific
piRNAs-linked CpG methylation, we performed a comparative
analysis with a differentiated somatic cell type (B cell) and a colon
cancer cell type (HCT116).
By comparing the three cell types, we observed substantial
differences in the methylation status of the piRNA-linked CpGs. In
somatic cell, 95% of piRNA-linked CpGs show an intermediate
methylation level, with a remaining 4.5% hypomethylated and
0.4% hypermethylated loci. On the contrary, similar to sperma-
tozoa, cancer cells showed a polarization toward hypo/hyper-
methylation, but with an opposite pattern of methylation
compared to spermatozoa i.e. 26% of the HCT116 cell piRNA-
linked CpGs was hypomethylated and 53% was hypermethylated.
Next, we aimed to define the number of overlapping and
distinct CpGs within the three cell types showing the same DNA
methylation pattern (hypo or hypermethylation) ( Figure 10).
Sperm DNA methylation profile largely overlaps with that of the
cancer cell, especially for the hypermethylated loci (86.8%). The
overlap was 51.5% within the hypomethylated CpGs. On the
contrary, there is only a limited number of overlapping CpGs with
the somatic cell, with the largest overlap within hypomethylated
loci (8.9 %) and the lowest for the hypermethylated CpGs (1.1%).
Given the functional importance of histone-retained regions in
spermatozoa [14; [34], we extended our analysis to histone-
retained regions associated to piRNAs A total of 408 piRNA-
linked CpGs revealed to be overlapping with histone-retained
regions in spermatozoa and interestingly, 97% of them showed
,20% of methylation level. When comparing the 342 hypo-
methylated piRNA-linked CpGs in B cells to the 3,657
hypomethylated piRNA-linked CpGs in the sperm, we found that
all, except 16 CpGs, were also present in spermatozoa. However,
when comparing the same 342 hypomethylated piRNA-linked
CpG sites in B cells to the 408 hypomethylated histone enriched
piRNA-linked CpG sites in the sperm, only 3.2% of them
overlapped. The same phenomenon was observed for the cancer
cell i.e. almost all piRNA-linked hypomethylated loci in the
HCT116 cell (1883 out of 1959) overlapped with the 3657
hypomethylated piRNA-linked CpGs in the sperm whereas only
263/1959 were shared between the two cell types when comparing
to the sperm histone–enriched loci (408 CpG sites).
We next focused on the characterization of sperm-specific
piRNAs. Accordingly, we identified the sperm-specific hypo and
hypermethylated sites i.e. not overlapping with any of the two
other cell types. We performed a GO analysis for the genes
overlapping sperm-specific piRNA in order to define the type of
biological processes in which the associated genes are involved
(Table S6). A total of 213 genes were identified in association with
piRNAs showing exclusive hypomethylation in the spermatozoa.
Strikingly, some of these genes are involved in embryonic
development.
Discussion
The mammalian germ line undergoes extensive epigenetic
reprogramming during development and gametogenesis. In pre-
implantation embryo, a pattern of somatic-like DNAhypermethyla-
tion is established in all cells, including those which are destined to
give origin to germ cells. This active de novo methylation process is
followed by a widespread erasure of DNAmethylation in primordial
germ cells. Subsequently, another wave of de novo methylation takes
place during spermatogenesis, ensuring a male germ line specific
pattern of DNA methylation. The understanding of this complex
process and the description of spermDNAmethylome havemultiple
implications, including evolutionary [15] and clinical aspects [35].
The entire sperm DNA methylome has been recently described by
Molaro et al. [15] and it is based on the analysis of the whole semen
(without quality fractioning) belonging to two sperm donors. Studies
dealing with a larger group of subjects analyzed only a few genes or
were based on low resolution arrays [16–19,21–25]. This implies
Figure 5. Intra-group epigenetic distances for the promoters of BRCA1, BRCA2, HTT, DMPK1, PSEN1 and PSEN2 genes. This distance
represents the net dissimilarity of DNA methylation profiles between two sequences: the higher the distance, the more dissimilar are the compared
samples. Different individuals were crossed with each other and Euclidean distances were calculated for beta-values of CpG sites as a marker of inter-
individual variability in three different sperm subpopulations: A) Whole sperm population; B) swim-down and C) swim-up fractions. Numbers on the X
axis indicate the identity of the pair-wise comparisons inside the experimental group: individuals EC01, EC07, EC10, EC12, EC14, EC16, EC18 and EC10
are numbered 1 to 8. Distance values are displayed on the Y axis. The top and bottom blue guidelines represent the 0.025 and 0.975 quartiles, while
the red guideline represents the mean distance value.
doi:10.1371/journal.pone.0044479.g005
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that information about what we can consider as a normal sperm
DNA methylome and whether this methylome is stable among
different normozoospermic individuals is still missing.We addressed
the above questions by using the 450 Kplatformwhich allowed us to
provide the most extensive and comprehensive investigation on
DNA methylation profile, available to date, on quality fractioned
sperm populations in a group of normozoospermic subjects. By
comparing data from the whole sperm DNA methylome [15] with
that obtained with our array, we found a highly significant
correlation Rho= 0.97 (Figure S1), indicating that our data and
conclusions are highly reliable.
Our first aim was to provide data on sperm DNA methylation
profile in quality-fractioned spermatozoa from the same subjects.
Human semen is peculiar for the heterogeneity of its sperm
population presenting a number of different qualitative features
that include kinetic, morphological, metabolic and genetic/
chromatin differences. It is for this reason that sperm selection
methods have been developed for assisted reproductive techniques
in order to obtain a highly enriched subpopulation of spermatozoa
exhibiting the best structural and functional characteristics,
indicative of optimal fertilizing ability. The question whether
these quality differences between sperm subpopulations are also
reflecting modifications in the DNA methylation pattern has not
been addressed so far. In fact, all studies published to date, except
for one, focused on either whole semen or just one selected sperm
subpopulation. Our analysis of 487,517 CpGs revealed a profound
stability of the sperm DNA methylome without significant
differences between sperm fractions enriched in ‘‘poor’’ (swim-
down) and ‘‘good’’ quality (swim-up) spermatozoa. For all
comparisons we obtained surprisingly high correlations (R2
.0.989) and the two subpopulations did not show distinct
clustering of their methylation profiles. However, by analysing
the epigenetic distances between the two sperm fractions we were
able to detect a significant difference only in one subject, although
the correlation between his two sperm subpopulations was high
also in this case, R2 = 0.9896. We separately analyzed a series of
genes for which DNA methylation defects had been previously
reported in association with impaired sperm production/quality
that included 45 imprinted genes, available on the array, and 10
additional genes selected from the literature. Despite expectation,
the DNA methylation profile of these genes showed no differences
in relationship with sperm quality. These data indicate that in
normozoospermic men, the global DNA methylation profile is not
affected significantly by structural and functional differences
between sperm subpopulations. The extensive conservation of
the DNA methylation status is especially surprising if we consider
Figure 6. Sperm DNA methylation profile (swim-up sperm samples) according to i)functional genomic distribution; ii) CpG content/
neighbourhood context and iii) associated RNA transcripts. (A) Distribution of hypomethylated (n = 220.300) and hypermethylated
(n = 161.542) CpGs conserved within individuals B) Distribution of variable CpGs within individuals (n = 1674).
doi:10.1371/journal.pone.0044479.g006
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that differences have been described also at the metabolic level of
‘‘poor’’ quality spermatozoa which could theoretically influence
the DNA methylation process [7,8].
The definition of sperm DNA methylation profile between
different normozoospermic subjects derives from a previous
observation showing a significant epigenetic variability in human
germ cells. Our aim was to further explore this observation both
by increasing the number of analyzed CpGs (the previous study
analyzed only12,198 CpG sites) and by comparing different sperm
fractions from different normozoospermic individuals. Our data,
clearly proved that the methylation pattern in different individuals
showing similar sperm characteristics without contaminating cells
is highly conserved. In fact, the discrepancy with the previous
study may well be due to a technical issue i.e. to the presence of
contaminating somatic cells, which could account for the observed
inter-individual differences in the methylation profile. The highest
correlation was found in the selected fraction enriched with
‘‘good’’ quality spermatozoa with R2 .0.98. This observation
indicates that regardless of slight differences in life style factors, age
and BMI, those cells which are designated to the fertilization
process (good quality sperm-enriched fraction) show a highly stable
sperm methylation profile between individuals. The few moderate
smokers (, 10 cigarettes/day) included in the study did not cluster
together, however it remains an important question whether
sperm methylome can be altered by heavy smoking or other
exogenous factors.
For the general description and comparative analyses of the
sperm DNA methylome, we focused on the fraction enriched with
‘‘good’’ quality spermatozoa showing a complete lack of significant
inter-individual differences. An interesting feature of the ‘‘normal’’
sperm DNA methylome is its highly polarized methylation profile
towards the two extreme of DNA methylation levels: hypomethy-
lation (,20%) and hypermethylation (.80%). We found that 96%
of all CpGs belonged to one of the above categories. Hypo- and
hypermethylated loci were highly conserved in different individ-
uals reaching to a concordance of 95% for hypomethylated CpGs
Figure 7. Sperm DNA methylation profile in histone-enriched regions according to i) functional genomic distribution; ii) CpG
content/neighbourhood context; iii) associated RNA transcription. (A) Distribution of hypomethylated (n = 347) CpGs in swim-up sperm
samples. (B) Distribution of hypermethylated (n = 30244) CpGs in swim-up sperm samples.
doi:10.1371/journal.pone.0044479.g007
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and to 83.3% for the hypermethylated ones. These, so called
‘‘conserved CpGs’’ were further analyzed in comparison with the
relatively few ‘‘variable CpGs’’ (0.3%) present in spermatozoa and
with the B cell DNA methylation profile. The qualitative analysis
of hypo-, hyper- and variably methylated regions showed
significant differences between the conserved hypomethylated loci
and the other two methylation categories; in fact, we observed a
significant enrichment with promoters (63.6%) and islands/shores
-linked CpGs in the hypomethylated loci. On the other hand,
among the hypermethylated and ‘‘variable’’ CpGs there was a
significant overrepresentation of gene body-linked CpGs which,
together with intergenic CpGs, build up .60% of all CpGs. The
high inter-individual conservation of hypomethylated loci, espe-
cially abundant in promoter regions, suggests that normal
spermatogenesis requires strictly controlled methylation levels in
specific gene promoters. At this regard, for the first time we
provide evidence about an exceptionally high number of
‘‘conserved’’ hypomethylated X and Y chromosome-linked loci
which further supports previous predictions on the importance of
sex chromosome linked genes in spermatogenesis and stimulates
further research on the sex chromosome methylation status in
pathological conditions [36] On the other hand, ‘‘variable’’ loci
mainly in gene bodies and intergenic sequences may indicate their
irrelevant role in spermatogenesis or may represent epigenetic
changes which may act as fine-tuners of spermatogenetic efficiency
and thus may contribute to the inter-individual variability of sperm
production in normal healthy men.
An increasing number of studies are converging on the
importance of histone-retained regions in spermatozoa for embryo
development. The first study by Hammoud et al. [14] posited that
genes involved in early embryonic development had a distinct
chromatin status in sperm, being hypomethylated, histone-
retained, enriched in H3K4me3 marks, and thus poised for
expression. On the other hand, Brykczynska et al demonstrated
that histone-retained regions with H3K27me3 mark may also play
a role in post-fertilization, whereas histone H3Lys4 demethylation
(H3K4m2) marks genes which are relevant in spermatogenesis
[37]. In addition, an other recent study reports a striking link
between the retention of nucleosomes in sperm and the
establishment of DNA methylation-free regions in the early
embryo [34]. By using the 450 K array, we found that
‘‘conserved’’ hypomethylated CpGs mapping inside histone-
enriched regions were associated with genes involved in develop-
mental processes. Accordingly, the majority of developmental gene
promoters available in the array were mapping inside histone-
retained regions. Interestingly, the correlation with developmental
genes was missing when the entire set of ‘‘conserved’’ hypomethy-
lated regions were analyzed. In fact, genes belonging to this
category are, indeed, involved in metabolic processes which
indicate a differential biological function of genes situated in
histone-enriched and histone-depleted regions.
The most relevant finding concerning the comparison between
the DNAmethylation profiles of the male germ cell and the B cell, is
that only aminority of CpGs showed differential methylation (4.6%)
between the two cell types and was mainly due to the overrepre-
sentation of hypomethylated loci in spermatozoa. A total of 3,344
distinct genes were related to sperm-specific hypomethylated CpGs
and among the strongest associations appeared ‘‘DNA methylation
involved in gamete generation’’ and ‘‘piRNAmetabolic processes’’.
Similarly to the general sperm DNA methylome data, those genes
(n = 195) which were hypomethylated in histone-retained regions
were involved in developmental processes (organogenesis, especially
neuronal development) and spermatogenesis. The different meth-
ylation, in respect to the somatic cell, of the promoters of
spermatogenesis genes is in accordance with the well known
importance of epigenetic regulation of cell specific functions. The
association with developmental genes further reinforces the
hypothesis about a programmed histone retention in spermatozoa,
which would serve for rapid activation of genes involved in
embryonic development.
Finally, the complete lack of studies focusing on the methylation
status of piRNAs in spermatozoa prompted us to provide a detailed
analysis of this specific class of small non coding RNAs. Although
piRNAs were first described as specifically expressed in the testis,
Figure 8. Bar graph illustrating the percentage of hypermethylated and hypomethylated CpGs in swim-up sperm samples and B
cells. The number of detected CpGs varies according to the data extrapolation performed separately for each tested group: i) total CpGs, ii)
autosomal CpGs, iii) X chromosome-linked CpGs and iv) Y chromosome-linked CpGs. * corresponds to p values ,0.05 (the whiskers show the SD;
n = 7).
doi:10.1371/journal.pone.0044479.g008
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recent data suggest their potential role in tumorigenesis and in
somatic cell function [29,30]. In addition the presence of
piRNAs has been also described in spermatozoa [38]. The 450K
array is able to provide the characterization of a total of 2,591
unique piRNAs covered by 7,528 CpGs on the array. In
spermatozoa we found a significantly higher proportion of
piRNA-linked CpGs within the total hypomethylated loci
compared to those found within the hypermethylated loci
(p = 1.585E-05). The preferential hypomethylation of piRNAs
was evident also in comparison with two other cell types: a
differentiated somatic cell type (B cell) and a colon cancer cell
type (HCT116). In fact, in spermatozoa 48.6% of CpGs were
Figure 9. Spermatozoa versus B cell: a 450K DNA methylation portrait. (A) Graph showing percentages of equally and differentially
methylated CpG sites in swim-up sperm samples compared to B cells. (B) Graph showing percentages of hypermethylation and hypomethylation in
spermatozoa relating to the differentially methylated CpGs proportion (4,3%). Graphs describing the hypermethylated (C) and hypomethylated (D)
sites according to their i) functional genomic distribution; ii) CpG content/neighborhood context and iii) association with RNA transcripts.
doi:10.1371/journal.pone.0044479.g009
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hypomethylated, whereas the percentages were 26% and 4.5%
in HCT116 and B cell, respectively. Intriguingly, among those
piRNAs which were located in histone-retained regions in
spermatozoa, 97% of them showed low level of methylation.
This observation represents a starting point for future studies
aimed to explore the biological significance of these cell-
dependent differences. An additional novel finding concerns the
involvement of piRNA-related genes in distinct biological
processes according to the methylation status of the related
piRNAs. Most importantly, hypomethylated piRNAs are linked
to genes associated with embryonic development and cell
adhesion. Interestingly, piRNAs in histone-retained regions,
showing hypomethylation exclusively in spermatozoa, are
involved in the negative regulation of metabolic and biosyn-
thetic processes which could be potentially relevant to the
embryo. Given that almost all of these piRNAs are located
inside or in the 39UTR regions of the abovementioned genes, a
potential RNA interfering mechanism can be hypothesized
[29,39]. The interference with those RNAs which would have a
negative regulatory effect on metabolism and biosynthesis may
have an important biological function in early embryonic
development.
In conclusion, our study, based on the largest number of
subjects ever considered for such a high number of CpGs,
provided clear evidence of a highly conserved DNA methylation
profile among normozoospermic subjects. We also demonstrated
that sperm methylation is stable in different quality-fractioned
sperm subpopulations of the same individual i.e. sperm methyl-
ation is not altered in ‘‘poor’’ quality spermatozoa of normozoo-
spermic men despite the fact that these cells are clearly different
from a metabolic and DNA integrity point of view. In addition,
our array-based analysis provided both confirmatory and novel
data concerning the ‘‘normal’’ sperm DNA methylome, including
its peculiar features in respect to somatic and cancer cells. Our
description about a highly polarized sperm methylation profile,
the clearly distinct genomic and functional organization of hypo
versus hypermethylated loci and the association of histone-
enriched hypomethylated loci with embryonic development,
which we now extended also to hypomethylated piRNAs-linked
genes, represents a solid basis for future basic and clinically
oriented research.
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Figure S1 Comparison of the methylation levels ob-
tained in the array versus data reported in Molaro et al
paper (ref 15). Heatmap generated from the distance correla-
tion matrix for the 8 individual samples ‘‘up’’ (A) and ‘‘down’’ (B),
the scale of the correlation is shown above the matrix (scale values
from 0 to 0.03); Correlation scatter plots between Molaros data vs
the average methylation level for all ‘‘up’’ samples (C) and ‘‘down’’
samples (D), the Pearson correlation coefficient (rho) is shown.
(DOC)
Table S1 Clinical description of the 8 normozoospermic
individuals.
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Figure 10. Venn diagram reporting unique and overlapping CpGs in/between the three cell types. A) Hypermethylated CpGs. B)
Hypomethylated CpGs. C) Hypomethylated CpGs in histone-retained regions. HCT116: colorectal cancer cell line.
doi:10.1371/journal.pone.0044479.g010
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5.!DISCUSSION!
In! the! era! of! assisted! reproductive! technology! (ART),! previously! infertile! men! can! now!
generate!their!own!progeny.!Despite!being!a!great!advancement!for!the!treatment!of!male!
infertility,! the! growing! application! of! ART! is! indeed! a! doubleSedged! sword! because!
otherwise! nontransmissible! defects! could! be! then! transmitted! to! the! future! offspring.!
Though!the!prevalence!of!male!infertility!amounts!to!up!to!7%!of!men!of!reproductive!age,!
the! etiology! cannot! be! identified! in! up! to! half! of! cases.! This! deficit! of! understanding!
significantly! limits! the! ability! to! counsel! patients! regarding! prognosis! for! treatment;! in!
particular,! if! not! able! to! identify! the! cause! for! a! man’s! infertility,! it! is! impossible! to! tell!
patients! the! likelihood!of! infertility!or!other!potential!pathological! conditions! in!ARTS!born!
offspring.!Therefore,!intense!research!has!been!and!is!still!being!done!to!detect!novel!factors!
involved!in!idiopathic!male!infertility.!Considering!the!abundant!number!of!genes!involved!in!
spermatogenesis!(more!than!2000)!and!that!only!a!fraction!of!them!has!been!analyzed!so!far,!
a!genetic!origin!is!highly!probable.!To!date,!few!genetic!defects!have!been!found!to!have!a!
clearScut! causeSeffect! relationship! with!male! infertility,! with! the!most! important! being! YS
chromosome! microdeletions! and! Klinefelter! syndrome.! The! identification! of! additional!
genetic! causes!of!male! infertility!will! further! improve! the!ability! to!appropriately!diagnose!
and!treat!the!disease.!However,!male!infertility!is!a!complex!problem!where!not!only!genes,!
but!also!epigenetic! factors!seemingly!play!an! important! role.!A!number!of! studies! focused!
on!male! infertility! from! the!epigenetic! standpoint,! and! there! is!now!sufficient! information!
supporting!the!idea!that!epigenetic!changes!do!contribute!to!this!condition.!This!thesis!had!
the! aim! to! investigate! on! the! etiology! of! idiopathic! male! infertility! by! addressing! both!
genetic!and!epigenetic!aspects!potentially! involved.!Two!aspects!were!especially!explored:!
the!role!of!sex!chromosomesSlinked!CNVs!and!the!human!sperm!methylome.!
5.1.!XSlinked!CNVs!
Copy! number! variations! might! lead! to! gene! expression! changes! and! thus! result! in!
phenotypically!evident!consequences!(McCarroll!et!al.,!2006;!Nguyen!et!al.,!2006;!Repping!et!
al.,!2006),!or! they!could! just! represent!neutral! variants! responsible! for! the! interSindividual!
variability.!The!phenotypic!effect!not!always!can!be!ascribed!to!the!presence!of!genes!within!
the!region!involved!by!the!CNV!(geneSdosage!effect),!but!it!can!also!be!due!to!the!alteration!
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of! either! the! sequence! or! the! position! of! nonScoding! genomic! regions! that! regulate! the!
expression!of!neighboring!genes.!The!potential!role!of!CNVs!in!complex!diseases!(Buchanan!
and!Scherer,!2008)!is!fully!supported!by!a!growing!number!of!data!available!in!the!literature!
(Wain!et!al.,!2009;!Choy!et!al.,!2010;!Fanciulli!et!al.,!2010),!which!represent!the!fruit!of!the!
rapid!development!of!groundSbreaking!technologies!allowing!the!systematic!analysis!of!the!
whole! genome! through! microarrays! (aSCGH,! SNPs! arrays)! or! highSthroughput! sequencing!
(next9 generation9 sequencing).! Among! the! pathologies! associated! with! CNVs! are! several!
neurological! disturbances,! autoimmune! diseases,! some! types! of! cancer! and! even! HIVS1!
susceptibility.! Diseases! that! develop! as! the! consequence! of! an! alteration! in! the! genome!
causing!the!copy!number!reduction!(or!complete!loss)!or!increase!of!dosageSsensitive!genes,!
as!well!as!the!loss!of!their!structural!integrity,!are!referred!to!as!“genomic!disorders”!(Lupski,!
1998;! Stankiewicz! and! Lupski,! 2002);! this! term! includes! CNVs! that! involve! genes! and! that!
have!a!clear!clinical!significance.!The!results!of!molecular!studies!on!the!model!of!genomic!
disorders! provided! evidence! regarding! the! mechanism(s)! for! their! recurrent! origins.! In!
contrast! to! alleleSspecific! mutations,! which! generally! originate! from! duplication! errors! or!
DNA! mismatch! repair,! these! rearrangements! result! from! events! of! deletion,! duplication,!
inversion! and! translocation! and! their! generation! is! associated! with! mechanisms! of!
recombination! that!mainly! involve! instable!genomic!architectures! (Stankiewicz!and! Lupski,!
2002),!such!as!regions!full!of!segmental!duplications!(SDs),!favorable!substrate!for!NAHR.!In!
addition!to!SDs,!repetitive!sequences!such!as!the!retrotransposable!L1!elements!(LINE),!Alu!
can!act!as!NAHR!substrates,!if!from!similar!families!or!with!high!enough!sequence!identity!to!
facilitate!homologous!recombination.!NAHR!events!occurring!in!the!germline!are!responsible!
for!more! than! 30! known! genomic! disorders! (Sasaki! et! al.,! 2010),! including! YSchromosome!
microdeletions,!which!are!the!second!most!frequent!cause!of!male!infertility.!The!research!
presented! in! this! thesis! in! relation! to! the! role! of! sex! chromosomesSlinked! CNVs! provides!
encouraging!data!regarding!novel!CNVs!with!potential!implication!in!spermatogenic!failure,!
thus!representing!an!important!step!forward!in!the!field!of!male!infertility.!!
The! analysis! by! aSCGH! performed! in! our! pilot! study! allowed! us! the! identification! of! a!
consistent!number!of!CNVs!on!the!X!chromosome,!the!majority!of!which!(75.3%)!were!novel.!
Peculiarity!of!our!study!was!the!employment!of!a!highSresolution!(probe!distance!of!2S4!Kb)!
aSCGH!platform!specific!for!the!X!chromosome!that!allowed!detecting!even!smaller!CNVs!(of!
4S5! Kb! size);! another! peculiar! characteristic! of! our! study! was! represented! by! the! study!
population,! in! which! only! strictly! selected! subjects! were! included:! 96! idiopathic! infertile!
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patients! with! different! grade! of! spermatogenic! impairment! (49! azoospermic,! 25!
cryptozoospermic!and!22!oligozoospermic!men)!and!103!normozoospermic!men.!
By!classifying!CNVs!in!three!sizeSbased!categories!(<10!Kb,!10S100!Kb!e!>100!Kb)!we!showed!
that! losses!had!the!tendency!of!being!smaller!that!gains:!this!difference!became!especially!
evident!by!assessing!the!prevalence!of!losses!and!gains!belonging!to!the!group!of!CNVs!>100!
Kb:!it!could!be!appreciated!that!86%!of!CNVS!was!represented!by!gains,!and!the!remaining!
14%!was! represented! by! losses.! This! finding! is! not! surprising! if! assuming! that! the! loss! of!
genetic!material!is!probably!more!deleterious!compared!to!a!gain!of!a!determined!genomic!
fragment.!From!this!standpoint,!the!tendency!of!deletions!of!showing!reduced!sizes!can!be!
indication!of!a!greater!pathogenicity!of!larger!deletions,!which!presumably!undergo!negative!
selection!and!are!thus!less!represented!in!the!general!population.!
The!main! finding! of! this! pilot! study!was! the! significantly! higher! burden! of! CNVs! found! in!
patients! compared! to! controls,! in! terms! of! both! mean! number! of! CNVs/person! (mainly!
dependent! on! an! overSrepresentation! of! losses)! and! mean! size/person.! Furthermore,! a!
significantly!lower!sperm!concentration!and!total!sperm!count!was!found!in!patients!with!>1!
CNV!compared!to!those!with!≤1!CNV.!This!excess!of!XSlinked!CNVs!and!DNA!loss!in!patients!
with!reduced!sperm!count!and!the!significant!association!between!CNV!number!and!sperm!
count!in!the!infertile!group!supports!a!potential!link!between!the!observed!CNV!burden!and!
spermatogenic!failure.!These!conclusions!are!supported!by!two!other!genomeSwide!studies!
evaluating!the! involvement!of!CNVs! in!male! infertility!(Tüttelmann!et!al.!2011;!Lopes!et!al.!
2013).! More! specifically,! Tüttelmann! and! colleagues! (2011)! reported! a! significant! overS
representation! of! sexSchromosomal! CNVs! in! azoospermic! men! with! SCO! histology! and! a!
significant!negative!correlation!between!sperm!count!and!the!number!of!deletions!at!whole!
genome! level,! among! normozoospermic! men.!More! recently,! Lopes! ad! colleagues! (2013)!
also! reported! a! genomeSwide! CNV! burden! in! azoospermic! and! oligozoospermic! men!
replicating!our!finding!of!an!XSlinked!CNV!burden!in!men!with!spermatogenic!failure!(Krausz!
et! al.! 2012).! From! a! clinical! standpoint,! of! particular! interest! were! patientSenriched!
(significantly!more! frequent! in! patients)! and! patientSspecific! (not! found! in! controls)! CNVs,!
since! genes/regulatory! elements! within/nearby! these! regions! presumably! have! a! higher!
probability!of!being!implicated!in!spermatogenic!failure.!
Following! our! aSCGH! study,! a! number! of! patientSspecific! deletions! and! duplications! were!
then! selected! for! further! investigation.! As! for! deletions,! the! screening! of! a! large! group!of!
patients!and!controls!revealed!that!>90%!of!these!deletions!were!private!or!rare!(frequency!
<1%).! Again,! these! findings! are! in! line! with! previous! whole! genome! arraySCGH! studies!
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(Tüttelmann!et! al.,! 2011;! Stouffs!et! al.,! 2012);! in! the! former,!27!patientSspecific!CNVs!and!
only! one! recurrent! CNV! (gain)! was! found,! whereas! the! latter! reported! that! among! 10!
patientSspecific! autosomal! CNVs,! only! two! were! recurrent.! Furthermore,! Lopes! and!
colleagues! (2013)! reported! the! enrichment! in! large! rare!CNVs! in!men!with! spermatogenic!
failure.!The!role!of!rare!CNVs!has!already!been!established!for!other!multifactorial!diseases!
(Manolio! et! al.,! 2009;! Pinto! et! al.,! 2010)! and! since! mutations! causing! spermatogenic!
disturbance!are!unlikely!transmitted!to!the!next!generation,!it!is!plausible!that!de9novo!rare!
mutations!play!a!prominent!role!in!primary!testicular!failure.!
Of!the!abovementioned!deletions,!3!recurrent!deletions!(frequency!>1%)!drew!our!attention!
for! their! exclusive! (CNV67)! or! prevalent! (CNV64! and! CNV69)! presence! in! patients.! The!
analysis!of!these!deletions!was!object!of!the!second!part!of!this!thesis!(Lo!Giacco,!Chianese!
et!al.!2013.).!A!comprehensive! investigation!was!performed!including:! i)! the!screening!of!a!
large! series! of! strictly! idiopathic! patients! (n=627)! and! normozoospermic! controls! (n=628)!
from!two!Mediterranean!populations!(Spanish!and!Italian);!ii)!the!molecular!characterization!
of! deletions;! iii)! the! exploration! for! functional! elements! in! the! region! of! interest;! iv)! a!
genotypeSphenotype!correlation!analysis.!All!three!deletions!were!mapping!to!the!long!arm!
of!the!X!chromosome!in!q27.3!(CNV64)!and!q28!(CNV67!and!CNV69).!The!smallest!deletion!
was!CNV64!removing!at!least!3.923!Kb,!followed!by!CNV67,!the!minimum!size!of!which!was!
estimated!to!be!11.664!Kb,!and!CNV69!removing!between!16.06S18.53!Kb.!The!alignment!of!
the! flanking! sequences! indicates! that! none! of! deletions! originates! from! homologous!
recombination!and!that!the!most!likely!mechanism!NHEJ.!!
Deletion!carriers!displayed!a!higher!probability!of!having!impaired!spermatogenesis!(OR=1.9!
and! 2.2! for! CNV64! and! CNV69,! respectively)! as! well! as! sperm! concentration/total! motile!
sperm!number!was!lower!in!carriers!compared!to!nonScarriers.!These!observations!suggest!
that! both! CNV64! and! CNV69! resulted! significantly! associated! with! spermatogenic! failure.!
Interestingly,! the!molecular! characterization!of!CNV69!deletion,! revealed! that!at! least! two!
subtypes!of!CNV69!exist,!named!type!A!and!type!B.!Since!type!B!deletion!was!significantly!
more!represented! in!patients! than!controls,! there! is!a!possibility! that! this!deletion!pattern!
may!account!for!the!potential!deleterious!effect!of!CNV69!on!sperm!production.!This!may!be!
related!to!the!closer!position!of!type!B!deletion!to!an!upstream!insulator!compared!to!type!
A.!Importantly,!through!the!breakpoint!definition!of!type!B!deletion,!we!developed!a!simple!
PCRSbased! assay! that! will! allow! its! screening! to! be! effortlessly! performed! in! other!
independent! series! of! cases! and! controls.! Despite! the! significant! association! observed!
between! these! deletions! and! the! infertile! phenotype,! no! genes!were! identified! inside! the!
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maximum! size! of! the! deletions.! However,! we! also! explored! the! regions! surrounding! each!
CNV! for! the! presence! of! functional! elements! as,! according! to! the! ENCODE!project,! a! very!
high!percentage!of!nonScoding!DNA!(80%)!could!have!a!biochemical!function.!A!number!of!
regulatory!elements,! including!weak!and!strong!enhancers,! insulators!and!weak!promoters!
were! potentially! affected! because! of! their! proximity! to! the! deletion.! For! instance,! large!
deletions!may!affect!gene!transcription!also!by!changing!3D!structure!of!chromatin!leading!
to!downstream!effects!on!the!regulation!of!protein!coding!regions.!
The!most!interesting!deletion!was!CNV67!because!it!was!exclusively!found!in!patients!with!a!
frequency!of!1.1%!(p<0.01).!The!highly!repetitive!nature!of!the!genomic!region!involved!and!
the! incomplete! assembly! of! the! currently! available! reference! sequence! of! the! human! X!
chromosome! prohibited! a! fine! characterization! of! deletion! breakpoints;! notwithstanding,!
chromosome!walking!allowed!a!better!definition!of!the!deletion!and!lead!to!the!hypothesis!
that!the!proximal!copy!of!the!MAGE9A!gene!Sa!CTA!family!memberS!and/or!of!its!regulatory!
elements!might!be!involved.!Furthermore,!considering!that!largeSscale!CNVs!may!also!affect!
gene!activity!through!a!positional!effect,!the!distal!copy!of!MAGEA9!may!also!be!affected!by!
CNV67.! There! is! consistent! evidence! suggesting! a! potential! involvement! of! CTA! genes! in!
spermatogenesis!and!of!CTA!gene!dosage!variation!in!spermatogenic!impairment,!therefore!
it! is! plausible! that! the! loss!of! one!MAGEA9! copy!would! affect! spermatogenesis! explaining!
the!phenotype!observed!in!CNV67!carriers.!Since!CNV67!may!also!affect!regulatory!elements!
of! another! independently! acquired! XSlinked! multiScopy! gene,!HSFX1/2! with! testisSspecific!
expression,! the! alteration! of! the! expression! of! this! gene! may! also! account! for! the!
pathological!semen!phenotype!observed!in!CNV67!carriers.!Pedigree!analyses!of!two!CNV67!
carriers! indicated! that! CNV67! deletion! is! maternally! inherited,! thus! not! affecting! female!
fertility! in!heterozygous!state.!This! is! in!accordance!with!the!lack!of!expression!of!both!the!
MAGE9A! and!HSFX1/2! in! the! ovary.! Patient! 11S041’s! family! is! especially! informative! since!
the!pathological!semen!phenotype!of!the!carrier!(11S041)!versus!his!normozoospermic!nonS
carrier! brother! is! a! strong! indicator! for! a! pathogenic! effect! of! the! deletion! on!
spermatogenesis.!
The! second! line! of! investigation! deriving! from! the! initial! pilot! study! focused! on! patientS
specific!duplications.!Of!16!patientSspecific!duplications,!five!(DUP1A,!DUP5,!DUP20,!DUP26!
and! DUP40)! were! selected! for! further! investigation! on! a! larger! study! population.!
QuantitativeSPCR! screening! for! these! CNVs! was! performed! in! 276! idiopathic! infertile!
patients!and!327!controls! in!a!conventional! caseScontrol! setting! (199!subjects!belonged! to!
the!previous!and!aSCGH!study).!Our!analysis!revealed!a!significantly!higher!duplication!load!
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in!infertile!patients!compared!to!normozoospermic!men.!This!data!are!in!line!with!a!recent!
study!by!Tüttelmann!et!al!(2012),!who!provided!evidence!for!the!first!statistically!significant!
duplication! burden! on! the! X! chromosome! and! reported! a! significantly! higher! number! of!
gains! in! azoospermic! patients! compared! to! both! oligozoospermic! patients! and! normal!
controls.!!
While! four! of! the! five! CNVs! (DUP5,!DUP20,!DUP26! and!DUP40)! did! not! individually! reach!
statistical! significance,! they! remained! patientSspecific.! All! CNVs! include,! or! are! in! close!
proximity! to,! genes! with! testisSspecific! expression! and! potential! implication! in!
spermatogenesis.!One!gain!(DUP1A)!was!found!at!a!significantly!higher!frequency!in!patients.!
This! gain! contains! a! long! nonScoding! RNA! (LINC00685)! that! potentially! acts! as! a! negative!
regulator! of! a! gene! with! potential! role! in! spermatogenesis,! PPP2R3B.! This! proposed!
mechanism! could! not! be! confirmed! by! functional! studies! because! in9 vitro! human!
spermatogenic! cell! culture! is! not! available! and! the9 LINC00685! antisense! is! not! present! in!
easily!accessible!model!organisms!such!as!mouse!and!Drosophila.!However,!expression!data!
provides!evidence! for!an! inverse! relationship!between!PPP2R3B! and!LINC00685! levels! in!a!
number!of!different!tissues!(Chalmel!et!al.,!2007,!2012).!Concerning!the!testis,!samples!with!
a! high! expression! of!PPP2R3B! show! comparatively! low! expression! of! LINC00685! (Chalmel!
2007,!2012).!Based!on! this!observation,!we!propose! that! the!mechanism!by!which!DUP1A!
could!lead!to!spermatogenic!failure!is!through!increased!negative!regulation,!caused!by!the!
duplicated! LINC00685! that!would! decrease!PPP2R3B! transcription! in! the! developing! germ!
cells.! Although! the! role! of! PPP2R3B! in! spermatogenesis! has! not! been! explored,! indirect!
functional!evidence!supports!its!involvement!both!in!mitosis!and!meiosis.!To!further!support!
our!hypothesis,!we!reanalyzed!raw!data!deposited!in!dbVar!and!found!that!in!the!study!by!
Tüttelmann!et!al.!a!number!of!CNVs!(5!gains!and!2! losses)!were!found!in!the!PAR1!of!men!
suffering!azoospermia!due!to!SCOS.!A!second!mechanism!by!which!large!PAR1Slinked!CNVs,!
like!DUP1A!and!DUP5,!may!lead!to!impaired!spermatogenesis!is!represented!by!a!structural!
effect!disturbing!male!meiosis!i.e.!altering!the!recombination!event!that!occurs!between!the!
PAR1! regions! of! the! sex! chromosomes! (Chandley,! 1989;! Mohandas! et! al.,! 1992).! PAR1!
recombination!becomes!progressively!more!frequent!towards!the!distal!telomeric!boundary!
(Filatov,!2004),!where!DUP1A!and!DUP5!are!located,!showing!the!importance!of!this!region!
during!meiosis.!
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5.2.!YSchromosome!microdeletions!and!SHOX!CNVs.!
YSchromosome! microdeletions! are! the! most! frequent! genetic! cause! of! male! infertility,!
second!only!to!the!Klinefelter!Syndrome.!Hence,!the!molecular!diagnosis!of!these!deletions!
has! become! an! important! test! in! the! diagnostic!workup! of! the! infertile!male! (Vogt! et! al.,!
1996;! Krausz! and! Degl’Innocenti,! 2006;! Krausz! et! al.,! 2014).! For! some! couples! with!male!
partners! carrying! YSchromosome! microdeletions,! ART! represents! the! only! opportunity! to!
father!their!own!biological!children.!However,!genetic!defects!on!the!Y!chromosome!will!be!
inevitably! transmitted! to! a!male! progeny;! therefore,! current! EAA/EMQN!guidelines! assess!
that!genetic!counseling!is!mandatory!before!the!couple!undergoes!ICSI/IVF!treatment.!But,!
what!should!these!couples!be!counseled!for?!!
Until! now,! the! answer! to! this! question!would! have! been! one! and! certain:! since! deletions!
occurring! in! the! father’s! Y! chromosome! will! be! unavoidably! transmitted! to! the! son,! the!
latter! will! suffer! from! impaired! sperm! production.! Of! numerous! articles! focused! on! YS
chromosome!microdeletions,!only!a!few!aimed!to!define!whether!Y!chromosome!deletions!
might! lead! to! other! pathological! conditions,! beside! spermatogenic! failure.! Concerns! have!
been!raised!about!the!potential!risk!for!Turner’s!syndrome!(45,X)!in!the!offspring!and!other!
phenotypic! anomalies! associated! with! 45X/46XY! mosaic! karyotype,! including! ambiguous!
genitalia!(Papadimas!et!al.,!2001;!Patsalis!et!al.,!2002,!2005;!Papanikolaou!et!al.,!2003;!Tian!
et!al.,!2012).!However,!the!number!of!reported!ICSI!babies!born!from!fathers!affected!by!Yq!
microdeletions! is!roughly!50,!thus!still! relatively! low!(Kleiman!et!al.;!KentSFirst!et!al.,!1996;!
Mulhall!et!al.,!1997;!Jiang!et!al.,!1999;!Kamischke!et!al.,!1999;!van!Golde!et!al.,!2001;!Oates!
et!al.,! 2002;!Peterlin!et!al.,! 2002;!Choi!et!al.,! 2004;!Cram!et!al.,! 2004;! Stouffs!et!al.,! 2005;!
Kihaile!et!al.,!2005;!Simoni!et!al.,!2008;!Mau!Kai!et!al.,!2008;!Mateu!et!al.,!2010;!Lo!Giacco!et!
al.,!2013a).!From!these!data,! it!can!be!evinced!that!apparently!children!are!phenotypically!
normal!S!except!for!one!case!of!pulmonary!atresia!and!a!hypoplastic!right!ventricle!(Page!et!
al.,! 1999)! S! and!no! ambiguous! genitalia! or! cases! of! Turner! syndrome!have!been!observed!
among!them.!
To!sound!a!note!of!warning!in!this!regard!was!the!paper!by!Jorgez!et!al.!2011!reporting!that!
YSchromosome!microdeletions!might!not!only!cause!spermatogenic!failure!but!also!increase!
the! risk! for! PARSrelated! pathologies,! especially! emphasizing! SHOX! gene! involvement.! The!
SHOX! gene! is! the! bestSestablished! disease! locus! in! PAR1! and! aberrations! in! this! gene!
account! for! 3.2%!of! patients!with! isolated! short! stature,! 89%!of! patients!with! LériS!WeillS
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dyschondrosteosis!and!100%!of!patients!with!LangerSmesomelicSdysplasia!(Belin!et!al.,!1998).!
The! severest! consequences! are! due! to! SHOX! haploinsufficiency,! which! can! cause! short!
stature! as!well! as! Turner! skeletal! abnormalities! such! as! short! fourth!metacarpals,! cubitus9
valgus9and!characteristics!of!LériSWeill!dyschondrosteosis!(LWD;!OMIM!#127300)!(Kosho!et!
al!1999).!If!YSchromosome!microdeletions!carriers!truly!were!at!risk!of!incurring!also!SHOXS
linked!pathologies,!genetic!counseling!would!need!to!change!radically;!for!instance,!infertile!
couples! undergoing! ART! would! need! to! be! informed! that! their! sons! will! have! not! only!
fertility! problems! but! also! a! higher! risk! of! developing! SHOXSrelated! disorders.! This!would!
then! require! the! compulsory! testing! for! SHOXS! linked! CNVs! in! men! carrying! Yq!
microdeletions.!!
The!most!alarming!finding!reported!by!Jorgez!et!al.!was!that!on!a!total!of!87!men!with!Yq!
microdeletions,!five!samples!had!SHOX9haploinsufficiency:!four!carrying!a!normal!karyotype!
and!one!carrying!an!idic(Y);!however,!the!authors!did!not!specify!whether!these!patients!also!
had!any!phenotypic!features!typical!of!SHOX!haploinsufficiency.!Given!the!relevance!and!the!
potential! clinical! impact!of! this! issue,!we!performed!a!multicenter! investigation!on!a! large!
study!population!in!order!to!investigate!whether!the!hypothesis!of!an!association!between!
Yq!microdeletions!and!SHOX!haploinsufficiency!could!be!confirmed.!Our!study!provides!the!
largest! collection! of! men! carrying! YSchromosome! microdeletions! analyzed! so! far! in!
association!with!SHOX!copy!number.!The!inclusion!of!partial!YSchromosome!rearrangements,!
such!as!gr/gr!deletions!and!gr/gr!deletionSduplications,!is!an!important!novelty!of!our!study,!
as! it! is! relevant! the! inclusion! of! a! very! large! number! of! men! with! complete! AZFc!
microdeletions! (4Sfold! higher! than! the! previous! study),!who! represent! the!more! plausible!
candidates!for!ART!attempts.!Our!data!seemingly!indicate!that!SHOX!CNVs!are!mainly!linked!
to!the!individual’s!karyotype!rather!than!the!mere!presence!of!microdeletions.!For!instance,!
among!men!with!normal!karyotype!we!found!that!only!1.1%!(2/177)!YSchromosome!deletion!
carriers! displayed! duplications! of! the! SHOX! gene;! however,! apart! from! a! relatively! high!
stature!(though!still!within!the!normal!range)!the!men’s!clinical!workSup!revealed!no!other!
pathological!conditions!than!azoospermia.!Our!study!had!the!limitation!that!the!number!of!
controls!analyzed!was!rather!low!to!assess!whether!these!duplications!represented!a!neutral!
polymorphism!or!are!actually!associated!with!the!presence!of!the!microdeletion.!
The!most! important!and!reassuring!finding!of!our!study!was!that!none!of!the!men!with!Yq!
microdeletions!had!SHOX!deletions,!utterly!contrasting!the!aforementioned!hypothesis!that!
microdeletion! carriers! are! at! a! higher! risk! of! developing! pathologies! caused! by! SHOX!
haploinsufficiency.! The! reasons! underlying! the! discrepancy! between! our! study! and! the!
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previous!publication!might!be!related!to!either!methodological!or!ethnical!issues.!However,!
a! proper! comparison! was! made! difficult! by! the! succinct! description! of! the! methods!
employed!in!the!previous!study!and!of!the!ethnic!background!of!their!study!population.!
5.3.!The!“normal”!sperm!methylome!
The!influence!of!the!paternal!epigenome!on!embryo!development!has!long!been!sidelined.!
However,! abundant! scientific! evidence! has! been! produced! to! support! that! the! peculiar!
nature! of! the! sperm! epigenetic! landscape! might! play! a! larger! role! in! development! than!
previously! thought.! Among! the! diverse! epigenetic! modifications,! DNA! methylation!
represents! an! important! signaling! tool! involved! in! mammalian! development.! After!
fertilization,!the!genomes!inherited!from!both!spermatozoa!and!oocytes!undergo!a!massive!
wave! of! nearly! complete! demethylation,! and! then! lineageSspecific! patterns! of! de9 novo!
methylation! occur! during! or! after! gastrulation.! Information! nowadays! available! suggests!
that! this! epigenetic! reprogramming! is! associated! with! reSestablishment! of! the! gamete!
developmental!potential,!correct! initiation!of!embryonic!gene!expression!and!early! lineage!
development!in!the!embryo.!The!understanding!of!this!complex!process!and!the!description!
of! the! sperm! DNA! methylome! have! both! evolutionary! and! clinical! (Molaro! et! al.,! 2011;!
Carrell,! 2012)! implications.! The! first! description! of! the! entire! sperm!DNA!methylome!was!
based!on!the!analysis!of!whole!semen!samples!of!only!two!sperm!donors.!Studies!including!a!
larger!study!population!do!exist,!but!were!based!either!on!the!analysis!of! few!genes!or!on!
lowSresolution!arrays!(Kobayashi!et!al.,!2007;!Marques!et!al.,!2008,!2010;!Hammoud!et!al.,!
2009,!2010;!NavarroSCosta!et!al.,!2010b;!Poplinski!et!al.,!2010;!Pacheco!et!al.,!2011).!
In! this! regard,! our! study! represents! an! important! step! forward.! For! instance,! in! order! to!
obtain!a!comprehensive!overview!of! the!sperm!DNA!methylome,!we!used!a!487,317!CpGS
feature!microarray! S! the! larger! performed! so! far! S! to! investigate! on! the!DNA!methylation!
profile!in!eight!normozoospermic!men.!!
The!first!question!we!wanted!to!address!was!whether!qualitySfractioned!sperm!populations!
coming!from!the!same!subject!had!different!methylation!patterns.!With!the!advent!of!ART,!
sperm!selection!methods!have!been!developed!to!obtain!an!enrichment!of!a!subpopulation!
of! spermatozoa! exhibiting! the! best! structural! and! functional! characteristics,! indicative! of!
optimal!fertilizing!ability.!Whether!quality!differences!between!sperm!subpopulations!were!
mirroring! differences! in! the!DNA!methylation! pattern!was! still! an! unexplored! field.! Below!
expectation,! we! observed! a! strong! stability! of! the! methylation! patterns! between! sperm!
fractions!enriched!in!‘‘poor’’!and!‘‘good’’!quality!spermatozoa.!Any!difference!was!observed!
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neither! in! genes! for! which! DNA! methylation! defects! had! been! previously! reported! in!
association!with! impaired!sperm!production/quality,! including!45! imprinted!genes,!already!
available! on! the! array,! and! 10! genes! additionally! selected! from! the! literature.! These! data!
indicate!that!in!normozoospermic!men,!structural!and!functional!differences!between!sperm!
subpopulations! do! not! derive! from! DNA! methylation! defects.! It! is! plausible! that!
environmental! factors! altering! the! histone! codes! during! adult! spermatogenesis! are!
responsible! for! the! anomalies! observed! in! the! “poor! quality”! sperm! fraction.! We! also!
hypothesize!that!previous!observations!on!the!association!between!infertility!and!abnormal!
sperm!methylation!profile!reflect!a!defect!that!occurs!during!fetal!life!or!in!early!puberty!and!
thus!similarly!to!the!normozoospermic!data,!will!be!present!in!all!sperm!quality!fractions!of!a!
given!infertile!man.!!
The!significant!epigenetic!variability!previously!observed! in!human!germ!cells! (Flanagan!et!
al.,! 2006)! led! us! to! the! second! question! addressed! in! our! study:! is! there! a! difference!
between! DNA! methylation! profiles! of! different! normozoospermic! subjects’! sperm!
subpopulations?!In!contrast!with!the!previous!observations,!our!data!clearly!proved!that!the!
methylation! pattern! in! different! individuals! with! similar! sperm! characteristics! was! highly!
conserved.! The! meticulous! attention! given! to! the! sperm! selection! process,! by! which! we!
obtained! highSpurity! sperm! fractions,! gave! security! that! our! data! did! not! result! from! the!
presence!of!contaminating!somatic!cells.!The!high!correlation!found!in!the!selected!fraction!
enriched! with! goodSquality! spermatozoa! might! suggest! that! spermatozoa! destined! to!
fertilize! show! a! highly! stable! sperm! methylation! profile! between! normozoospermic!
individuals,!irrespective!of!differences!in!life!style,!age!and!BMI.!
In! order! to! provide! a! general! description! and! comparative! analyses! of! the! sperm! DNA!
methylome,!we!focused!on!the!fraction!enriched!with!goodSquality!spermatozoa!showing!a!
complete! lack! of! significant! interSindividual! differences.! Interestingly,! the! ‘‘normal’’! sperm!
DNA!methylome!appeared!highly!polarized! towards! the! two!extreme!of!DNA!methylation,!
with!96%!of!CpGs!being!either!hypomethylated!(20%)!or!hypermethylated!(80%).!HypoS!and!
hypermethylated! loci! were! highly! conserved! among! different! individuals! reaching! to! a!
concordance!of!95%!for!hypomethylated!CpGs!and!to!83.3%!for!the!hypermethylated!ones.!
Of!note,!we!observed!a!high!interSindividual!conservation!of!hypomethylated!loci,!especially!
abundant! in! promoter! regions! (63.6%),! suggesting! that! normal! spermatogenesis! requires!
strictly! controlled! methylation! levels! in! specific! gene! promoters.! Among! conserved!
hypomethylated!loci,!an!exceptionally!high!number!was!linked!to!the!X!and!Y!chromosomes,!
supporting!the!importance!of!sex!chromosomeSlinked!genes!in!the!spermatogenic!process.!!
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Another!notable!finding!was!that!conserved!hypomethylated!CpGs!mapping!inside!histoneS!
enriched! regions! were! associated! with! genes! involved! in! developmental! processes.!
Accordingly,! the! majority! of! developmental! gene! promoters! available! in! the! array! were!
mapping! inside! histone! S! retained! regions.! Our! data! are! outright! consistent! with! what!
reported!in!the!literature.!It!is!known!that!the!histoneSprotamine!replacement!occurs!in!a!n!
incomplete! manner,! with! about! 5–15%! of! chromatin! remaining! bound! to! nucleosomes!
(Tanphaichitr! et! al.,! 1978;!Wykes!and!Krawetz,! 2003).! Interestingly,! this!phenomenon!was!
found! to! be! programmatic! and! not! simply! a! causality,! suggesting! that! retained! histones!
might!play!a!role!in!epigenetic!regulation!(Arpanahi!et!al.,!2009;!Hammoud!et!al.,!2009).!In!
proven! fertile!patients,!histone! retention! is! found!at! the!promoters!of! genes! important! in!
the!embryo!including!developmental!gene!promoters,!microRNA!clusters,!and!imprinted!loci,!
suggesting! the! programmatic! nature! of! nucleosome! retention! is! programmatic! in! nature!
(Hammoud!et!al.!2009).!
Our! comprehensive!description!of! the! sperm!DNA!methylome! included! the! comparison!of!
the! latter! with! the!methylation! profile! of! somatic! cells.! Differential! methylation! could! be!
found! only! in! 4.6%! of! CpGs! and! was! mainly! due! to! the! overrepresentation! of!
hypomethylated! loci! in! spermatozoa.! The! analysis! of! functional! genomic! distribution,! CpG!
content! and! associated! RNA! transcripts! in! differentially! methylated! sites! revealed! that!
promoters! of! genes! related! to! spermSspecific! hypomethylated! CpGs! were! strongly!
associated! with! gamete! generation.! Further,! hypomethylated! genes! mapping! to! histoneS
retained! regions! were! found! to! be! involved! in! developmental! processes! and!
spermatogenesis,!further!highlighting!that!sperm!histone!retention!is!naturally!programmed!
to!rapidly!activate!genes!involved!in!embryonic!development.!
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6.!CONCLUSIONS!
Aim!1:!
• A!significantly!higher!X!chromosomeSlinked!CNV!burden!was!observed!in!idiopathic!
infertile!patients!and! its! association!with! lower! sperm!counts! indicates!a!potential!
link!to!spermatogenic!failure.!!
• The! X! chromosomeSlinked! recurrent! deletions! CNV64,! CNV67,! CNV69! are!
significantly! associated! with! spermatogenic! failure.! CNV67! specificity! to! impaired!
spermatogenesis! and! its! frequency! of! 1.1%! in! oligo/azoospermic! men! make! this!
deletion! particularly! interesting,! since! it! resembles! the! AZF! regions! on! the! Y!
chromosome!with!potential!clinical!implications.!
• The! X! chromosomeSlinked! recurrent! gain! DUP1a! is! significantly! associated! with!
spermatogenic!failure!and!two!possible!mechanisms!have!been!provided!to!explain!
the!pathogenesis!of!the!associated!infertile!phenotype:!one!relating!a!gene!dosage!
effect! due! to! LINC00685/PPP2R3B9misbalance,! and! the! other! due! to! a! potential!
structural!effect!in!the!PAR1.!
Aim!2:!
• Both!partial!and!complete!microdeletions!in!men!with!normal!karyotype!are!unlikely!
associated!with!SHOX!haploinsufficiency,!reassuring!that!the!only!established!risk!for!
ART! offspring! born! from! men! with! Yq! microdeletions! remains! spermatogenic!
impairment.!
Aim!3:!
• The!DNA!methylation!profile!is!highly!conserved!among!normozoospermic!subjects,!
indicating!a!lack!of!interSindividual!variability.!
• Different!qualitySfractioned!sperm!subpopulations!deriving!from!the!same!individual!
have!a!stable!methylation!profile.!This!data!suggest!that!the!acquisition!of!the!sperm!
methylation!status! is!a!process! that!occurs!during!early!development!of! the! testis,!
and!thus!poor9quality!spermatozoa,!present!in!a!normozoospermic!ejaculate,!is!not!
related!to!altered!methylation!status.!!
• The!majority! of! CpGs! are! either! hypomethylated! or! hypermethylated,! indicating! a!
stable!polarization!of!the!sperm!methylation!profile.!
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• Hypomethylated! or! hypermethylated! loci! show! a! distinct! genomic! and! functional!
organization.!
• HistoneSretained!hypomethylated!loci!are!associated!with!embryonic!development,!
further!supporting!the!importance!of!sperm!epigenetic!regulation!in!the!mammalian!
development.!
!
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 CURRENTOPINION Genetic testing and counselling for male infertility
Csilla Krausz and Chiara Chianese
Purpose of review
Genetic disorders can be identified in about 15% of cases of male infertility. With the widespread
application of assisted reproductive technology, infertile patients are now given the possibility of having
their biological children; however, a genetic risk exists for assisted reproductive technology–born offspring,
implying the necessity for future parents to be appropriately informed about potential consequences. In this
review, we provide current recommendations on clinical genetic testing and genetic counselling.
Recent findings
New insights are presented concerning Klinefelter syndrome, X and Y chromosome–linked deletions,
monogenic diseases and pharmacogenetics.
Summary
As for Klinefelter patients, novel preventive measures to preserve fertility have been proposed although they
are not yet applicable in the routine setting. Y-chromosome deletions have both diagnostic and prognostic
values and their testing is advised to be performed according to the new European Academy of
Andrology/European Molecular Genetics Quality Network guidelines. Among monogenic diseases, major
advances have been obtained in the identification of novel genes of hypogonadotrophic hypogonadism.
Pharmacogenetic approaches of hormonal treatment in infertile men with normal values of follicle-
stimulating hormone (FSH) are promising and based on FSHR and FSHB polymorphisms. X chromosome–
linked deletions are relevant for impaired spermatogenesis. In about 40% of male infertility, the cause is
unknown and novel genetic factors are expected to be discovered in the near future.
Keywords
azoospermia, genetics, Klinefelter syndrome, male infertility, Y chromosome
INTRODUCTION
Nearly 15% of couples wishing to conceive seek
medical treatment for infertility. The male factor
accounts for approximately half of these involun-
tarily childless partners and in at least 15% of cases
it is related to genetic disorders, including both
chromosomal and single-gene alterations [1]. Gene-
tic causes can be detected in all major etiologic
categories ofmale infertility (pretesticular, testicular
and post-testicular forms) and genetic tests became
part of the routine diagnostic workup in selected
groups of patients. With the widespread application
of assisted reproductive technology (ART), infertile
men are now given the possibility of having their
biological children; however, a genetic risk exists for
ART-born offspring, implying the necessity for
future parents to be appropriately informed on
potential consequences. In this review, we provide
an outline of the most recent innovative aspects of
the genetics of male infertility with a primary focus
on clinical genetic testing (Table 1) and genetic
counselling of the infertile couple.
CHROMOSOMAL ANOMALIES
Chromosomal abnormalities can be either num-
erical or structural, and the anomalies most
frequently found in relationship with male infer-
tility are Klinefelter syndrome and translocations
(Robertsonian and reciprocal) or inversions. A gen-
eral consensus exists on the correlation between
the severity of the testicular phenotype and a
higher frequency of chromosomal anomalies, thus
karyotype analysis is recommended in Europe
for men with fewer than 10 million spermatozoa
per milliliter [2]. This cutoff for testing has been
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established on the observations that patients with
fewer than 10 million spermatozoa per milliliter
show a 10-fold higher incidence (4%) of mainly
autosomal structural abnormalities compared with
the general population. The highest frequency
of karyotype anomalies has been observed in
nonobstructive azoospermic men (15–16%) and
Klinefelter syndrome accounts alone for 14% of
cases, whereas the remaining are structural
anomalies [2]. In 80–90% of Klinefelter patients,
a 47,XXY karyotype is encountered, whereas the
remaining cases can display a mosaic karyotype
(46,XY/47,XXY), additional X chromosomes (e.g.,
48,XXXY) or structurally abnormal X chromo-
somes. Klinefelter men usually suffer from azoosper-
mia and thus are unable to spontaneously conceive.
Nowadays, testicular sperm retrieval from micro-
dissection testicular sperm extraction (TESE) may
detect residual foci of active spermatogenesis in
the testes of azoospermic 47,XXY adult men [3].
Sperm retrieved by microdissection TESE can be
used for subsequent intracytoplasmatic sperm
injection (ICSI) procedure. However, the positive
outcome of ART in Klinefelter patients is threatened
by the fact that the potential of successful sperm
retrieval decreases with age and after testosterone
therapies [4]. Consequently, new approaches of
fertility preservation have been introduced in the
counselling of pubertal Klinefelter patients. Because
germ cell depletion starts with the onset of puberty,
spermatogonial stem cell (SSC) banking at early
puberty has been proposed as a strategy to preserve
the fertility of these patients. Two recent studies
focused on this matter: a histological study investi-
gating whether cryopreservation of SSCs might
benefit to Klinefelter boys [5] and the other propos-
ing a combined clinical-hormonal strategy to detect
early spermatogenesis for further SSCs retrieval
from a single testicular biopsy [6]. Data by van
Saen et al. [5] suggest that for optimal SSCs preser-
vation, spermatogonia should be retrieved prefera-
bly before testis hyalinization occurs. However,
their results show that it is rather difficult to find
spermatogonia in tubules with a normal architec-
ture even in pubertal boys, as massive fibrosis and
hyalinization was observed in all, except one,
patients over a total of seven patients. Likely, the
hyalinization process might progress very rapidly in
some Klinefelter adolescents; therefore, the basis
for a maximum SSCs preservation would be the
early detection of the syndrome. Furthermore,
Gies et al. [6], investigating on seven Klinefelter
adolescents, failed in the attempt to determine
the optimal timing for SSCs retrieval, because
neither clinical nor hormonal parameters were
sufficiently predictive. A third study [4] claims the
possibility of sperm retrieval for fertility preser-
vation from semen samples of Klinefelter adoles-
cents (n¼8) before the administration of hor-
mone replacement treatments, and suggest bilateral
testicular biopsy for TESE or tissue freezing in case
of TESE failure only if azoospermia was confirmed
after two/three semen collection attempts. How-
ever, only in one boy (with a mosaic karyotype)
spermatozoa could be recovered in the ejaculate.
Of the five patients undergoing TESE, mature sper-
matozoa could be retrieved only in one (16 years
old), whereas in another (15.5 years old) only imma-
ture sperm cells could be recovered.
Overall, data available in the literature seem
to not fully support the feasibility of fertility
preservation in Klinefelter adolescents. It is worth
noting, though, that the number of patients ana-
lyzed overall is rather small (n ¼ 22), because the
diagnosis of Klinefelter is rarely made prepubertally.
Still, the retrieval rate of mature germ cells seems
rather low and SSCs cryopreservation would appear
as the only approach; however, germ cells in vitro
maturation techniques are still at an experimental
KEY POINTS
" Genetic factors can be identified in about 15% of
infertile men and, because approximately 2000 genes
are implicated in male fertility, idiopathic cases are
likely related to genetic/epigenetic factors acting
either alone or in combination with environmental
factors.
" Testicular tissue and SSCs banking have been
proposed as an option for Klinefelter syndrome, the
most frequent chromosomal anomaly in azoospermic
men, but cannot be recommended on a routine basis.
" Kallmann syndrome and normosmic congenital
hypogonadotrophic hypogonadism are currently
considered different phenotypic expression of the
same disease, which is apparently inherited in an
oligogenic rather than a Mendelian fashion and
characterized by the occurrence of reversibility in a
subset of patients.
" The definition of the extension of the AZFa and AZFb
deletions is strongly recommended by the European
Academy of Andrology/European Molecular Genetics
Quality Network guidelines because of its prognostic
relevance for sperm retrieval in patients undergoing
assisted reproductive technology.
" FSHB and FSHR polymorphisms are important
determinants of male fitness and their analysis opens
new perspectives toward a pharmacogenetic approach
in FSH therapy in oligozoospermic men with normal to
low serum FSH level, although it cannot be
recommended yet in a routine clinical practice.
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stage in animal models and far from guaranteeing
future fertility in humans. Further studies are
needed in order to clarify whether SSCs banking
could be considered a valid approach to the fertility
preservation of Klinefelter patients.
Genetic counselling
Structural anomalies might become unbalanced in
the offspring [7] with serious health consequences
and for this reason preimplantation genetic diagno-
sis (PGD) or prenatal diagnosis is highly advisable
as preventive measures concerning Klinefelter
syndrome, although studies of sperm fluorescence
in-situ hybridization (FISH) in these patients
revealed an increased rate of both gonosomal and
autosomal (especially chromosomes 13, 18 and 21)
aneuploidy in their spermatozoa, overall data are
quite reassuring that children born from Klinefelter
patients apparently do not demonstrate a higher
risk for aneuploidies [8]. Notwithstanding, couples
are generally offered PGD in order to ensure that
the embryo selected for transfer is karyotypically
normal.
Y-CHROMOSOME MICRODELETIONS
AZF deletions on the Yq represent themost frequent
molecular genetic cause of impaired spermato-
genesis. There are five recurrent deletion types
(generally called AZFa, AZFb, AZFbþc and AZFc)
and their frequency varies according to the semen
phenotype, reaching the highest frequency in idio-
pathic azoospermia (approximately 10%) (Fig. 1a).
Indications for routine testing include men with
fewer than 5 million spermatozoa per milliliter
although the large majority of carriers have fewer
than 2 million spermatozoa per milliliter [10&,11].
In the novel European Academy of Andrology/
European Molecular Genetics Quality Network
guidelines for Y-chromosome microdeletions [10&],
it is now clearly stated that the definition of the
extension of AZFa and AZFb deletions with the so-
called ‘second-step’ markers is of clinical relevance,
because carriers of large deletions have virtually zero
chance of successful sperm retrieval in the testis. The
role of the gr/gr deletion, removing half of the gene
contentof theAZFc region,hasbeenwidelydiscussed
during the last 10 years. Thanks to the publication of
fourmeta-analyses, there is nowa general acceptance
Table 1. Outline of the genetic testing currently included in the diagnostic workup of male infertility
Phenotypic category Indication for testing Genetic target Test
Hypogonadotrophic
hypogonadism
Kallmann syndrome
and normosmic
hypogonadotrophic
hypogonadism
KAL1, FGFR1, FGF8, PROK2/PROKR2,
CHD7, KISS1/KISS1R, TAC3/TACR3,
GNRH1/GNRHR, NELF, FGF17,
IL17RD, SOX10, DUSP6, SPRY4,
FLRT3, SEMA3A
Mutational screening through direct
sequencing
Isolated gonadotrophin
deficiency
FSH and LH
Primary testicular
dysfunction
Azoospermia or
<10 millions sp./ml
Chromosomal anomalies Detection of numerical and structural
alterations through karyotype analysis
Azoospermia or
<5 millions sp./ml
Y-chromosome AZF regions Detection of AZF microdeletions
(AZFa, AZFb, AZFc) through a
PCR " method using the
recommended set of STSs
(EAA/EMQN guidelines [1])
Oligozoospermia
(<20 millions sp./ml)
AZFc regiona Detection of gr/gr deletion through
a combined method including the
analysis of recommended STSs
and DAZ/CDY1 gene dosage
(EAA/EMQN guidelines [1])
Hypoandrogenization
due to PAIS
AR Screening for AR mutations
(http://androgendb.mcgill.ca/)
Congenital
obstruction
Oligo/azoospermia
due to CAVD
CFTR Mutational screening through a
mutation panel including the
more frequent CFTR mutations
specific to a given population;
second step analysis through
direct sequencing
CAVD, Congenital Absence of the Vas Deferens (uni/bilateral): All men with CAVD should be screened for CFTR mutation except for patients with renal agenesis/
malformation; PAIS, Partial Androgen Insensitivity Syndrome; sp., spermatozoa.
aRecommended in countries where solid data exist in terms of risk for oligozoospermia.
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on its role as a significant genetic risk factor for
impaired spermatogenesis [10&]. However, its routine
screening is advised only in those countries where
solid data exist on the level of risk conferred by this
deletion.According to theguidelines [10&], testing for
isolated gene-specific deletions in the AZFa andAZFb
region is not advised because of their very low inci-
dence as well as the highly heterogeneous testis
phenotype.
Genetic counselling
AZF deletions are transmitted obligatory to the
male offspring who will suffer from impaired sperm
production. Apart from infertility, another potential
risk is 45,XO/46XYmosaicism with ambiguous gen-
italia. Recently, it has been proposed that Y-chromo-
some microdeletions are also associated with a
risk of developing pseudoautosomal region (PAR)–
related anomalies. One study [12] reported that
5.4% of microdeletions carriers and normal karyo-
types had SHOX haploinsufficiency in the PAR1, a
condition related to disproportionate short stature
and diverse skeletal anomalies. This finding led to
hypothesis that microdeletion carriers undergoing
ART would expose their future sons to the risk
of having not only fertility problems but also
SHOX-linked pathologies. However, these alarming
data have been contradicted by a more recent study
performed on an almost doubled study population
[13], in which none of the microdeletion carriers
displayed SHOX deletion. This discrepancy might
depend on either methodological issues or the
different ethnic background of the two examined
study populations.
CONGENITAL HYPOGONADOTROPHIC
HYPOGONADISM
Congenital hypogonadotrophic hypogonadism
(cHH) is a rare disease (incidence of 1 : 8000 men)
[14] characterized by a deficit of gonadotropins
leading to delayed puberty and azoospermia in
men. Although major advances have been made
for the discovery of novel candidate genes, the cause
X
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FIGURE 1. Deletions on the sex chromosomes. (a) Schematic representation of the Y chromosome showing the localization of
the three azoospermia factor regions and the two pseudoautosomal regions (PAR1 and PAR2). On the right side, a model of
the six recurrent deletions occurring on the Yq is provided. The slimmer lines indicate the deleted portions. In the upper part,
the genomic size (Mb) of each deletion is specified. In the lower part, AZF microdeletions and gr/gr deletion frequencies in
patients and controls are reported. Azoo, azoospermic; OAT, oligoasthenoteratozoospermic. !Mean frequencies of the gr/gr
deletion relative to the Italian and Spanish populations. (b) Schematic representation of the X chromosome depicting the two
pseudoautosomal regions (PAR1 and PAR2) and the region including the recurrent deletions discovered by Giacco et al. [9&].
On the right side, a model of the three deletions is provided with slimmer lines indicating the deleted portions. In the upper
part, the genomic size (Kb) of each deletion is specified. In the lower part, frequencies of each deletion in patients and
controls are reported.
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remains unknown in about 50% of cases. cHH may
be an isolated condition (normosmic cHH) or may
be associated with hyposmia/anosmia (Kallmann
syndrome). This classification is actually being
questioned in recent years, because these conditions
have been observed in different relatives belonging
to the same family setting, as if they actually
represented different phenotypic manifestations
of the same genetic defect. Therefore, cHH is
considered a complex genetic disease with variable
expressivity, penetrance and inheritance fashions
and does not seem to follow the rules of Mendelian
inheritance. As such, the pathogenesis of cHH is
likely to include the influence of environmental
factors as well as the involvement of genetic variants
in two or multiple interacting genes (oligo/digenia)
[15]. A relatively newly identified feature of this
disease is the presence of reversible cases, which
represent about 10% of all cHH and does not seem
to correlate with specific gene defects [14,16,17].
Mutations of cHH candidate genes are potentially
related to late-onset hypogonadism and accordingly
a GNRHR mutation has been described in this
pathological condition [18].
Genetic counselling
cHH is highly responsive to gonadotrophin therapy;
therefore, more than 90% of patients conceive
either spontaneously or by assisted reproductive
techniques. Genetic testing for the most frequently
mutated candidate genes is available in many
diagnostic genetic laboratories and depending
on the gene involved, that is, whether a clear-cut
cause–effect relationship is found, PGD or prenatal
diagnosis may be offered to the couple.
PHARMACOGENETICS IN MALE
INFERTILITY
Spermatogenic alterations might also be dependent
on the presence of polymorphisms mapping to
genetic regions that regulate the expression of genes
involved in the reproductive endocrine system [19].
In this regard, single-nucleotide polymorphisms
(SNPs) of the FSHB gene, encoding for the b-subunit
of follicle-stimulating hormone (FSH), and the FSHR
gene, encoding for the FSH receptor have been the
object of recent studies in relationship with repro-
ductive parameters and with individual responsivity
to FSH therapy [20,21,22&,23]. It is now widely
accepted that one of the major determinants of
serum FSH level is the FSHB-221G>T (rs10835638)
in the gene promoter [20]. The T allele confers one-
half of the activity of the wild-type promoter carry-
ing the G allele [19]; therefore, levels of serum FSH,
as well as sperm count, are significantly lower in G/T
heterozygous men and, even lower, in T/T homo-
zygous carriers [20,21,22&]. Concerning the FSHR
2039A>G (rs6166) polymorphism and its effect on
male reproductive parameters, a recent large study
reported a highly significant effect of the G allele on
testicular volume, which remarkably decreased in
the G-allele carriers [23]. In another study, no sig-
nificant associations but only trends of higher
serum FSH and lower testicular volume have been
found when this SNP was considered separately
[22&]. However, in the same study a combinedmodel
involving both SNPs demonstrated that the coex-
istence of the two minor alleles (T/T and G/G)
empowered the worst phenotype, that is, the lowest
testicular volumes [22&]. Instead, the homozygous
FSHR 2039A/A allele, associated to higher receptor
sensitivity, seems to compensate for the lower FSH
serum levels conferred by the FSHB -221T/T geno-
type. The advantage of detecting these polymorphic
variants resides in the possibility of targeting them
as a pharmacogenetic tool in the treatment of idi-
opathic infertile patients. This is of special import-
ance if we consider the high cost of the therapy and
that only a proportion of men (30–55%) result
responsive to the treatment in terms of improve-
ment of sperm parameters. To date only one pilot
study addressed the question about the role of the
!FSHB !221 in relationship with FSH treatment
[21]. In this study, all T/T homozygotes (n¼9)
resulted responsive to the treatment and showed a
significantly higher improvement in sperm count
and quality compared with carriers of the G allele
[21]. In the group of G/T heterozygous, only 60%
were responsive. Based on the Tu¨ttelmann et al.
study [22&], it is evident that future pharmacoge-
netic studies should be based on the combined
analysis of the FSHB -221 G>T and the FSHR 2039
A>G, in order to further improve the selection of
potentially responsive or unresponsive subjects.
MUTATIONS AND POLYMORPHISM IN THE
ANDROGEN RECEPTOR
Pathogenic mutations in the gene encoding the
androgen receptor (AR), located on Xq12, are associ-
ated with two main diseases: androgen insensitivity
syndrome (AIS; MIM: 300068) and Kennedy
syndrome (MIM: 313200). AIS can also manifest
with a mild phenotype, for which patients suffer
from oligo/azoospermia. The low frequency of AR
mutations in OAT patients, the lack of selection
criteria for testing and the extremely high number
of mutations for which functional analyses should
be performed in order to establish its cause–effect
relationship with oligozoospermia limits the intro-
duction of AR gene mutation screening in infertile
Androgens
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men. The AR gene also contains two polymorphic
sites in the N-terminal trans-activation domain
of the receptor: a polyglutamine tract –(CAG)n–
and a polyglycine tract !(GGC)n, which were the
subject of many publications related to male infer-
tility [24].
The (CAG)n length normally ranges between
6 and 39 repeats in the general population, with a
median value that varies according to the ethnicity
(21–22 in Caucasians, 19–20 in African-American,
22–23 in Asian populations). The originally
described inverse relationship between CAG repeat
length and the receptor trans-activation led to the
hypothesis that longer CAG repeat conferred a
higher risk for infertility and cryptorchidism. This
hypothesis, which has been demonstrated also by an
in-vivo animal model [25], has been questioned
recently by novel functional [26] and observational
studies reporting that both a longer CAG tract
and a shorter CAG tract might have a negative
effect on the receptor function [27&,28]; hence,
the highest transcription seemingly occurs in the
presence of an optimal number of CAG repeats,
which is represented by the median CAG length
encountered in the general population. These
models are based on genomic signaling pathways,
but a recent study pioneered a new perspective: for
instance, Davis-Dao et al. reported an unexpected
association between shorter CAG repeats (CAG"19)
and the risk of cryptorchidism (an androgen-
dependent disease), suggesting that the effect of
this polymorphism might also be indirectly medi-
ated by nongenomic signaling pathways [27&].
We can speculate that the optimum range may vary
between the genomic and nongenomic actions and
also in different tissues because the effect of polyQ
repeat on transactivation is cell specific, presumably
due to distinct profiles of coregulator proteins [29].
Indeed, the role of CAG repeats in male infertility is
probably more complex than it has been previously
considered and more functional, and clinical
studies are needed before this polymorphism can
be introduced into the diagnostic setting.
NOVEL RESEARCH ASPECTS
Recently, whole-genome studies based on array-
comparative genomic hybridization revealed the
presence of a deletion burden in the genome (especi-
ally evident in the sex chromosomes) of infertile
men [30–32]. This finding suggests that these
men might display a higher genome instability,
which might have consequences not only on their
fertility status, but also on their general health. This
phenomena could explain the lower life expectancy
and higher morbidity of infertile men [33,34]. The
unexpectedly high number of X chromosome–
linked genes with specific testicular expression
(especially multicopy genes that have been recently
acquired on the human X chromosome during
evolution) [35&&] are in agreement with the higher
deletion load in this chromosome in infertile men
[31]. In 2013, for the first time, X chromosome–
linked recurrent deletions have been reported
and one of them (CNV67) resulted specific to
oligo/azoospermia representing a novel diagnostic
target in male infertility [9&] (Fig. 1b).
CONCLUSION
In about 40% of male infertility cases, the patho-
physiology remains unknown and the diagnosis
and/or treatment still represent a challenge, especi-
ally when the infertile couple contemplates ART,
and there exists the risk of transmitting genetic
disorders to the future offspring.
Given that the so-called ‘idiopathic’ infertility
cases are likely to be related to unidentified genetic/
epigenetic and environmental factors, it is of out-
standing importance to identify their missing cause.
On the ‘genetic’ side, major progresses are expected
with the diffusion of the Next-Generation Sequenc-
ing approach that will surely accelerate the
identification of new genetic factors and will allow
obtaining a comprehensive picture about the role
of the combined action of low-size-effect genetic
risk factors.
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ABSTRACT. Since the first definition of the AZoospermia Fac-
tor (AZF) regions, the Y chromosome has become an impor-
tant target for studies aimed to identify genetic factors in-
volved in male infertility. This chromosome is enriched with
genes expressed exclusively or prevalently in the testis and
their absence or reduction of their dosage is associated with
spermatogenic impairment. Due to its peculiar structure, full
of repeated homologous sequences, the Y chromosome is pre-
disposed to structural rearrangements, especially dele-
tions/duplications. This review discusses what is currently
known about clinically relevant Y chromosome structural vari-
ations in male fertility, mainly focusing on copy number varia-
tions (CNVs). These CNVs include classical AZF deletions, gr/gr
deletion and TSPY1 CNV. AZF deletions are in a clear-cut cause-
effect relationship with spermatogenic failure and they also
have a prognostic value for testis biopsy. gr/gr deletion rep-
resents the unique example in andrology of a proven genetic
risk factor, providing an eight-fold increased risk for oligo-
zoospermia in the Italian population. Studies on TSPY1 CNV
have opened new perspectives on the role of this gene in sper-
matogenic efficiency. Although studies on the Y chromosome
have importantly contributed to the identification of new ge-
netic causes and thus to the improvement of the diagnostic
work-up for severe male factor infertility, there is still about
50% of infertile men in whom the etiology remains unknown.
While searching for new genetic factors on other chromosomes,
our work on the Y chromosome still needs to be completed,
with special focus on the biological function of the Y genes.
(J. Endocrinol. Invest. 34: 376-382, 2011)
©2011, Editrice Kurtis
INTRODUCTION
It has been known for many decades that the Y chromo-
some harbors the master gene for testis determination
(SRY) and the so called AZoospermia Factor (AZF) re-
gions, which contain genes involved in spermatogene-
sis. Structural anomalies, such as deletions and duplica-
tions of the AZF regions have been reported in associa-
tion with male infertility and the screening for Y chromo-
some microdeletions became part of the routine diag-
nostic work-up of men with severe spermatogenic im-
pairment (1). Recently, a role in spermatogenesis for a
multicopy gene family, the TSPY1 array, has also been
proposed and it has been demonstrated that TSPY1 copy
number influences spermatogenic efficiency.
In this review, we will discuss what is currently known
about clinically relevant Y chromosome structural varia-
tions in male fertility, with special attention to copy num-
ber variations (CNV).
CNVs ON THE HUMAN Y CHROMOSOME:
MECHANISM OF FORMATION
The Y chromosome is singular for its haploid nature which
precludes recombination with the X-chromosome for most
of its length. This has led to the consequent accumulation
of a high proportion of segmental duplications which pro-
vide the structural basis for the generation of CNVs (2, 3).
The presence of such duplicated sequences allows two
mechanisms to occur: a) gene conversion; b) non-allelic
homologous recombination (NAHR). The first is an unidi-
rectional conversion-based system of gene copy “correc-
tion” which permits the preservation of a certain number
of Y genes from the gradual accumulation of deleterious
mutations ensuring their continuity in time; on the other
hand, NAHR produces recurrent deletions/duplications af-
fecting the dosage of different Y genes (2, 4) (Fig. 1).
CNVs ON THE HUMAN Y CHROMOSOME:
WHO ARE THEY?
Y- chromosomal microdeletions: the AZF deletions
Microdeletions of the Y chromosome are themost frequent
known genetic cause of spermatogenic failure in infertile
men, second only to the Klinefelter syndrome (5). The first
association between azoospermia (absence of spermato-
zoa in the ejaculate) and microscopically detectable dele-
tions of the long arm of the Y chromosome (Yq) has been
demonstrated by Tiepolo and Zuffardi, in 1976 (6). They
proposed the existence of a spermatogenesis factor, the
AZF, encoded by a gene on distal Yq. With the develop-
ment of molecular genetic tools it became possible to cir-
cumscribe the AZF region, in which microdeletions arise,
and to highlight a certain deletion pattern with 3 recurrent-
ly deleted sub-regions in proximal, middle and distal Yq11,
designated AZFa, AZFb and AZFc, respectively (7, 8) (Fig. 2).
Type of clinically relevant AZF deletions
The AZFa region is 792 Kb long and contains 2 single
copy genes USP9Y and DDX3Y (former DBY) which are
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ubiquitously expressed. Complete AZFa deletions occur
after homologous recombination between identical se-
quence blocks within the retroviral sequences in the same
orientation HERVyq1 and HERVyq2 (9-11).
The complete deletion of AZFb is caused by homologous
recombination between the palindromes P5/proximal P1
which removes also part of the AZFc region belonging
to P1 (8). This deletion removes 6.2 Mb (including 32
copies of genes and transcription units). The AZFc region
includes 12 genes and transcription units, each present in
a variable number of copies making a total of 32 copies.
The complete deletion of AZFc removes 3.5 Mb, origi-
nates from the homologous recombination between am-
plicons b2 and b4 in palindromes P3 and P1, respective-
ly (12). Deletions of both AZFb and AZFc together occur
in 2 breakpoints between P4/distal P1 (7.0 Mb, 38 gene
copies removed) or between P5/distal P1 (7.7 Mb and 42
gene copies removed).
Clinical correlations of AZF deletions
The vast majority of complete AZF deletions are de no-
vo, although exceptional cases of transmission have
been reported and pertain uniquely the complete AZFc
deletion. However, “fertility” simply reflects that natu-
ral fertilization may occur even with relatively low sperm
counts depending on the female partner’s fertility sta-
tus. AZF deletions are specific for spermatogenic fail-
ure as no deletions have been reported in the genom-
ic DNA (derived from lymphocytes) of normozoosper-
mic men (13). AZF deletions are likely to occur in germ
cells during meiosis, when NAHR between sister chro-
matids may take place (Fig. 1). In order to investigate
whether a testicular mosaicism for AZF deletions exists,
we estimated the meiotic rate of AZFa deletions in 15
normozoospermic men. We found a meiotic deletion
rate varying between 0.4 and 4.7 × 10−5, implying that
in an ejaculate containing several millions of spermato-
zoa, those bearing AZF deletions are several thousands
(unpublished data).
Indications for AZF deletion screening are based on
sperm count since clinical parameters such as hormone
levels, testicular volume, varicocoele, maldescended
testis, infections, etc. do not have any predictive value
(14-16). The test is currently performed in all infertile men
with <5 millions/ml spermatozoa during the routine di-
agnostic work-up. The highest deletion frequency is
found in idiopathic azoospermic men (10%) who are more
likely to be carrier of genetic anomalies. AZF deletions
are less frequent in severe oligozoospermic men (2-5%)
and have been exceptionally reported in mild oligo-
zoospermic men. Since AZF genes are mainly expressed
in the testis, a number of studies have been undertaken
in order to clarify if AZF deletions may cause testis relat-
ed pathologies other than spermatogenic failure. No fi-
nal evidence for a cause-effect relationship was observed
with varicocele, cryptorchidism and testis cancer [for re-
view see (5) and references therein].
Apart from the diagnostic value, Yq deletion screening
provides additional prognostic information for testicular
biopsy (TESE) in azoospermic men. In fact, deletions re-
moving the entire AZFa or AZFb regions (“complete”
deletions) are associated with Sertoli cell only syndrome
(SCOS) and spermatogenic arrest, respectively, resulting
in the absence of mature spermatozoa in the testis.
Therefore, the presence of such deletions represents a
negative predictive factor for TESE and carriers are dis-
couraged from undergoing this invasive procedure (17,
18). Such a strict genotype/phenotype correlation is
lacking for both partial deletions of these regions (ex-
ceptionally rare events) and AZFc deletions, which are
associated with a semen phenotype varying from oligo-
zoospermia to azoospermia with different testis histol-
ogy. An azoospermic man with complete AZFc deletion
has an average chance of 50% for successful testicular
sperm retrieval. This variable phenotype might be due
to a progressive regression of the germinal epithelium
over time leading from oligozoospermia to azoosper-
mia. An alternative explanation for this phenotypic vari-
ability could be the influence of the genetic background
(i.e. compensation for the absence of Yq genes, by au-
tosomal or X-linked factors), the presence of 45, XO
lines (a more severe phenotype), and environmental fac-
tors in different individuals.
In case the deletion is found in a man undergoing ICSI
or TESE/ICSI, genetic counselling is mandatory in order
Fig. 1 - A) Representation of 2 sister chromatids on which the 4
arrows represent homologous sequences at the border of re-
currently deleted regions on the Yq [i.e. AZoospermia Factor
(AZF)a, AZFb, AZFc and gr/gr region). B) Schematic represen-
tation of the molecular mechanism responsible for dele-
tions/duplications involving the AZF regions: interchromatidic
non-allelic homologous Recombination (NAHR), occurring be-
tween homologous sequences orientated in the same direction.
C) Meiotic division of a spermatocyte gives origin to four sper-
matozoa: i) two bearing the X-chromosome (X); ii) two bearing
the Y chromosome. If NAHR between sister chromatids occurs
(see B), it will lead to a spermatozoon bearing: i) a Y chromo-
some with a duplication (Y+); ii) a Y chromosome with a dele-
tion (Y–).
A
Sister chromatids
Intermolecular NAHR
(interchromatid)
b* = recurrently
deleted regions
(AZF and
gr/gr regions)
Spermatocyte
B
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to provide information about the risk of giving birth to a
son with impaired spermatogenesis.
Diagnostic testing for AZF deletions
The diagnostic testing of Yq deletions should follow the
European Academy of Andrology (EAA)/European Mo-
lecular Genetics Quality Network (EMQN) guidelines (1).
The standard procedure is based on PCR amplification of
AZF specific STS primers and control markers. Although
alternative methods have been proposed (19), the use of
the method described in the guidelines is highly advised
for its high specificity and sensibility (detection of clini-
cally relevant deletions is close to 100%). It is worth not-
ing that the MSY sequence and the mechanism underly-
ing microdeletions have definitely established that a
fourth AZFd region postulated by Kent-First et al. (20)
and considered in a popular commercial kit does not ex-
ist.
Partial AZFc deletions and duplications
The AZFc region consists almost entirely of repetitive se-
quence blocks called ‘amplicons’ which are arranged in
direct and/or inverted repeats (12, 21). The region con-
tains multicopy genes expressed specifically in the testis
and their dosage may vary according to different types of
rearrangements.
The first AZFc candidate gene isolated from the AZFc re-
gion on the long arm of the human Y chromosome was
DAZ (Deleted in AZoospermia), which is specifically tran-
scribed in the adult testis (22). The DAZ gene belongs to
a gene family consisting of 3 members: BOULE on chro-
mosome 2, DAZ-Like (DAZL) on chromosome 3 and DAZ,
on the Yq. Members of this gene family are expressed
exclusively in germ cells and encode testis-specific RNA-
binding proteins that contain a highly conserved RNA-
Recognition Motif (RRM) and a unique DAZ repeat (23).
With regard to the reference sequence (corresponding
to a Y chromosome belonging to haplogroup R), DAZ is
present on the Y chromosome in 4 copies (DAZ1, DAZ2,
DAZ3, and DAZ4). The AZFc region also harbors CDY1,
present in 2 copies (CDY1a and CDY1b). CDY protein
products have been identified as histone acetyltrans-
ferases with a strong preference for histone 4 (24), thus
are likely to be involved in both spermatogenic histone
replacement and DNA transcription. Other genes in-
volved in AZFc deletions are BPY2, the function of which
is still unknown, and 5 transcription units TTTY3, TTTY4,
TTTY17, CSPG4LY, and GOLGA2LY.
Due to its structure, the AZFc region is particularly sus-
ceptible to NAHR events which may cause the formation
of both partial deletions or duplications and therefore al-
ter the AZFc gene dosage (Fig. 2). Although a number
of different partial AZFc deletions have been described,
only one of them resulted to be clinically relevant. This is
Fig. 2 - Schematic representation of
the Y chromosome showing different
regions/genes involved in sper-
matogenesis and Y-linked copy num-
ber variations. A) AZoospermia Fac-
tor (AZF)a, AZFb, and AZFc regions
are located on the long arm of the Y
chromosome (Yq) with an overlap
between AZFb and AZFc; the TSPY1
gene is present on the short arm of
the Y chromosome (Yp) arranged in a
tandemly repeated array. B) AZFc re-
gion showing the location of multi-
copy genes and transcription units in
the reference sequence (Y ha-
pogroup R). The arrows with the
same motifs represent repeated ho-
mologous sequences, which may un-
dergo NAHR. C) The “b2/b4” dele-
tion (complete AZFc deletion) re-
moving all AZFc genes is depicted.
Three alternative breakpoints for
gr/gr deletion(s) are shown which all
remove half of the AZFc gene con-
tent. An example of partial AZFc du-
plication (gr/gr) is shown (similarly to
the gr/gr deletion, different break-
points may give origin to different
types of gr/gr duplications).
A
B
C
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the “gr/gr” deletion, named after the fluorescent probes
(“green” and “red”) used when it was detected for the
first time (21). It removes half of the AZFc gene content,
including two DAZ copies, one CDY1 copy, and one
BPY2 copy. The clinical significance of the gr/gr deletion
has been the object of a long debate. Controversies are
mainly related to a number of selection biases (lack of
ethnic/geographic matching of cases and controls; inap-
propriate selection of infertile and control men) and
methodological issues (lack of confirmation of gene loss)
(25-27). Moreover, another potential confounding factor
derives from the fact that the frequency and phenotypic
expression may vary among different ethnic groups, on
the basis of the Y chromosome background; for exam-
ple, in specific Y haplogroups, such as D2b, Q3, and Q1,
common in Japan and certain areas of China, the dele-
tion is fixed and apparently does not have any negative
effect on spermatogenesis (28, 29). The presence of gr/gr
deletion in Caucasian normozoospermic controls (al-
though at a significantly lower frequency) prompted us
to evaluate whether the Y background could influence
the phenotypic variability in Caucasians, as well (30). It
has been previously described that the loss of
DAZ1/DAZ2 and CDY1 is prevalent (or even specific) in
carriers with impaired sperm production (31-33) while it
was hypothesized that the restoration of normal AZFc
gene dosage in case of gr/gr deletion followed by b2/b4
duplication may explain the lack of effect on sperm count
(22). Using a combined method based on gene dosage
and gene copy definition of DAZ and CDY1 genes (31),
we could identify 4 different subtypes of gr/gr deletions
characterized by the loss of different gene copies and
could assess the presence of deletion followed by dupli-
cation. Notwithstanding the detailed characterization of
subtypes of gr/gr deletions based on the type of miss-
ing gene copies and the detection of secondary rear-
rangements (deletion followed by b2/b4 duplication) to-
gether with the definition of Y haplogroups, it was im-
possible to define a specific pattern which would be as-
sociated with either a “neutral” or a “pathogenic” effect
(30). Moreover, we also demonstrated that the restora-
tion of normal gene dosage after secondary duplication
is not specific for normozoospermic men. However, it is
undeniable that the gr/gr deletion has some sort of ef-
fect even within the normal range of sperm count. It was
observed, indeed, that normozoospermic carriers have a
significantly lower sperm count, compared to men with
intact Y chromosome (25). In addition, Yang et al. (34) re-
ported that, in the Asian population, the deletion fre-
quency drastically decreases in subgroups with sperm
counts >50 millions spermatozoa/ml. More than 20 stud-
ies have been published during the last 7 years on this
topic. According to the largest study population pub-
lished to date on Caucasians (30), gr/gr deletion is sig-
nificantly more frequent among oligozoospermic men
(3.4%) compared to normozoospermic men (0.4%) and
gr/gr deletion carriers are at a 7.9-fold increased risk for
spermatogenic impairment [odds ratio (OR)=7.9 (95%
confidence interval 1.8-33.8]. As stated above, the het-
erogeneity of the study populations available in the lit-
erature thwarts the fulfillment of a reliable meta-analysis.
Nevertheless, despite multiple biases, 4 meta-analyses
have been attempted on this topic all achieving signifi-
cant OR reporting on average a 2-2.5-fold increase of risk
(25, 35, 36). The gr/gr deletion represents a unique ex-
ample of a significant risk factor for impaired sperm pro-
duction.
The screening for gr/gr deletion is based on a PCR
method described by Repping et al. (21). However, giv-
en a 5% false deletion rate detected in our multicenter
study (30), deletions should be confirmed by gene
dosage analysis.
The reasons why infertile men should undergo gr/gr dele-
tion testing are mainly two: a) the deletion contributes
to the etiopathogenesis of impaired sperm production
since it is able to influence significantly the spermato-
genic potential of the carrier; b) the couple should be
aware that the deletion (i.e. a genetic risk factor for im-
paired sperm production) will be obligatorily transmitted
to their male offspring and may become a complete AZFc
deletion (i.e. a clear-cut causative factor for spermato-
genic impairment) in the next generations (37, 38).
Since a detailed characterization of Y chromosomes be-
longing to different lineages found limited variation in
the copy number of Y-linked genes, it raised the possi-
bility of selective constraints (39). In this regard, about
90% of men carries four DAZ copies implying that a nor-
mal spermatogenesis requires an optimal copy number
and therefore both a reduction and an increase of AZFc
gene dosage may have a negative effect. This observa-
tion prompted two research groups to study the clini-
cal consequences of partial AZFc duplications (26, 40),
but they reached different conclusions, reporting an as-
sociation between increased AZFc gene dosage and
male infertility in the Han Chinese study and a lack of
effect in our Italian study population. Since this discor-
dance may reflect genuine ethnic differences, such as
those observed for the corresponding partial AZFc dele-
tions, if increased AZFc gene content is to play a role in
spermatogenic impairment, the effect will probably be
modulated by population specific factors. Further stud-
ies are needed to provide evidence to support this hy-
pothesis.
AZF gene-specific deletions
Despite the efforts of many laboratories, only 5 cases of
confirmed (after sequencing the breakpoints) isolated Yq
gene mutation have been reported to date (41). The rar-
ity of single AZF gene-specific mutations or deletions is
in sharp contrast with the relatively high frequency of AZF
deletions (described above) and this might be a conse-
quence of the peculiar organization of the Y chromo-
some, which makes it more prone to the loss of large por-
tions – such as the AZF region – rather than single genes.
The only reported isolated mutation occurs in the AZFa
region which contains two widely expressed genes,
USP9Y and DDX3Y (2). In the first place, sequencing of
the two genes in 576 patients brought to believe that the
loss of USP9Y had a direct effect on spermatogenesis,
causing azoospermia, whereas no mutation was found in
the DDX3Y gene (42). However, following findings re-
vealed that what seemed to be a definitive result turned
out to be just one of the possible phenotypes related to
USP9Y deletion. In fact, Luddi et al. (43) reported that
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this deletion has no effect on spermatogenesis and is
thus compatible with fertility. On the other hand, previous
studies (42, 44, 45) irrefutably demonstrate that the loss
of the gene disturbs spermatogenesis to different de-
grees and that natural transmission is possible in case of
a mild phenotype. Therefore, USP9Y has been proposed
as a fine spermatogenic modulator (44), the absence of
which is compatible with a highly variable phenotype
probably linked to the genetic or other background of
the carrier (41). Given the extreme rarity of AZF gene spe-
cific deletions and the heterogeneous phenotype of the
USPY9 deletion, the routine screening for AZF gene spe-
cific deletions is not advised.
TSPY1 array
During the last years, Y-linked CNV analyses have been
extended to the short arm of the Y chromosome which
contains a TSPY1 gene array with variable number of
TSPY1 copies (46, 47 and references therein). The TSPY1
belongs to a protein superfamily comprising SET and
NAP, which are activating factors of the replication pro-
cess. Indeed, TSPY1 is abundantly expressed in early
stages of tumorigenesis in gonadoblastoma and could
be potentially involved in other human cancers (48). Ex-
pression analysis in the testis indicates the involvement of
the TSPY1 in spermatogenesis as a pro-proliferative fac-
tor (48). In fact, TSPY1 is mainly expressed in gono-
cytes/pre-spermatogonia of embryonic testis and in sper-
matogonia and spermatocytes at meiotic prophase I in
adult testis. A role in early fetal germ cells development
has also been addressed by Schoner et al. (49) who pro-
vided evidence of TSPY1 ability to partially rescue sper-
matogenesis and fertility in transgenic KitW-v/KitW-v mice.
TSPY1 is unusual in being arranged in a tandem array of
20.4 Kb of repeated units, bearing a single active TSPY1
copy each (Fig. 2). Although copy number varies among
individuals within a range of 11 to 76 (26, 46, 50, 51), the
majority of men (about 65% of the Italian population) re-
main within a restricted interval (21 to 35 copies) (46).
The evolutionary conservation of multiple TSPY1 copies
on the Y chromosome of other mammals as well as the
above mentioned limited variation in copy number in hu-
mans suggest that a minimum TSPY1 copy number is like-
ly to be maintained through selection (52). Only few stud-
ies have focused on the eventual TSPY1 influence on
spermatogenesis and frustratingly they all reached 3 dif-
ferent conclusions, probably due to study design biases
(46, 50, 51). Indeed, crucial for a reliable analysis is the
TSPY1 CNV susceptibility to stratification biases. As a
matter of fact, significantly different means of TSPY1 copy
number were found among different Y haplogroups (46,
53), highlighting the importance of Y haplogroups-match-
ing between cases and controls. The only available study
to date in which cases and controls were matched for Y
hgr distribution has been performed in the Italian popu-
lation by our group. The method used for the detection
of TSPY1 copy number was validated against pulsed-field
gel electrophoresis (the gold standard method) (46). The
initially published study population has been recently en-
larged and previous results confirmed i.e. a significantly
lower TSPY1 copy number in 212 infertile men with ab-
normal sperm parameters compared to 168 normo-
zoospermic subjects (28.5±7.9 vs 32.6±10.1, respective-
ly; p<0.001) has been found. The relevance of TSPY1
CNV in spermatogenesis is also attested by the positive
correlation observed with sperm count both in infertile
and normozoospermic subjects (Fig. 3). In the light of
these findings, low TSPY1 copy number can be regarded
as a new genetic risk factor for male infertility with po-
tential clinical consequences and should be taken into
consideration in the context of a multigenic approach to
idiopathic infertility.
CONCLUSIVE REMARKS
The pivotal role of the Y chromosome in spermatogen-
esis is supported by the presence of Y-linked genes
specifically expressed in germ cells and by pathologi-
cal phenotypes deriving from the deletion of regions
containing the genes mentioned above. Although Y
studies have importantly contributed to the identifica-
tion of new genetic factors in male infertility and thus
to the improvement of the diagnostic work-up of severe
male factor infertility, there are still many unsolved is-
sues. Among them the most relevant are: a) the lack of
knowledge about the exact function of AZF gene prod-
ucts; b) the correlation, if existing, between TSPY1 copy
number and its level of expression; c) lack of information
about the consequences of AZFc gene dosage varia-
tion on mRNA involved in spermatogenesis and even-
tually in embryogenesis. It is also unknown whether the
“fragility” of the Y chromosome is a marker for general
“genomic instability” potentially affecting the general
health status of the Y deletion carrier. In this regard,
gr/gr deletion has been reported as a risk factor also
for testicular germ cell tumors, but data need further
confirmation (54). Beside the Y chromosome-linked
genes, several thousands autosomal and X-linked genes
are predicted to play a role in the complex process of
spermatogenesis. The two sex chromosomes share
common features, in particular the peculiar repeated
structure containing a number of multicopy gene fami-
lies with testis specific expression. Therefore, we expect
that similarly to the Y chromosome, also X-linked CNV
Fig. 3 - Scatter plots between TSPY1 copy number and total
sperm count in normozoospermic controls. Spearman’s correla-
tion coefficient (Rho) =0.179; p=0.021.
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would affect gene dosage and thus be responsible for
a portion of severe male factor infertility. Then, it seems
high time to stop focusing only on the Y chromosome
rearrangements and to start shifting our attention also
on its partner, the X chromosome.
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 Abstract  Modern society is witnessing a widespread tendency to postpone 
parenthood due to a number of socioeconomic factors. This ever-increasing trend 
relates to both women and men and raises many concerns about the risks and con-
sequences lying beneath the natural process of aging. The negative infl uence of the 
advanced maternal age has been thoroughly demonstrated, while the paternal age has 
attracted comparatively less attention. A problematic issue of defi ning whether advanced 
paternal age can be considered an independent risk factor, not only for a man’s fertility 
but also for the offspring’s health, is represented by the diffi culty, linked to reproductive 
studies, in characterizing the impact of maternal and paternal age, separately. Researchers 
are now trying to overcome this obstacle by directly analyzing the male germ cell , and 
emerging data prove this sperm-specifi c approach to be a valid tool for providing novel 
insights on the effects of aging on the spermatozoa and, thus, on the reproductive out-
come of an aging male. The purpose of this chapter is to summarize most of what is 
known about the relationship between male aging and changes in the spermatozoa, giv-
ing special focus on the events occurring with age at the genomic level. 
 Keywords  Aging male •  Spermatozoa  • Genomic anomalies 
 Introduction 
 History provides fascinating episodes of men fathering children at very old ages. 
In 1935, a 94-year-old man was the oldest age-of-paternity case reported by a sci-
entifi c publication (Seymour et al.  1935 ). Other examples of greatly aged fathers 
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have appeared more recently, such as that of two Indian farmers, Nanu Ram Jogi, 
who fathered his twenty-fi rst child at age 91 in 2007, and Ramjit Raghav, who 
became the world’s oldest dad, giving birth to his fi rst child at the age of 94. 
 Beyond anecdotal curiosity, it is interesting to note that in industrialized countries 
delayed parenthood is becoming an increasingly widespread social phenomenon. 
Many factors account for this trend, but referring to literature citations increasing 
life expectancy, economic stability, and career ambitions represent the most relevant 
issues for parenthood postponement, raising not a few concerns about age- associated 
risks and consequences. Indeed, the process of aging can be ascribed to a number of 
endogenous and environmental factors inducing DNA damage. 
 As demonstrated by epidemiological data, the last decades saw a considerable 
increase in the mean age of childbearing mothers, refl ecting for women a birth rate 
shift toward 35 years of age and older. A similar tendency shows up in the paternity 
rate, which has been continuously rising since 1980, in parallel with a decrement of 
paternity among men between 25 and 29 years old (Martin et al.  2007 ). In fact, the 
percentage of men fathering children over 35 years old has been markedly rising 
from 15 % to 25 % during the last 40 years, as has the number of men aged between 
50 and 54 desiring to conceive children (Fisch  2009 ). In line with these data, a rise 
in the number of fathers over 60 is predicted to happen over the next 10–20 years 
(US Census Bureau 2005). 
 The effect of delayed motherhood has been studied to such an extent that it is 
now possible to acknowledge advanced maternal age as the most important risk 
factor for infertility, spontaneous abortions, and genetic defects among offspring. 
Only lately has male age attracted more attention in this regard, but whether a 
comparable age-dependent effect also exists for delayed fatherhood remains to be 
fully elucidated. There is suggestive epidemiological evidence that paternal age 
correlates with an increased incidence of abnormal reproductive outcomes and 
heritable defects (Tarin et al.  1998 ; de la Rochebrochard and Thonneau  2002 ), 
including several types of genomic modifi cation. In particular, there is growing 
evidence that advancing male age is associated with an increased frequency of 
certain genetic and chromosomal defects in spermatozoa (Crow  2000 ; Shi and 
Martin  2000 ; Tiemann- Boege et al.  2002 ; Bosch et al.  2003 ; Sloter et al.  2004 ). 
The last-named authors prove that the male germ cell  represents a direct target of 
study for a straightforward identifi cation of merely paternal risk factors, overcom-
ing the diffi culty, often present in reproductive studies, in distinguishing between 
the impact of maternal and paternal ages. Nevertheless, it is as yet impossible to 
even defi ne a general consensus of what can be considered  advanced paternal age, 
although some studies and the precautionary measures taken for sperm donations des-
tined for assisted conception advise a threshold of 40 years old (de la Rochebrochard 
et al.  2003 ). 
 This chapter aims at summarizing data available on male age-related effects in 
spermatozoa, describing with specifi c focus how the sperm genome can be modifi ed 
during meiosis of aging men. 
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 Chromosomal Alterations in the Aging Male 
 Chromosomal aberrations were among the fi rst observed manifestations of decreased 
genome integrity with age. Studies comprising chromosomal analyses from human 
peripheral blood lymphocytes corroborate these observations, demonstrating that 
the occurrence of various genomic changes (i.e., aneuploidies, translocations, acen-
tric fragments, chromosomal loss, micronuclei formation) increases linearly with 
the age of the individuals (Sloter et al.  2004 ). In light of these data, concerns have 
arisen that certain types of chromosomal alterations may increase with age in male 
germ cells as well. 
 Aneuploidies 
 In humans, aneuploidies represent the most common heritable chromosomal 
anomaly, with approximately 0.3 % of infants born with an altered number of 
chromosomes (Hassold  2001 ). This genomic rearrangement derives mainly from 
nondisjunction during meiotic divisions [both meiosis I (MI) and meiosis II (MII)] 
and its primary reproductive consequence is spontaneous abortion. Analyses on 
fetal material retrieved from abortuses show that 60 % of all aneuploidies consist 
in 45, XO monosomy and trisomies of chromosomes 16, 21, and 22 (Hassold 
 2001 ). A subset of aneuploidies involving sex chromosomes as well as trisomies 
13, 21, and 18 make it to birth and lead to typical developmental and morphologi-
cal defects. 
 Several studies proved maternal age to be a risk factor for trisomy formation, 
although the nature of such a relationship is not unequivocally defi nable: in fact, the 
effect of maternal age is differently exerted among chromosomes, increasing either 
linearly (e.g., trisomy 16) or exponentially (e.g., trisomy 21). The characterization 
of such an age-dependent connection for individual trisomies has not progressed 
much for men due to the relatively low number of trisomy cases determined to be 
paternally derived. Moreover, whether paternal age is associated with the generation 
of aneuploidies is still controversial due to the paucity of data available on the affected 
offspring because most abnormal embryos are lost and because studies performed so 
far were limited by the diffi culty in separating paternal from maternal effects (Wiener-
Megnazi et al.  2012 ). Cytogenetic data from human oocytes, fertilized eggs, preim-
plantation embryos, and spermatozoa allowed to compensate for the issue of 
discriminating the pure paternal effect. The approach of targeting solely the germ cell 
genome , extracting parent-specifi c information, indicates that most constitutional 
aneuploidies are generated de novo during parental meiosis. 
 The fi rst data about the chromosomal content of human spermatozoa date back 
to 1978 and derive from the insemination of hamster eggs with human spermatozoa, 
a cytogenetic method known as the hamster-egg penetration test (Rudak et al.  1978 ). 
2 Genomic Changes in Spermatozoa of the Aging Male
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This study showed that 2–3% of spermatozoa from normal men carried an aneuploid 
karyotype. Other large hamster-egg studies followed, but an effect of the donor’s 
age on the rate of aneuploidies was not found (Estop et al.  1995 ; Brandriff et al. 
 1988 ); this was probably due to a bias related to the study population, which 
included only a few men aged over 40 years old. Finally, two more studies based on 
the same method reached divergent conclusions: in one, a signifi cantly negative cor-
relation was found between the rate of aneuploidy and the donor’s age (Martin and 
Rademaker  1987 ), while in the other study the authors observed a signifi cantly 
higher incidence of hyperploid spermatozoa from a comparison between seven old 
donors (aged between 59 and 74 years old) and fi ve young donors (aged between 23 
and 39 years old) (Sartorelli et al.  2001 ). 
 In the early 1990s, fl uorescent in situ hybridization (FISH) replaced the hamster- 
egg method for the detection of sperm aneuploidy, introducing the advantage of a 
quicker labour- and cost-saving analysis of greater amounts of spermatozoa. With 
regard to sperm autosomal aneuploidies, FISH data show modest evidence for a 
paternal age effect. One study (Martin et al.  1995 ) reported an increase with age in 
disomy 1 in the spermatozoa of men aged from 21 to 52 years old, although none of 
the following studies confi rmed their result. Another study found a signifi cant cor-
relation between a decreased incidence of chromosome 18 sperm disomy and 
increased age (Robbins et al.  1997 ). In contrast, studies on chromosome 21 sperm 
disomy all converge on the independence of such a rearrangement from men’s age, 
with the exception of only one small study (Rousseaux et al.  1998 ) in which the 
authors found that advanced age correlated with a higher incidence of sperm 
disomy 21. 
 A different scenario is offered by FISH studies on sex chromosomes, for which 
more distinct  evidence exists for an age-related increase in aneuploidies in male 
germ cells. In the literature, 11 sperm FISH studies are available on the effects of 
paternal age on the frequency of aneuploidy formation within spermatic X and Y 
chromosomes, and only 2 reached a negative conclusion with respect to the age–
aneuploidy link. The rest provide evidence that errors in MI and MII are more likely 
to occur with the advancement of age. As for nondisjunctions in both MI and MII, 
the literature reports a general positive paternal age effect by which men aged over 
50 have about a two- to threefold higher risk of carrying spermatozoa with a 24, XY 
karyotype as a consequence of MI errors (Guttenbach et al.  2000 ; Bosch et al.  2001 ; 
Asada et al.  2000 ; Griffi n et al.  1995 ; Lowe et al.  2001 ) and a two to threefold higher 
frequency of producing X or Y disomic spermatozoa as a consequence of MII errors 
(Kinakin et al.  1997 ; Martin et al.  1995 ; Robbins et al.  1997 ; Rubes et al.  1998 ). 
 Multiprobe FISH analyses have proven their utility in the detection of sperm 
diploidy, the incidence of which in association with paternal aging is still controver-
sial. For instance, the literature offers a number of studies reporting an age-related 
increase of the frequency of diploid sperm in older men compared to younger men 
with about a twofold increased risk. However, several other studies do not reach the 
same conclusion because they report no association between sperm disomy formation 
and advanced paternal age (Sloter et al.  2004 ). 
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 Structural Aberrations 
 Although the incidence of structural chromosomal abnormalities is lower compared 
to aneuploidies at birth (0.25 % versus 0.33 %, respectively) (Hassold  1998 ), a 
study based on chromosome heteromorphisms fi rst estimated that 80 % of such de 
novo rearrangements are of paternal origin (Olson and Magenis  1988 ). These data 
were supported by subsequent fi ndings on paternally derived aberrations. Thomas 
et al. observed a paternal derivation of de novo unbalanced structural chromosomal 
abnormalities detectable by light microscopy, with 84 % interstitial deletions and 
58 % duplications and rings (Thomas et al.  2006 ). Even more recently, de novo 
microdeletions associated with de novo reciprocal translocations as well as cases of 
complex chromosomal rearrangements were determined to be paternally derived in 
all cases. Likewise, array comparative genomic hybridization (aCGH) analyses 
helped in determining that all de novo deletions identifi ed in men carrying balanced 
translocations and abnormal phenotypes derived from the fathers (Baptista et al. 
 2008 ). Other studies reported that both a recurrent de novo translocation, i.e., t(11;22), 
and nonrecurrent balanced reciprocal translocations were almost entirely of paternal 
origin, with 100 % for the former and 96 % for the latter being inherited from the 
fathers (Kurahashi et al.  2009 ; Ohye et al.  2010 ; Thomas et al.  2012 ). 
 Concerning the aging male, the literature provides confl icting evidence of a 
paternal age effect for structural rearrangements. The incongruence emerges 
between case studies noting that structural aberrations spontaneously occur in children 
conceived by older fathers and population-based studies in which such a correlation 
does not appear to be real (Sloter et al.  2004 ). Although the paternal contribution 
still seems rather high, information on structural aberrations in human male gametes 
is still scarce. This is partly due to the overall lower occurrence of such rearrange-
ments among live births that render the paternal effect enormously complicated to 
defi ne. However, the mounting development of assays that allow the detection of 
structural chromosomal aberrations directly within spermatozoa represents an 
important incentive for the evaluation of those factors, such as age, that will poten-
tially increase the formation rate of anomalies in a man’s sperm population. 
 The fi rst clue of a relationship between the incidence of structural aberrations in 
male germ cells and paternal age comes from rodent studies. There is consistent 
evidence that structural aberrations in rodent spermatozoa increase with age, 
although the pre- and postmeiotic spermatogenetic compartments seem differently 
affected, with late-step spermatids, and not primary spermatocytes, showing a 
greater fold increase in the frequency of abnormalities between old and young mice 
(Pacchierotti et al.  1983 ). These data are supported by two micronucleus assays 
(Allen et al.  1996 ; Lowe et al.  1995 ) focusing on the age effect on the frequency of 
aberrations in round spermatids of mice and hamsters, respectively, and both leading 
to the conclusion that older animals have a signifi cantly higher frequency of unstable 
aberrations in their spermatids compared to young animals. 
 Concerning human semen, the hamster-egg method in the fi rst instance revealed 
itself as a relevant tool for the detection of spermatozoa bearing structural 
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chromosomal abnormalities such as unrejoined breaks and acentric fragments, of 
which 75 % resulted in unstable aberrations. The examination of 1,582 sperm 
chromosomal complements from 30 fertile men divided into six age groups ranging 
from 20 to 24 years to older than 45 years reported a fourfold increase in the total 
structural chromosomal abnormalities for older men (Martin and Rademaker  1987 ). 
The reanalysis of these data by Sloter et al. ( 2004 ) demonstrates that this effect is 
mainly due to the signifi cant increase in chromosomal breaks, but not in acentric 
fragments, indicating the greater susceptibility to aging of postmeiotic DNA-repair- free 
spermatids. Another human-sperm/hamster-egg study (Sartorelli et al.  2001 ), 
including several men between 59 and 74 years old, reported a signifi cantly higher 
frequency of acentric fragments and of complex radial fi gures in sperm comple-
ments of older donors compared to younger donors. 
 Notwithstanding its importance in producing the aforementioned results, the 
hamster-egg method is ineffi cient to measure  the frequency of deletions and dupli-
cations as well as of the so-called stable rearrangements, i.e., translocations, inver-
sions, insertions, isochromosomes, small deletions, and small duplications, in the 
spermatozoa and thus has been replaced by the FISH strategy. An age-related effect 
was observed for the frequency of centromeric deletions of chromosome 1 in a cohort 
of 18 men aged 20–58 years old (McInnes et al.  1998 ); likewise, a signifi cant 
age-related increase was reported for the frequency of spermatozoa with duplications 
and deletions at the centromeric and subtelomeric regions of chromosome 9 in a 
cohort of 18 men aged 24–74 years old (Bosch et al.  2003 ). Another FISH- based 
analysis demonstrated a signifi cant increase in the frequency of spermatozoa carrying 
breaks and segmental duplications and deletions of chromosome 1 among older men 
compared to younger men. In particular, older men showed twice the frequency of 
segmental duplications and deletions in chromosome 1 in their spermatozoa. 
Similarly, the researchers found a signifi cant age-related increase in the frequency 
of spermatozoa carrying breaks within the 1q12 fragile-site region that was almost 
doubled in older men (Sloter et al.  2007 ). A more recent study based on a multi-
color, multichromosome FISH strategy was performed on the semen of ten male 
donors 23–74 years old and found that older patients had a higher rate of structural 
abnormalities (6.6 %) compared to younger men (4.9 %); interestingly, although 
both duplications and deletions occurred more frequently in older men, an excess of 
duplications versus deletions was observed in both groups. In addition, the authors 
demonstrated a nonlinear distribution of duplications and deletions along the chro-
mosomes and observed an inclination toward a higher susceptibility to rearrange-
ments in larger chromosomes (Templado et al.  2011 ). 
 Overall, both human and animal studies suggest that the increased trend of delaying 
fatherhood could predict an augmented risk of delivering offspring liable to pater-
nally derived genetic diseases resulting from chromosomal aneuploidies or structural 
aberrations, assuming that spermatozoa bearing such rearrangements are as capable 
of fertilizing as normal spermatozoa. However, animal models provide evidence for 
a paternal age effect mostly on chromosomal breaks, duplications, and deletions 
rather than chromosomal numeric alterations. Along these lines, duplications appear 
to occur more frequently than deletions, suggesting a mitotic rather than meiotic 
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origin for some of these sperm de novo abnormalities. As for stable rearrangements, 
it has been hypothesized that they would originate during spermatogenic mitotic 
divisions or during meiosis. 
 Doubtlessly, further research is needed to identify whether there are specifi c 
environmental or paternal host factors that are associated with paternally transmis-
sible chromosomal abnormalities. Another fascinating challenge is posed by the 
lack of knowledge about whether there exist specifi c types of chromosomal abnor-
malities that are produced at a specifi c stage of germ cell production, the relative 
contribution that spermatogenetic mechanisms might exert on the development of 
chromosomal aberrations, and how both processes are affected by age. 
 Sperm DNA Damage 
 What makes DNA damage an extensively investigated topic is the irreplaceable 
nature of the DNA molecule. Vital information about cellular content and function 
is sheltered in the DNA, rendering it a crucial target for age-related degeneration. 
For instance, damage in the DNA can cause cell cycle arrest, cell death, or mutations 
the accumulation of which may lead to deregulation of transcription pathways, 
reduced fi tness, and, ultimately, the aging phenotype. In spermatozoa, DNA damage 
could show up in the form of DNA fragmentation, abnormal chromatin packaging, 
and protamine defi ciency potentially leading to cell impairment, and a number of 
studies have contributed to our understanding of whether an association with male 
aging exists. Higher levels of double-stranded DNA breaks were reported in older 
men (Singh et al.  2003 ), and a gradual age-related upward trend has been proposed 
for DNA fragmentation (Wyrobek et al.  2006 ) since the DNA fragmentation index 
(DFI) more than doubled in men between 20 and 60 years old. As for DNA frag-
mentation, data in the literature are not completely homogeneous concerning its 
relationship with paternal age, but there is undeniable ever-increasing evidence for 
a DFI augment with advancing age (Belloc et al.  2009 ; Plastira et al.  2007 ; Schmid 
et al.  2012 ; Vagnini et al.  2007 ). 
 In the myriad of DNA changes that occur as a consequence of aging, several 
theories collocate oxidative stress among those mechanisms predicted to play a 
causal role. Similarly to somatic cells, the continuous generation of reactive oxygen 
species (ROSs) produces oxidative damage, especially in spermatozoa, because of 
their high content of polyunsaturated fatty acid in the cell membrane (Aitken and 
Krausz  2001 ). Since ROSs production is likely to increase with age, it is plausible 
to hypothesize that, in men of advanced age, growing oxidative stress might be 
responsible for the age-related augment in sperm DNA damage. Moreover, changes 
in the effi ciency of mismatch repair, base excision repair, nucleotide excision repair, 
and double-strand break repair mechanisms might endure the effect of aging and 
present themselves as cofactors in age-infl icted DNA damage. In conclusion, pater-
nal age does indeed appear to be an additional factor that is positively correlated 
with an increase in DNA damage in spermatozoa deriving from men of both fertile 
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and infertile couples (Sartorius and Nieschlag  2010 ). Clearly, further research 
should be conducted to better defi ne not only the nature but also the mechanisms 
underlying age-related changes in DNA and the extent of the damage  that could be 
consequently produced. 
 Effect of Father’s Age on Disease Risk 
 It is now fully recognized that children born from older parents are exposed to a 
much higher risk of having genetic disorders. This has been extensively proven for 
women delivering children at advanced ages, as witnessed by the strong maternal 
age effect for Down syndrome. However, there is an ever-growing evidence that 
paternal age also confers to offspring a susceptibility to a broad range of conditions, 
including spontaneous dominant disorders, congenital anomalies, neurological 
diseases (i.e., schizophrenia and autism), and some types of childhood cancers. 
 De Novo Mutation Rate in Male Gametes 
 Paternal aging is considered the major cause of new mutations in human popula-
tions (Crow  1999 ). Indeed, it is common knowledge that male germ cells undergo 
continuous cell divisions, which clearly accumulate with age, consequently lead-
ing to an accelerated mutation rate in spermatozoa. This could be due to several 
mechanisms, the fi rst of which are the alterations of age-sensitive processes such 
as DNA replication and repair (Crow  2000 ). Moreover, the accumulation of 
mutagens from either external or internal sources, which would certainly increase 
with age, might also contribute to the increased occurrence of DNA replication 
inaccuracy. 
 Information available on de novo mutation rates mainly derives from studies in 
which the direct examination of parent-to-child transmission is limited to testing 
specifi c genes or regions, whereas the innovative whole-genome, sequencing-based 
studies are still inadequate to address this question. A recent study by Kong et al. 
addressed this issue by performing an estimate of the genome-wide mutation rate 
by sequencing the entire genomes of 78 parent-offspring trios (Kong et al.  2012 ). 
In particular, they focused on single nucleotide polymorphisms (SNPs), showing 
that the transmission of mutations to children is mainly due to fathers, and this 
behavior seemed closely linked to the paternal age. Considering that in this study 
the father’s average age was 29.7 years old, the mean of the de novo mutation rate 
of SNPs was 1.20 × 10 –8 per nucleotide per generation (Kong et al.  2012 ). This effect 
increased with the father’s age (approximately two mutations per year), and the risk 
that children carrying harmful mutations, which could potentially lead to pathological 
conditions, increased proportionally. 
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 Although in some circumstances the evidence for an association with advanced 
paternal age is not always consistent and reproducible, this is not the case for a 
small group of conditions known as paternal age effect (PAE) disorders, of which 
Apert syndrome and achondroplasia are considered the best representative exam-
ples. PAE disorders include some other disorders due to specifi c mutations in the 
fi broblastic growth factor receptor (FGFR) genes: mutations in FGFR2 cause Apert, 
Crouzon, and Pfeiffer syndromes, mutations in FGFR3 cause achondroplasia, than-
atophoric dysplasia, hypochondroplasia, and Muenke syndrome. All these condi-
tions are caused by substitution: transition/transversion at CpG dinucleotides or 
transition/transversion at non-CpG dinucleotides at key points within the growth 
factor receptor-RAS signaling pathway. These syndromes are characterized by 
autosomal dominant transmission; 1:30,000/130,000 birth prevalence for new muta-
tions; paternal origin of mutations; strong paternal age effect; and a high apparent 
germ line mutation rate. Apert syndrome is a form of acrocephalosyndactyly, char-
acterized by malformations of the skull, face, hands, and feet. In most cases there 
are two different mutations in the germ line occurring in the FGFR2 gene: C to G at 
position 755, and C to G at position 758, which cause, respectively, a serine to tryp-
tophan and a proline to arginine change in the protein (Wilkie et al.  1995 ). 
Achondroplasia is a common cause of dwarfi sm, and more than 99 % of the cases 
are caused by two different mutations in the FGFR3 gene. In about 98 % of the 
cases, a G to A point mutation at nucleotide 1138 of the FGFR3 gene causes a 
glycine- to-arginine substitution (Rousseau et al.  1996 ) and a G to C point mutation 
at nucleotide 1138 causes about 1 % of cases. These point mutations originate from 
unaffected fathers, suggesting that these events take place in the spermatogonial 
stem cells during spermatogenesis. The common explanation for these effects is the 
copy-error hypothesis, which postulates an accumulation of recurrent mutations in 
specifi c DNA hotspots. Although this process may play a specifi c role, alone it 
cannot explain these paternal age effects (Goriely and Wilkie  2012 ). Using a new 
polymerase chain reaction approach, it was possible to reveal that, although the 
mutational events in Apert syndrome are rare, when they take place, they become 
enriched because the encoded mutant proteins confer a selective advantage on sper-
matogonial cells, originating the so-called protein-driven  selfi sh selection (Goriely 
et al.  2005 ). This mechanism is better known for somatic mutations that occur 
during neoplasia rather than in germ line diseases. In fact, if the same mutations that 
take place in PAE disorders occurred in somatic cells, they would lead to neoplasia: 
755C > G and 758C > G substitutions in the FGFR2 gene defi ne endometrial cancer, 
and 1138G > A and 1138G > C in the FGFR3 gene cause bladder cancer (Goriely 
and Wilkie  2012 ). Thus, it is important to consider that these mutational events may 
lead to both a specifi c syndrome and an oncogenetic process. 
 In conclusion, what are the long-term consequences of selfi sh selection? It seems 
that with age, spermatozoa of all men are progressively enriched with PAE muta-
tions , even though PAE disorders fortunately have a low reproductive fi tness; con-
versely, other mutations that defi ne mild syndromes can be transmitted over many 
generations, representing a contribution to genetic variability. 
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 Telomeres: The Bright Side of Aging 
 Telomeres are specifi c DNA sequences enclosing a number of (TTAGGG) n repeats 
located at the ends of all chromosomes. Although their function is not yet fully 
established, it is widely known that telomeres are involved in the protection of chro-
mosomes from fusion, recombination, and degradation. In many tissues, telomere 
length (TL) is shortened by successive cell divisions, and consequently it tends to 
progressively diminish with age. Therefore, TL changes are believed to be impli-
cated in cell senescence and aging as well as tumorigenesis and DNA repair (De 
Meyer et al.  2007 ; Unryn et al.  2005 ). Consistent with this, elderly people, whose 
leukocytes display shorter telomeres due to their advanced age, are presumably sub-
jected to a higher morbidity and reduced life expectancy. 
 Although it is well known that TL reduces with age in most proliferating tis-
sues, spermatozoa represent the exception to the rule. For instance, there is sub-
stantial evidence that sperm TL dynamics follows a fascinating divergent trajectory 
that entails the elongation of sperm telomeres with age (Aston et al.  2012 ; Baird 
et al.  2006 ; Kimura et al.  2008 ). This notion provides a completely novel facet of 
the effects that might be exerted by paternal age and demonstrates that sometimes 
clouds do have a silver lining. In fact, emerging data provide growing evidence that 
older fathers will transmit to their offspring longer leukocyte telomeres (Arbeev 
et al.  2011 ; De Meyer et al.  2007 ; Unryn et al.  2005 ). In addition, a recent study 
performed on delayed human reproduction found that such an association between 
paternal age and offspring’s TL is cumulative across multiple generations since the 
paternal grandfather’s age predicts longer telomeres in grandchildren at their 
father’s birth ( p = 0.038) (Eisenberg et al.  2012 ). The most common explanation for 
telomere lengthening among offspring of older fathers is the high telomerase activ-
ity in the testes (Baird et al.  2006 ; Kimura et al.  2008 ). Aston et al. ( 2012 ) suggest 
that sperm TL elongation is dependent on an overactivation of telomerase in male 
germ cells, leading to TL lengthening at every replication cycle (estimated 
value = 2.48 bp/replication). However, it remains to be defi ned why testicular 
telomerase would lead to the progressive lengthening of sperm telomeres rather 
than just maintain a stable length. Kimura et al. ( 2008 ) proposed that testicular 
telomerase exerts a preferential effect on long telomeres. This might depend on 
the fact that spermatozoa displaying short telomeres undergo a negative selection 
that with age progressively leads to their disproportional extinction (Kimura 
et al.  2008 ). 
 In light of these data, telomere lengthening might be considered the bright 
side of aging because delayed fatherhood would not only imply negative conse-
quences, but could also confer positive traits to future generations conceived by 
aged fathers such as higher survival and lower risk of developing TL-related 
diseases. 
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 Conclusions 
 Human aging includes a number of time-related processes occurring throughout 
adult life that guide a wide range of physiological changes that increase an indi-
vidual’s vulnerability to death and weaken normal functions and intensify one’s 
susceptibility to a number of diseases. The ever-spreading phenomenon of postpon-
ing parenthood till older ages represents one of the multiple aspects of the aging 
process, given the recognition of advanced parental age effects. 
 While extensive evidence has proven maternal age to be a major and independent 
negative factor for fertility, the effects of paternal age remain poorly understood. 
However, there is growing evidence that advanced paternal age correlates with a 
number of complications, and 40 years old has been proposed as the “amber light ” in 
a man’s reproductive life. Reproductive studies suggest that male aging does not 
affect a couple’s fecundity as an independent factor but that its effects manifest them-
selves in combination with maternal age or in the presence of altered spermatogen-
esis. This information might depend on the diffi culty in discriminating paternal from 
maternal age effects, implying the need to direct further research straight to the male 
germ cells . This sperm-specifi c approach helped to defi ne a pure paternal age effect 
on a multitude of issues discussed throughout this chapter (Fig. 2.1 ). Current data in 
the literature suggest that the spermatozoa of aged men apparently more frequently 
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 Fig. 2.1  Graphical summary of various consequences reportedly derived from the process of 
aging in the male gamete 
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undergo age-related modifi cations, potentially leading to various consequences. The 
occurrence of such alterations in male germ cells has rather important implications 
because any damage to reproductive cells might produce permanent effects not only on 
the fertility status of the questioned patient but also on the health and viability of the 
offspring, with potential consequences on the fi tness of future generations.
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